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ABSTRACT
One of the most important parts of the nitrogen cycle is nitrogen fixation.
We present a computational investigation into two aspects of nitrogen fix-
ation: (1) For the mechanism of nitrogenase action in K. pneumoniae, we
present the full Thorneley and Lowe model developed from the literature
with clarifications and corrections in SBML. Additionally, we perform an
analysis of the rate-limiting step and protein ratio in this mechanism. This
shows The ratio of proteins plays key role in ammonia production and it
decrease the sensitivity of the system to the dissociation constant (k−3, rate
limiting state). (2) We study the genetic regulation of nitrogen fixation in
A. vinelandii and K. pneumoniae. To take into account the module-like
behavior of the NifL−NifA system in response to environmental signals,
we broke the system up into a set of subsystems including the NifL−NifA
system in oxidized conditions, the 2− oxoglutarate system, and the GlnK
system. Computational studies of these three systems reveal some of the
characteristics of the NifL−NifA system in various environmental condi-
tions including (a) oxygen increases the affinity of NifL to interact with
NifA 10 fold (b) in contrast to biochemical knowledge that stoichiometric
amount of NifA and NifL is available in the system the ratio of NifL to
NifA had to be approximately 2 for satisfactory simulations of the system (c)
GlnK is a master regulator in the NifL−NifA system, forming an on and
off binary system. Finally, we present abstract models of nitrogen fixation
in A. vinelandii and K. pneumoniae based on current understanding of
these systems. Comparison of these two models showed that A. vinelandii
has a more sensitive system to the availability of fixed nitrogen and responds
faster than K. pneumoniae to environmental conditions. Moreover both
models were able to oscillate.
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PREFACE
my ph .d. years
This thesis is the result of almost four years of hard effort at the University of
East Anglia and the John Innes Centre. In the course of my MSc dissertation
on bioinformatics I became involved for some time in a systems biology
project that I initiated based on my desire to learn this subject area and my
interest in nitrogen fixation. I made up my mind to undertake a Ph.D. in the
systems biology. Although this was new for my supervisors, we initiated a
plan to study this complex system in silico.
I enjoyed this exciting project, as it demanded the initiation of new direc-
tions, motivation, and hard work. In addition, my student life for the last
four years has been highly challenging. Although the studentship converted
a ’mission impossible’ into a mission possible, it covered only tuition fees so
I had to find a way to obtain the rest of my living costs. Gratefully, I was
offered a part-time job as a support bioinformatician at the John Innes Centre
(20 hours a week). Even though being a full-time Ph.D. student as well as
working 20 hours a week is demanding, my inspiration and motivation for
my Ph.D. helped me to make progress and finish my thesis.
project evolution
We started this project with no prior systems biology knowledge about
nitrogen fixation. Furthermore, the complexity of the system and the avail-
ability of data were also not clear. Hence I started by literature review of
nitrogen fixation and discussing the system with experts to extract relevant
knowledge and data. The initial aim was set to investigate full nitrogen fixa-
tion in A. vinelandii in dynamical conditions. We attempted to model the
complete system, however, the complexity of nitrogen fixation and lack of
experimental data resulted in an uninformative dynamic model. Meanwhile,
I was offered the possibility to work on a related side project concerning the
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mechanism of nitrogenase action by David J Lowe, head of computational
systems biology at the John Innes Centre at that time. He had developed
a pre-steady a state kinetic model of nitrogenase action in 1984, although
the model was not available due to technical issues. The aim of the side
project was to explore systems biology tools for an example system which
is relevant to nitrogen fixation, and also to make Lowe’s full model of the
system available for the scientific community in the system biology markup
language (SBML).
As my understanding of the relevant tools and nitrogen fixation developed,
closer inspection concerning the availability of data, the complexity, and the
behavior of the NifL−NifA system in response to different environmental
signals suggested breaking it down into a more manageable set of sub
systems and to investigating the sub systems in steady state conditions
instead of dynamical modelling. Modelling the sub systems in steady state
revealed some of the characteristics of nitrogen fixation. Finally, the extracted
knowledge from modelling the sub systems, the complexity of the complete
system, and our experience in first attempt in modelling nitrogen fixation in
dynamical conditions allowed me to develop a dynamic regulation model of
nitrogen fixation at an abstract level which allowed us to uncover properties
of the nitrogen fixation and to reduce the complexity of our model.
presentation
This thesis consists of seven chapters. In Chapter 1 we review the relevant
biological literature, which covers the regulation of the NifL−NifA system
in A. vinelandii, the mechanism of nitrogenase action, and theNifL−NifA
regulatory system in K. pneumoniae. It is followed in Chapter 2 by an
overview of current computational methods in systems biology including
kinetics modelling, the dynamics of transcription, simulation methodologies,
and finally a brief description of structural analysis of systems. It also
includes a brief description of state of the art systems biology tools.
Chapter 3 is a small part of this thesis in which we present an SBML
model of nitrogenase action. The remaining part deals with the main topic
of the PhD work, the NifL−NifA regulatory system. We start by modelling
the smallest sub systems of the NifL−NifA system (Chapter 4). Then we
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extend these sub systems to larger systems (Chapter 5). Chapter 6 puts all
the bits and pieces of the last two chapters together, resulting in an abstract
model of nitrogen fixation in A. vinelandii and K. pneumoniae. Finally, in
Chapter 7 we presents a brief conclusion.
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Part I
BACKGROUND AND METHODOLOGY

1
INTRODUCTION
The main source of nitrogen is atmospheric N2, which comprises approxi-
mately 78% of the atmosphere. The process representing the transformation
of nitrogen in nature is called the nitrogen cycle [5, 20]. Nitrogen cycle
processes include assimilation, ammonification, nitrification, denitrification,
anaerobic ammonium oxidation, and nitrogen fixation. Figure 1 presents a
schematic overview of the nitrogen cycle.
One of the most important parts of the nitrogen cycle is nitrogen fixation,
since usable nitrogen is a limiting nutrient for living organisms. Nitrogen
fixation is the conversion of dinitrogen, N2, to ammonia, NH3, which is
usable for living organisms (Figure 1, r1). Plants are able to absorb ammonia,
nitrites, and nitrates from the soil and produce protein in the assimilation
process (r2). Animals do not have the enzyme required for catalyzing ni-
trogen fixation and consume plants as a source of nitrogen. Animals and
plants can be decomposed in an ammonification process by decomposers,
which results in the release of ammonia back into the environment (r3). Soil
ammonia converts to nitrites in a process called nitrification by nitrifying
bacteria (r4). Nitrites, which are useable for plants, can be converted to
nitrates by nitrifying bacteria (r5). Finally, nitrites return to the atmosphere
through conversion to N2 by denitrifying bacteria in the denitrification pro-
cess (r6) [5, 20]. In anaerobic ammonium oxidation, nitrite and ammonium
are converted directly into atmospheric N2 (r7).
Although atmospheric nitrogen is abundant, it is not easily accessible
since it requires the breakage of one of the strongest covalent bonds in
nature [94, 77]. One of the most important recent challenges of agriculture
is feeding the growing global population that is anticipated to be 8 billion
by the year 2020 [78, 4, 93]. The increasing demand for crops will extend
the use of nitrogen-based fertilizers dramatically, though this requires a
considerable amount of world energy. In contrast to industrial nitrogen
fixation, biological nitrogen fixation is catalyzed by the enzyme nitrogenase
in some microorganisms with no cost to world economics [6, 34, 28, 73]. As
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nitrogen is often the limiting nutrient for the growth of plants, industry has
invested in converting the relatively inert dinitrogen to the more accessible
form of ammonia, NH3. The Haber-Bosch process produces in the order
of 100 million tons of industrial fertilizer each year, which contributes to
sustaining around 40% of the world population [25, 83, 81]. This process
requires temperatures of about 400 ◦C and pressures of around 400 bar,
consuming approximately 1% of the world’s annual energy supply. In the
light of huge energy resources, the far-reaching environmental issues relating
to fertilizers [64], and especially for biofuels and crop productivity [84], the
process of biological nitrogen fixation is of prime importance and will remain
a focus of research for a long time [47, 71].
 


  









Figure 1: An overview of the nitrogen cycle. See main text for more details.
1.1 nitrogen fixation
Biological nitrogen fixation [98, 28, 35] is performed by a number of different
prokaryotes, including bacteria and actinobacteria, collectively known as
diazotrophs and archaea. It does not occur in eukaryotes. The main charac-
teristic of diazotrophic prokaryotes is the ability to utilize N2 as a source of
nitrogen for growth. Diazotrophic bacteria have very similar enzyme systems
to each other for fixing nitrogen. While most of diazotrophs are free-living
bacteria, some diazotrophs form symbiotic associations with plants, supply-
ing fixed nitrogen for plants. The availability of carbon and energy sources,
levels of oxygen, and presence of fixed nitrogen are environmental factors
that affect nitrogen fixation in free-living diazotrophs. Consequently, the
contribution of free-living diazotrophs to the nitrogen input for agriculture
depends on the availability of an energy source in their ecosystems [13, 73].
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Klebsiella pneumoniae is a common gram-negative bacterium, which
has been well studied among the diazotrophs [14]. K. pneumoniae is clini-
cally important as it is usually found in the intestine, on the skin, and in the
normal flora of the mouth, and it can cause infections. It has a close relation
to some well-studied bacteria such as Escherichia coli and Salmonella
typhimurium.
Azotobacter vinelandii is a free-living nitrogen-fixing bacterium, which
is an aerobic soil bacterium [14]. A. vinelandii is of interest to scientists
because it can fix nitrogen under aerobic conditions, conferring considerable
energetic benefits, and is capable of synthesizing three different nitrogenase
enzymes. A.vinelandii has a very high respiratory rate which generates
extra ATP, required to support the high-energy demands of nitrogenase
[15, 12, 60]. In addition to these capabilities, A. vinelandii is able to grow in
a variety of organic acids, alcohols, or carbohydrates. Although other bacteria
are able to fix nitrogen, there are some major differences between them and
A. vinelandii. It can fix nitrogen, and unlike others the fixation can occur
under high ambient oxygen tension. In this research work, nitrogen fixation
by A. vinelandii is the main topic because of these unique characteristics
[15].
There are two important aspects of nitrogen fixation; the mechanism of the
nitrogenase enzyme, catalyzing nitrogen fixation, and the genetic regulation
of nitrogen fixation, which is modulated by two key regulatory proteins,
NifA andNifL. In the following sections we review these aspects of nitrogen
fixation. K. pneumoniae is the focus of our work for the nitrogenase aspect
and A. vinelandii for genetic regulation.
1.2 nitrogenase
A family of enzymes known as nitrogenase (EC 1.18.6.1) catalyze bio-
logical nitrogen fixation [16, 32]. Nitrogenase contains two components,
which are named based on their constituent metals. The nitrogenase cofac-
tors may contain vanadium, V; molybdenum, Mo; or iron, Fe. There are
three types of nitrogenase systems available based on their cofactors; the
molybdenum- nitrogenase, the vanadium-nitrogenase, and the iron only
system. K. pneumoniae has a Mo-nitrogenase system. It consists of two oxy-
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gen sensitive metalloproteins, an iron (Fe) protein and a molybdenum-iron
(MoFe) protein [72, 11]. The vanadium-nitrogenase system has two compo-
nents. It has a Fe protein which is the same as other nitogenase systems
and the second component is a vanadium-iron (VFe) containing protein
which is different than two other systems. This type of nitrogenase has been
detected in A. vinelandii and A.chroococcum [13]. Vanadium-nitrogenase
has a very similar amino acid sequence to the molybdenum-nitrogenase.
The third type of nitrogenase, iron only, contains an iron (Fe) protein and
another protein, which is very similar to MoFe protein and VFe protein,
while it has only Fe as its cofactor [13]. This type of protein has also been
detected in A. vinelandii nitrogenase.
Nitrogenase has some unique characteristics, which distinguish it from
some other enzymes. It is highly sensitive to oxygen, and is degraded by
the reaction of oxygen within the iron component. The high sensitivity
of the enzyme to oxygen means the nitrogen-fixing bacteria need some
protection mechanism to prevent the degradation. Furthermore, the turnover
time of the enzyme is relatively slow, therefore, the organism needs to
synthesize large quantities of nitrogenase [10]. Nitrogenase also requires
considerable amounts of energy for catalyzing nitrogen fixation. In the
following sections we present the properties of the Fe protein, the MoFe
protein, and finally the mechanism of nitrogenase action. With regards
to K. pneumoniae nitrogenase, in the following sections we review the
molybdenum- nitrogenase system.
1.2.1 The Fe protein
The smaller component of nitrogenase is the Fe protein, which acts as a
redox-active agent and transfers electrons to the MoFe protein for reduction
of substrates from available electron donor in the system. Although this
transfer of electrons is the main function of the Fe protein, it has some other
functions. The Fe protein is needed for initial biosynthesis of the MoFe
cofactor. Following the biosynthesis of MoFe cofactor, the insertion of the
preformed MoFe cofactor into the MoFe protein requires the Fe protein [3].
The Fe protein is ATP-dependant and hydrolyses MgATP using the acquired
energy to transfer electrons to the MoFe protein. It has two identical subunits.
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The Fe protein of nitrogenase contains one iron sulfur cluster [4Fe-4S], which
bridges the two subunits. The oxidation state of the Fe protein can vary
through the iron sulfur cluster. The Fe protein has one MgATP binding site
in each subunit that binds to two MgATP molecules. Binding of MgATP to
the Fe protein induces conformational changes, which facilitate the electron
transfer from the Fe protein to the MoFe protein.
1.2.2 The MoFe protein
The larger component of nitrogenase is the MoFe protein, which is a α2β2
tetramer, containing two αβ dimer subunits. Each dimer contains one MoFe
cofactor and one P-cluster, [8Fe-7S]. The MoFe cofactor is located in the
active site of the protein where the reduction of substrates occurs. The
main role of the P-cluster is electron transfer by accepting an electron from
the Fe protein and donating it to the MoFe cofactor. The αβ dimeric units
communicate and contact each other through their β subunits [3]. The P
cluster bridges between each α and β subunit while the MoFe cofactor is
placed on the α subunits.
1.2.3 The mechanism of nitrogenase action
As described above, nitrogenase comprises two proteins, the Fe protein
and the MoFe protein. The MoFe protein contains a site where electrons
accumulate for substrate reduction. In order to pull the nitrogen atoms
away from each other in a dinitrogen molecule, a triple bond must be
broken, i.e. sufficient energy is required to break all three-paired orbitals.
Nitrogenase accomplishes this by accumulating electrons and breaking each
bond individually. The Fe protein and MoFe proteins form the Fe protein-
MoFe complex to catalyze the substrates. The nitrogenase complex contains
one MoFe protein in the middle and two Fe proteins at each side. The overall
behavior of nitrogenase is to transfer an electron from the Fe protein to the
MoFe protein and reduction of the substrate. The process starts from the
nucleotide binding sites in the Fe proteins and goes through the [4Fe-4S]
cluster which transfers an electron to the P cluster and finally from the
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P cluster to the MoFe cofactor side which is the active side of protein for
substrate reduction.
In 1984 Thorneley and Lowe presented a scheme based on kinetic stopped-
flow measurements, describing the nitrogenase N2 turnover cycle [56, 91, 57,
92]. The reaction mechanism of nitrogenase can be separated into two nested
cycles; the full cycle of N2 being reduced, which requires eight electrons
and the Fe-protein cycle which provides these electrons one at a time. Each
Fe protein cycle delivers one electron and the MoFe protein cycle is the full
cycle of the dinitrogen reduction. The delivery of electron is coupled to the
hydrolysis of two MgATP molecules which provides energy for electron
delivery. The Fe cycle occurs eight times to provide eight electrons which
catalyze the reduction of N2 to NH3. In vitro, nitrogenase activity requires
the interaction of the two protein components, a low-potential source of
electrons, MgATP and a substrate [90, 89, 85, 36, 17, 29]. The Fe protein
binds two MgATPs and, with dithionite as reductant, carries out functions
using the redox couple to transfer one electron to the MoFe protein and the
hydrolysis of two MgATPs [34]. The Fe protein cycle comprises (1) the Fe
protein-MoFe protein complex formation, (2) MgATP hydrolysis and electron
transfer which cause the Fe protein to be in an oxidised form with MgADP
and the MoFe protein to be in reduction state, (3) complex dissociation, and
finally, (4) nucleotide replacement and the Fe protein reduction.
Thorneley and Lowe introduced the MoFe protein cycle to understand the
kinetics of the nitrogenase action. In the MoFe protein cycle the electrons
and protons are transferred to one-half of MoFe protein. Binding of substrate
to the MoFe protein occurs after transfer of 3-4 electrons to the MoFe protein.
The MoFe protein cycle presents the full mechanism of nitrogenase actions
and the main conclusions of Thorneley and Lowe were that 1) the cycle is
controlled by the electron donation of the Fe-protein cycle, 2) protons and
electrons are added one-by-one to the MoFe-protein, 3) N2 binds after the
protein has been reduced by 3-4 electrons below the dithionite-reduced level
[3, 56, 91, 57, 92].
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1.3 the nifl-nifa regulatory system in a.vinelandii
Biological nitrogen fixation is regulated at the transcriptional level in re-
sponse to multiple environmental signals. The availability of fixed nitrogen,
free oxygen, and provision of sufficient energy are three important factors
in the regulation of nitrogen fixation [31, 54, 8, 74]. The nitrogen, redox, and
energy status regulate the activation of nitrogen fixation genes, nif. Nitrogen
fixation is energetically very expensive for microorganisms and the source
of energy has to be provided for this high-energy consuming process. In ad-
dition, the availability of fixed nitrogen controls the synthesis of nitrogenase
at the transcriptional level [10]. The other regulatory component is oxygen.
The presence of oxygen regulates nitrogen fixation at the transcriptional
level. The regulation of nitrogen fixation varies between microorganisms.
In the following section we review the regulation of nitrogen fixation in A.
vinelandii.
1.3.1 Physiology and genetic regulation of nitrogen fixation
As mentioned before nitrogen fixation imposes a considerable energy re-
quirement for bacteria. Two ATP molecules are hydrolyzed per electron
transfer in each Fe protein cycle. Moreover, the turnover time of nitroge-
nase is relatively slow forcing the nitrogen-fixing bacteria to synthesize
large amounts of nitrogenase, up to 20% of total cell proteins [10]. There-
fore, concentration of nitrogenase is regulated at the transcriptional level
in response to the availability of fixed nitrogen. The oxygen sensitivity of
nitrogenase causes diazotrophs to use different physiological strategies for
protection of nitrogenase from oxygen. The consumption of excess oxygen
by respiration, compartmentation of nitrogenase, the presence of an oxygen
diffusion barrier, conformational protection of the enzyme, and avoidance of
oxygen through anaerobic growth are some of the physiological protection
mechanisms in diazotrophs. From those strategies, A. vinelandii uses a
high rate of respiration and production of the oxygen-stable enzyme by
binding the enzyme to a protective protein [10, 15, 12, 60].
There are a number of proteins involved in nitrogen fixation which are
encoded by nif genes. NifL and NifA are two regulatory proteins of the
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nitrogen fixation system. NifA is a transcription activator protein, which
activates nif genes and NifL is an anti-activator protein, which inactivates
NifA by direct protein-protein interaction. In the following sections we
discuss the regulation of nitrogen fixation by NifA and NifL. Figure 2
presents a very simplified cartoon of the NifL−NifA system. It shows the
regulators and key components of the system. The elements which promote
the formation of the NifL−NifA complex have a negative effect on nitrogen
fixation, and the components, which enable NifA to escape from a complex,
have a positive effect on nitrogen fixation. In this regard, oxygen, GlnK, and
ADP act as negative regulators of nitrogen fixation and 2− oxoglutarate
acts as the positive regulator.
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Figure 2: Basic cartoon of the NifL−NifA system. It shows how the system moves
from "No Fixation" to "Fixation" in response to regulators. NifA and NifL
are indicated in blue when active and in red when passive. The regulators,
ADP, GlnK, and O2 (in red) represent inhibition and 2− oxoglutarate
(in blue) represents activation.
1.3.2 Regulation of nitrogen fixation by NifA
NifA protein belongs to the family of proteins called enhancer binding
proteins (EBP) which bind to upstream activator sequences and activate
transcription of nif genes by interacting with the RNA polymerase sigma
factor, σ54. EBPs comprise three domains; a regulatory N-terminal domain,
a catalytic domain which interacts with σ54 RNA polymerase, and a C-
terminal DNA binding domain. In the NifA protein, these domains are
called; the GAF domain (37-178), Sigma-54 factor interaction domain (211-
439), and C-terminal DNA-binding domain (480-522). GAF domains are
small-molecule binding domains and very widespread among regulatory
proteins in all kingdoms of life. The N-terminal GAF domain of NifA is
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required for interacting with another regulatory protein, NifL [60]. The cen-
tral domain of NifA belongs to the AAA+ super-family of ATPase (ATPase
associated with different cellular activities). The forming of a ring-shape
oligomer is an important characteristic of AAA+ proteins for their ATPase
activities [65]. The GAF domain of NifA interacts with the central domain of
NifL in order to regulate its ATPase activity. The C-terminal DNA-binding
domain encodes a helix-turn-helix motif structure that binds to the upstream
activator sequences.
1.3.3 The NifL-NifA complex
NifL is an anti activator of nitrogen fixation which works by prohibiting
the activation of transcription of nif genes through a direct protein-protein
interaction with NifA. It is a regulatory flavoprotein, which has FAD as
the prosthetic group, implying that NifL is redox-sensitive [31]. It inhibits
NifA in response to environmental oxygen and fixed nitrogen. NifL in
A. vinelandii has three main domains: the N-terminal sensory domain,
glutamine rich sequence providing a Q linker to the C-terminal kinase
like domain. The N-terminal of NifL has two PAS domains, PAS1 and
PAS2. The PAS1 domain has FAD and is responsible for the redox-sensing
function of NifL. The function of PAS2 is not completely known. The C-
terminal region of NifL belongs to the GHKL super family, which contains a
HATPase_c domain. ATP-binding proteins such as histidine kinases contain
this type of domain. The C-terminal region of the NifL does not have ATP
hydrolyse activity although it is needed for NifL−NifA interaction [30].
The C-terminal domain of NifL interacts with the catalytic domain of NifA.
The requirement for stoichiometric amounts of NifA and NifL for in-
hibition of NifA activity, indicates that the interaction between NifA and
NifL is not a catalytic interaction (Figure 3). The central domain of NifA
is responsible for transcriptional activation and NifL contacts the central
domain of NifA to suppress the transcription activation by inhibiting its
catalytic function [63] .
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Figure 3: Cartoon of NifL−NifA complex and inhibition mechanism including
free NifA and NifA in complex with NifL.
1.3.4 ADP stimulation of NifL
NifL in the reduced form does not show any inhibitory activity on NifA.
But In the presence of ADP and ATP even the reduced form of NifL shows
the inhibitory activity. The C-terminal domain of NifL protein can bind
ADP and ATP. Its affinity for ADP is 10 fold higher than ATP [60, 63]. This
binding creates a conformational change in the protein, which allows NifL
to interact with the central domain of NifA inhibiting the activity of NifA.
1.3.5 NifA binding to 2-oxoglutarate
2−oxoglutarate is a component of the citric acid cycle. It is a key metabolic
signal of the carbon and nitrogen status. It is also part of the ammonia
assimilation pathway that reflects the nitrogen status. The amino terminal
GAF domain of NifA has the capacity to bind to 2− oxoglutarate in order
to regulate nitrogen fixation in response to carbon. 2− oxoglutarate acts
as an activator of NifA, and binds to NifA in the NifL−NifA complex to
promote dissociation of the complex. Dissociation of the complex provides
free NifA to activate transcription of nif genes.
1.3.6 Oxygen sensing
Apart from the physiological protection of nitrogenase under oxidizing
conditions, A. vinelandii regulates the system at the transcriptional level
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by using the strategy of not wasting energy to transcribe nitrogenase, since
the nitrogenase enzyme is very sensitive to oxygen. NifL is a redox-sensitive
protein, and its oxidised form, inhibits the activity of NifA. In the oxidized
condition the prosthetic group of NifL, FAD, is oxidized and makes the
conformational change in NifL that facilitates the interaction of this protein
with NifA. This facilitation promotes the formation of the NifL −NifA
complex, which inactivates the transcription of nif genes [9, 60].
1.3.7 Nitrogen regulation
The PII signal transduction proteins are important proteins found in bac-
teria, which communicate and integrate the status of intracellular fixed
nitrogen and carbon to regulate nitrogen fixation. The signal for the status
of fixed nitrogen is glutamine, which regulates the uridylylation state of
PII protein. Uridylylation of the PII signal transduction protein alters its
conformation, thereby changing the interaction with its target. GlnK is a PII
signal transduction protein in A. vinelandii that regulates nitrogen fixation
with respect to nitrogen status. The non-uridylylated form of GlnK interacts
with NifL to inhibit the activity of NifA, while the uridylylated form of
GlnK cannot interact with NifL. The formation of the GlnK- NifL- NifA
complex inhibits the activity of NifA.
In addition to GlnK, A. vinelandii contains GlnD, which regulates ni-
trogen fixation through GlnK modification. The key signal of the nitrogen
status is the intracellular concentration of glutamine [10]. Under conditions
of fixed nitrogen sufficiency, the concentration of glutamine is high and
under conditions of limited fixed nitrogen, the concentration of glutamine
is relatively low. Sensing the amount of fixed nitrogen through the con-
centration of glutamine is integrated by GlnD followed by adjusting the
state of GlnK, which can be in two states: the uridylylated form or the
non-uridylylated form. The uridylylated form contains uridine monophos-
phate (UMP) covalently attached to GlnK. The uridylylated form of GlnK,
is not able to stimulate the formation of the NifL−NifA complex. GlnD
uridlylates GlnK at low concentrations of glutamine when the system is
in limited fixed nitrogen conditions. When the glutamine concentration is
high, GlnD is not able to uridylylate GlnK. Consequently, in conditions of
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fixed nitrogen sufficiency, GlnK prohibits the transcription of the nif genes.
In this chapter we analyze the system under conditions of fixed nitrogen
sufficiency.
1.3.8 The NifL-NifA system
In summary, the three important factors for A. vinelandii which lead the or-
ganism to have a highly regulatory system are high sensitivity of nitrogenase
to oxygen, high-energy demands of nitrogen fixation, and a low turnover rate
of nitrogenase that leads A. vinelandii to produce considerable amounts of
nitrogenase.
We divided the NifL−NifA system into four biological meaningful sub-
systems to overcome the complexity of the complete NifL−NifA system
(See Figure 4). The main sub-systems are NifA and NifL interaction, the 2−
oxoglutarate system, the NifL−NifA system in oxic conditions, and the
GlnK system. Furthermore, we investigated the effect of these sub-systems
on the dynamics of nif genes transcription. Figure 4 presents a simplified
model of the NifL−NifA system. Spiral A in Figure 4 shows the NifA
and NifL interaction and effect of 2− oxoglutarate on the NifL−NifA
complex. This part of the system has been named the 2− oxoglutarate
system. Spiral B presents the system in oxic conditions. The system is
extended to include GlnK is in Spiral C. Finally Spiral D represents the
dynamics of nif transcription in response to interaction of the modules.
Under the fixed nitrogen limitation conditions, A. vinelandii responds
to the nitrogen status and stimulates the transcription of nif genes through
activating NifA. In this condition the NifL−NifA system responds to 2−
oxoglutarate. Experimental evidence shows the relief of inhibition of NifA
in the presence of 2− oxoglutarate [53]. Interaction of 2− oxoglutarate
with NifA dissociates the complex between NifA and NifL. This relief of
inhibition has also been observed when ADP is available in the system
[53, 60, 10].
The physiological concentration of 2− oxoglutarate is about 100 µM
under the carbon limiting and nitrogen excess conditions. It increases to 1
mM under conditions of carbon availability and nitrogen limitation. This
increase in 2− oxoglutarate, increases the binding of 2− oxoglutarate to
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Figure 4: Abstract scheme of the NifL−NifA system. The empty square represents
the direction to the product of a reaction. ’OX’ represents the oxidized
form of the protein and ’e’ represents the reduced form. This figure
presents how the system reacts to various conditions. The scheme has
been categorized into four spirals to modulate the system. NifL−NifA
interaction and the 2 − oxoglutarate system is presented in Spiral A.
Spiral B is the system in oxidized condition and Spiral C summarizes
the GlnK system. Spiral D indicates how all these interaction modulate
transcription.
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NifA to prevent inhibition by NifL and also disassociates the complex of
NifL−NifA to provide the active form of NifA. The non-uridylylated form
of GlnK can promote the ternary complex of GlnK- NifL- NifA, even in
the presence of 2− oxoglutarate, but under the fixed nitrogen limitation
conditions, GlnK is mainly in its uridylylated form and cannot inactivate
NifA [60].
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Figure 5: An overview of the NifL−NifA system under the nitrogen excess and
nitrogen limitation conditions. Under nitrogen excess conditions the non-
uridylylated form of GlnK promotes the formation of NifL−NifA com-
plex. Under nitrogen limited conditions GlnK is converted to uridylylated
form and cannot promote the formation of the NifL −NifA complex,
while 2− oxoglutarate (2OG) promotes the dissociation of the complex.
Under nitrogen excess conditions, A. vinelandii does not fix nitrogen.
Under these conditions GlnK stimulates inhibitory activity of NifL. Under
conditions of fixed-nitrogen limitation the GlnK is mainly in the uridylylated
form and it cannot interact with NifL while in nitrogen excess conditions
it is in the non-uridylylated form and it can interact with NifL [9, 60, 53].
The complex of NifA-NifL-GlnK prevents the activation of transcription by
inhibiting NifA, even in the presence of 2− oxoglutarate and ATP.
NifL is in the reduced form provided that bacterium respires oxygen.
Under oxic conditions, NifL is oxidized rapidly to NifLox. The oxidized
form of NifL readily interacts with NifA to prevent the activation of nif
genes. The inhibitory activity of NifL is high in oxic conditions, even in
presence of 2− oxoglutarate, and it has a high affinity to interact with
NifA to form the NifL−NifA complex. Unlike reducing conditions, NifL
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does not need to interact with ADP in oxic conditions to interact with NifA.
This is the strategy that A. vinelandii produces to regulate nitrogen fixation
at the transcriptional level in oxic conditions.
1.4 the nifl-nifa regulatory system in k.pneumoniae
The nitrogen fixation regulatory system in K. pneumoniae has a similar
set of proteins to A. vinelandii. In this section the system in both species
will be compared. However, full details of the NifL−NifA system in K.
pneumoniae are not considered. NifA and NifL are the two main proteins
regulating of nitrogen fixation in K. pneumoniae. NifA and NifL act in K.
pneumoniae in a similar manner to A. vinelandii.
There are two major differences in the regulatory mechanism of the
NifL −NifA system related to nitrogen status between K. pneumoniae
and A. vinelandii. Firstly, transcription of the glnk gene is not subject to
nitrogen regulation in A. vinelandiiwhile it is subject to nitrogen regulation
in K. pneumoniae. Furthermore, the transcription of nifa and nifl is also
subject to nitrogen regulation. Therefore, the transcription of glnk, nifa,
and nifl genes decreases under the conditions of excess fixed nitrogen
in K. pneumoniae. Secondly, K. pneumoniae GlnK acts in an opposite
way to A. vinelandii GlnK. The non-uridylylated form of GlnK promotes
dissociation of the NifL−NifA complex in K. pneumoniae.
In summary, in K. pneumoniae under excess fixed nitrogen conditions,
the transcription of glnk, nifa, and nifl genes are decreased and NifA is
incorporated within the NifL−NifA complex when the concentration of
GlnK is low and there is not enough GlnK to promote the dissociation of this
complex. Under the limited fixed nitrogen conditions, the transcription of
glnk increases as the transcription of nifa and nifl genes increase; therefore,
GlnK activates nitrogen fixation by promotion of the dissociation of the
NifL−NifA complex.

2
COMPUTATIONAL TOOLS AND TECHNIQUES
Systems biology is a new and rapidly expanding field that aims at under-
standing biological systems at the systems level. Modelling can be used
to describe and help to understand a biological system of interest (such
as a metabolic pathway, gene regulation, protein-protein interactions, cell
signalling, or cell cycle systems) in a precise way. The aim of modelling
varies based on the requirement of each system, the availability of data,
and the question one wishes to answer. The basic aim of modelling is to
describe a specific system in a comprehensive manner, translate a hypothesis
into a mathematical model, then make it clearer, confirm or reject it, and
extend it to explain new data. Testing and analyzing the system to check for
consistent behavior with observed experimental results is crucial. Following
the determination of a consistent model, it is desirable to be able to do
virtual experiments, which would be time-consuming, very difficult, very
expensive or even impossible to do in the lab. Finally, pooling a number of
well-defined and related systems together to describe a larger model and
investigating the interaction between the models components should be
considered as a goal of systems biology. In this chapter, we summarize some
of the key modelling techniques that we used in this thesis and also give an
overview of some computational techniques that one can use to modelling
the biological systems.
2.1 reaction kinetics
Kinetics is the study of reaction rates of chemical reactions. The generation
of mathematical equations to describe the rates of reactions is the first step,
followed by their solution leading to a kinetic model for a set of reactions.
The aim of kinetic modelling is to analyze and predict system dynamics
based on the kinetic parameters. A kinetic model can be used for hypothesis
testing and also compared to experimental observations. Knowledge can
45
46 computational tools and techniques
be extracted leading to a better understanding of the system and it can
guide the direction of future experiments. Setting the rate equations of the
reactions in complex systems is an important task in this type of modelling.
In the following sections some of these rate equations are reviewed [82, 19].
2.1.1 The law of mass action
Mass action rate laws describe the rate of reactions in elementary steps
where one or more reactants react to form products. This law describes the
rate of change of any component in the system that is proportional to the
number of molecules of those components. The mass action equations can
be used for reactions where no intermediates are formed in a single reaction
step and with a single transition state[18]. Consider the following reactions
for chemical entities x1 to x7:
x1 + x2
k+1⇀↽
k−1
x3, (2.1)
x3 + x4
k+2⇀↽
k−2
x5, (2.2)
x4 + x6
k+3⇀↽
k−3
x7. (2.3)
In these equations, ki and k−i (for i=1, 2, 3) denote the forward and
backward rates of reaction. The rate of each reaction, v, is equal to the
forward rate constant multiplied by concentration of the reactants minus the
backward rate constant multiplied by the concentration of the products. The
following equations give the rates of reactions 2.1, 2.2, and 2.3:
v1 = k1x1x2 − k−1x3,
v2 = k2x3x4 − k−2x5,
v3 = k3x4x6 + k−3x7.
From the reaction rates the rate of change of each component of the system
can be determined. The reactants have a negative rate on the corresponding
reaction as long as they are being used and the products of reactions have a
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positive rate on the corresponding reaction since they are being produced.
The reactants and products can be involved in more than one reaction and
the rates of all corresponding reactions have to be added. The following
equations are a system of ordinary differential equations, which model the
rate of change of all components of 2.1,2.2, and 2.3 for all components in the
system:
x˙1 = −k1x1x2 + k−1x3,
x˙2 = −k1x1x2 + k−1x3,
x˙3 = k1x1x2 − k−1x3 − k2x3x4 + k−2x5,
x˙4 = −k2x3x4 + k−2x5 − k3x4x6 + k−3x7,
x˙5 = k2x3x4 − k−2x5,
x˙6 = −k3x4x6 + k−3x7,
x˙7 = −k3x4x6 + k−3x7.
The law of mass action can be used to translate a set of chemical or
biochemical reactions in this way into a set of mathematical equations for
further analysis. The above methodology was used to form the mathematical
equations in most cases in this thesis.
2.1.2 Michaelis-Menten kinetics
Enzymes are proteins which catalyze chemical reactions in biological sys-
tems. The Michaelis-Menten equation describes the rate of the enzymatic
reactions, and it relates the rate of enzymatic reaction to substrate concen-
tration [19]. We now recall how this equation is derived. The process starts
from the binding of a substrate (S) onto an active site of an enzyme (E). This
binding produces the enzyme-substrate (E-S) complex. The E-S complex
turns into the product (P) and enzyme (E) in an irreversible reaction. The
following reactions represent the whole process of S to P catalysis [82]:
E+ S
k+1⇀↽
k−1
ES
k+2⇀ E+ P.
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Under the steady state assumption that the rate of the formation of the ES
complex equals the rate of its dissociation we have
vformation = k1 · E · S,
vdissociation = k−1 · ES+ k+2 · ES.
Assuming vformation = vdissociation, we obtain
k1 · E · S = k−1 · ES+ k+2 · ES.
The total concentration of the enzyme is assumed to be constant in the
process. E0 is the total concentration of the enzyme, which is the total
available enzyme in the system and so:
E0 = Efree + ES.
Forming the equation using E0, we obtain
k1 · (E0 − ES) · S = k−1 · ES+ k+2 · ES,
and, solving for ES, gives
ES =
E0 · S
S+ k+2+k−1k+1
.
Assuming the rate of the whole process is the rate of productivity of P we
then obtain:
V = k+2 · ES = k+2 · E0 · S
S+ k+2+k−1k+1
. (1)
Here V is the rate of the enzymatic reaction and Vmax is the maximum speed
of the enzymatic reaction in converting the substrate into product. Increasing
the concentration of the substrate increases the rate of the enzymatic reaction
until it reaches Vmax, which is k+2 times E0. Km is the Michaelis-Menten
constant, corresponding to the concentration of substrate when the rate
reaches the half maximum [19] and it is given by k+2+k−1k+1 . Substituting Km
and Vmax into (1) finally yields the Michaelis-Menten equation:
V =
Vmax · S
Km + S
.
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2.1.3 Binding
Binding of an enzyme to a substrate is similar to binding of a protein to
a ligand, hormone, antibody, or any other type of protein. The following
equations can be applied for simulating a protein-protein or protein-ligand
interaction [19]. If P is a protein with only one binding site and L is a ligand,
the binding equilibrium equation is:
P+ L ⇀↽ PL,
where PL is the protein-ligand complex. Assuming that the concentration of
the complex is equal to Lb (ligand in complex), the dissociation constant of
this reaction is given by:
Kd =
P · L
Lb
.
Assuming that the total concentration of protein (Pt) in the system is equal
to the sum of free protein and ligand bounded protein, we obtain:
Pt = P+ PL,
PL = Lb,
P = Pt − Lb.
Finally, substitutions, the Lb function is given by:
Lb =
Pt · L
Kd + L
.
This equation can be applied to model a protein-protein interaction or a
protein-ligand interaction.
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2.2 dynamics of transcription
Cells in different environmental conditions sense signals and respond to
them by producing proteins. Interactions between transcription factors,
activators, repressors, RNA polymerases, and promoters of genes regulates
transcription, leading to the proteins that act in different environmental
situations. Regulatory proteins and transcription factors can control the
transcription rate of a gene. These controls can be either positive (activation)
or negative (repression). Increasing the rate of transcription is positive
control and decreasing the rate of transcription is negative control [1].
Assuming Y is a protein produced by regulation of X as a transcription
factor or regulator on genes, the productivity of Y is given as a function of
active form of concentration of X:
X⇀ Y,
Y˙ = f(X).
Note that Y increases with increasing X when it is an activator and de-
creases with increasing X when it is a repressor. The Hill function describes
the rate of production of Y based on the concentration of the regulators. The
following equation is the Hill function for an activator [1]:
f(X) =
β ·Xn
Kn +Xn
.
The Hill function for repression is:
f(X) =
β
1+ (XK)
n
.
The Hill function is an increasing S-shaped (sigmoid) function for an
activator starting from zero expression level and reaching the maximal
expression level, and for a repressor it is a decreasing S-shaped function
starting from the maximal expression level and reaching zero activity. The
parameters of the Hill function are K, β, and n. K called the activation coeffi-
cient in the activator Hill function and repressor coefficient in the repressor
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Hill function. The value of K is half of the concentration X when it reaches
the half of its expression level. Therefore, the unit of K is concentration.
β is the maximal expression level reached by high concentration of X in
an activator system or reached by as low concentration as zero of X in a
repressor system. The Hill coefficient n defines the steepness of the function.
The Hill function describes the transcription rate where there is only one
activator or repressor. It can be used to form a set of ordinary differential
equations in combination with other rate formulas [1].
In studying of the dynamics of gene regulation, the rate of change of con-
centration of Y is not only related to production as described but also related
to the rate of protein degradation and dilution. The degradation/dilution of
the protein needs to be considered in forming the system. Assuming α is
degradation/dilution rate in a unit of the time, the rate of production can be
arranged using different rate formulas. The rate of change of concentration
of Y is given by:
Y˙ = production−αY.
The basic regulation of transcription was presented in the last paragraphs,
however, in many situations the transcription is regulated by a network of
interactions among the regulators, transcription factors, and other reactants
in the cell. The networks of transcription are connected through some com-
ponents and complex networks are generated to govern the behavior in the
cell. Understanding the dynamics of such big networks is very challenging.
One way to understand networks dynamics is to look for common
building-block patterns known as network motifs which occur in complex
networks higher than randomized networks. There are variety of statisti-
cal methods for ranking network motifs such as Bayesian and maximum
likelihood-based methods. Out of many possible patterns in networks only
few of them tend to be considered as network motifs since these appear
in many networks. These network motifs have been detected in diverse
systems and have specific functions [1]. Negative auto-regulation, positive
auto-regulation, and feed-forward loop are examples of well-studied net-
work motifs (Figure 6).
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Figure 6: Positive auto-regulation (A), negative auto-regulation (B), and a feed-
forward loop (X, Y, and Z).
Negative auto-regulation is a simple example of the network motifs in
transcription. We briefly present the benefits of negative auto-regulation in
biological systems. Auto-regulation is the regulation of a gene by its own
product. The two types of auto-regulation are positive auto-regulation and
negative auto-regulation. In this type of motif, the product of a gene re-
presses its own transcription. Negative auto-regulation speeds the response
time to the steady state conditions in comparison with simple regulation
and positive auto regulation. Fluctuations in production rate of a gene
can change the steady state level leading to a change of the steady state
concentration of the gene product. Negative auto-regulation motifs pro-
mote robustness to fluctuations in production rate by buffering fluctuations
through repression [1]. Each biological network motif has its own function.
Detecting network motifs can help us to predict the function of biological
systems by comparison with known motifs.
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2.3 simulation
In the previous sections some reaction rate formulas, which can be used to
obtain a set of ordinary differential equations from a set of reactions, were
presented. A system of ODEs is a set of differential equations each of which
contains an ordinary derivative. A system of ODEs can be solved using
numerical integration algorithms. The Euler method and various forms of
Runge-Kutta are numerical techniques, which are implemented in many
modelling and simulation tools for biological systems.
The Runge-Kutta 4th order method calculates the value of a variable
at the next step based on its value at present. In each step of the Runge-
Kutta algorithm, the derivatives of four points are evaluated; The initial
point, two trial midpoints, and a trial endpoint [68]. A step size of h is
the difference between each initial point and the endpoint. Midpoints are
the points between initial point and endpoint. The algorithm continues by
taking a weighted average of the derivatives. Note that the derivatives at
the midpoints receive the greater weight for calculation of the average. The
average of the derivatives is added to the variable to calculate the next
variable.
For example, consider the following equation
x˙ = f(t, x).
Given step size h and initial conditions, four intermediate values are
calculated:
k1 = hf(tn, xn),
k2 = hf(tn + 1/2h, xn + 1/2k1),
k3 = hf(tn + 1/2h, xn + 1/2k2),
k4 = hf(tn + h, xn + k3).
In the next step, the next value of the variable x is calculated using the
present value of x using the weighted mean of the derivatives:
xn+1 = xn + 1/6(k1 + 2k2 + 2k3 + k4).
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This process is repeated a fixed number of times. Runge-Kutta is a popular
method among the numerical methods for solving differential equations for
biological systems. In this thesis, the author used the Runge-Kutta 4th order
method for solving ODEs in the computer program that he developed.
2.4 structural analysis
Kinetic modelling demands a considerable amount of kinetic information,
such as rate constants and the total concentrations of reactants. This infor-
mation is rarely available for complex biological systems. There are some
computational techniques which can be used to investigate the biological
system with minimal dependency on biochemical data. Structural analysis
of a set of ODEs gives properties of the system, which only depend on the
structure of the underlying network of interactions and not on the reaction
kinetics.
The structure of the model is defined in terms of the stoichiometric
reaction scheme, which describes how the metabolites of the system combine
together. The structural properties of the system, in contrast to kinetics, do
not depend on the environment of the system and on its internal state
[70]. Flux analysis, conservation relationships, minimal cut sets, elementary
modes, and extreme pathways are all approaches that are based on the
stoichiometric matrix [45, 39, 44, 24, 41, 42]. The following section describes
briefly an example of these approaches.
The first step in structural analysis is to compute the stoichiometric matrix
(N). N has ’m’ rows representing the metabolites in the system and ’n’
columns representing the corresponding reactions. The following example
illustrates how to derive N [70].
∗ → x1
x1 + x6 → x2,
x2 + 2x5 → x3,
x3 → x4 + x5,
x4 → x5 + x6 + ∗.
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the matrix N is given by:
N =

1 −1 0 0 0
0 1 −1 0 0
0 0 1 −1 0
0 0 0 1 −1
0 0 −2 1 1
0 −1 0 0 1

.
The values in N indicate the number of the molecules of the metabolites
that are assigned positive for products and negative for reactants. The
corresponding system of ODEs is given by
x˙ = Nv,
where x is the of the metabolite concentrations, and v is the vector of rate of
reactions, i.e.
x˙1
x˙2
x˙3
x˙4
x˙5
x˙6

=

1 −1 0 0 0
0 1 −1 0 0
0 0 1 −1 0
0 0 0 1 −1
0 0 −2 1 1
0 −1 0 0 1


v1
v2
v3
v4
v5

.
The aim of many modelling approaches is to describe and understand the
behavior of a set of ODEs within a period of time. In contrast, steady state
analysis investigates the system in the steady state condition, i.e.
x˙ = 0.
Consequently the steady state equation is given by
Nv = 0. (2.4)
This system can be solved and the rate of the reactions (fluxes) calcu-
lated. The Gauss elimination can be used to solve the system. These type
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of systems can be overdetermined, the number equations is more than un-
knowns, determined, the same number of equations and unknown, and
underdetermined, the number equations is less than unknowns. In general,
there is no solution for a overdetermined system, there is a unique solution
for a determined system, and underdetermined systems can have infinite
solutions.
2.5 modelling tools and databases
In this section we shall briefly review some of the tools that may be used
to simulate the behavior of biological systems. Many of these tools use
SBML, Systems Biology Markup Language, a machine-readable language
utilizing XML primary encoding [50, 80, 21, 38]. This was developed about
5 years ago and since then has been extended to represent cell-signalling
pathways, metabolic networks, regulatory networks, and other types of bio-
chemical reaction networks. The aim of SBML is to enable users to exchange
models between simulation/analysis tools and to publish in electronic for-
mat models for the scientific community [38, 21]. SBML is under constant
development for both fixing of problems and adding new features. This
development has resulted in a series of levels and the latest version, which
is not yet supported by all packages, is level 3.
There are many software packages which have been developed with the
aim of modelling biochemical systems. We now present an overview of some
of the most well known systems biology software packages; Copasi, SBW,
CADLive, Celldesigner, CellNetAnalyzer, and SBML-SAT. Supporting SBML,
platform availability, free availability, installation, usability and manual,
parameter estimation methods, and applicability for different kinds of mod-
elling are all important factors for making a good systems biology program.
A more detailed overview of SBML tools is presented in [2, 26, 88, 87].
2.5.1 Copasi and Gepasi
Gepasi was one of the first programs developed for systems biology. Pedro
Mendes developed it for modelling the dynamics, steady states and control
of biochemical systems. It is a Windows based program written in C [61].
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Copasi (Complex Pathway Simulator) was developed based on Gepasi by
the Mendes and Kummer group. It can be used to simulate and analyse
biochemical networks. It can import all levels of SBML and export some
versions. Copasi is available for MS Windows, Linux, OSX, and Solaris [33].
It is free for non-commercial use, and its installation is straightforward.
A good manual is available for Copasi. The latest version of Copasi has
most modelling methods available for simulating and analysing biological
systems. Furthermore, it has a flexible facility for plotting the results. The
latest version has the ability to perform steady-state analysis, structural anal-
ysis, time-course simulation, metabolic control analysis, parameter scans,
optimization, parameter estimation, and sensitivity analysis. For stoichio-
metric analysis, elementary modes and mass conservation are also available.
Genetics algorithms, Hooke & Jeeves, Evolutionary Program, Random search,
and Steepest Descent are methods which can be used for parameter estima-
tion and optimization tasks in Copasi. It does not have a graphical interface
for representing the biochemical network. Nevertheless, in the author’s
opinion Copasi is one of the best programs currently available for modelling
biochemical systems.
2.5.2 System Biology Workbench
System Biology Workbench (SBW) is a package of programs developed by
the System Biology Workbench Development Group for simulating and
analysing biochemical networks [37, 79]. It is an open source SBML type
package, originally Windows based, but now it is available for Linux and OS
X operating systems. The Windows version has more tools available from
the OS X version. The installation of SBW is easy, and it is well documented.
It performs time course simulation, steady state analysis, and stoichiometric
analysis. SBW consists of the following programs; JDesigner, Jarnac, SBW
Inspector, Structural Analysis tools, and WinSCAMP. JDesigner is the main
program, which has a parameter scan facility, however, parameter estimation
methods are not included. The author found that SBW was not as capable
as Copasi for modelling, but it had better documentation and is probably
simpler for novice modellers. In addition, it has a graphical interface for
representing the biochemical networks.
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2.5.3 CellDesigner
CellDesigner is a modelling tool for biochemical networks with a high
quality graphical user interface for drawing the biochemical network or gene
regulatory system [23]. It is a freely available SBML type program and has
been implemented in JAVA so is operating system independent. It has the
advantage of SBW simulation modules, and also has time course simulation
and parameter scan facilities. The installation of CellDesigner is straight
forward, and it is extensively documented. The author found this program
simple to use. In particular, the graphical representation of the biochemical
network was found to be one of its best aspects. In terms of simulation and
modelling methods, it was found to have less capability compared to other
software programs.
2.5.4 CADLIVE
CADLIVE is a freely available software package for construction and analysis
of biochemical systems [49, 48]. This is not SBML compatible. CADLIVE uses
genetic algorithms for parameter estimation. The installation of CADLIVE
was found to be difficult and time consuming. The authors claim that it
is possible to use Kd values in simulations using CADLIVE. A test of the
online version showed that it is not possible to use Kd values in simulations
as expected from the associated publication.
2.5.5 CellNetAnalyzer
CellNetAnalyzer is a further development of FluxAnalyzer [46, 43]. This
program was originally developed for the structural analysis of biological
networks. It is freely available to academic users but it requires MATLAB
version 6.1 or higher. It also needs the optimization toolbox of MATLAB.
This program is capable of metabolic flux analysis with flux optimization in
flux balance analysis task for an arbitrary linear objective function, analysis
of structural properties of biological networks, elementary modes, extreme
pathways analysis, minimal cut sets, and analysis of Boolean networks
[46, 43].
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2.5.6 SBML-SAT
SBML-SAT (system biology markup language sensitivity analysis tool) is
designed mainly for sensitivity analysis [97]. SBML-SAT is a freely available
SBML program, which has been implemented in MATLAB. Although it is
free software, it requires MATLAB. It performs time course simulation, local
sensitivity analysis, global sensitivity analysis, steady state analysis, and
robustness analysis. SBML-SAT was used for many tasks described in this
thesis and it was found to be reliable and useful. It runs in Windows, Linux,
and OS X platforms, requiring libSBML, SBMLToolbox, and sundialsTB. The
installation of SBML-SAT was not as straight forward as the installation
of SBMLToolbox and the corresponding libSBML was difficult in some
platforms such as Windows Vista and Mac Os X.
2.6 conclusion
In this chapter, we have reviewed some of the standard techniques used
to simulate the behavior of biological systems. As we have also seen, there
are now many programs available that implement these techniques. We
found that most of these programs are very similar. In fact many of them
are simply ODE solvers with a graphical user interface. One problem with
this type of software is that the programs are not flexible for using with
different types of biochemical systems and different types of data. Also they
are perfect for a system with large amounts of available data, but such data
is seldom available for most biochemical systems. Most of the tools were
developed for different purposes and they have their own advantages and
disadvantages. Although the programs are generally quite similar, some have
more extensive facilities for modelling such as Copasi and SBML-SAT. Based
on different modelling tasks and systems, occasionally it was necessary for
the author to develop a model specific tool. Copasi and SBML-SAT were
the main systems biology programs that were used and CellDesigner was
used for drawing biological networks. As we shall see, it was necessary to
develop additional code in JAVA, MAPLE, and MATLAB in the modelling
of nitrogen fixation.
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3
THE THORNELEY AND LOWE MODEL IN SBML
3.1 a review of the thorneley and lowe model
As we seen in Chapter 1, nitrogenase plays an important role in nitrogen
fixation. Diazotrophs regulate nitrogen fixation to respond to the character-
istics of nitrogenase such as its oxygen sensitivity and low turnover rate.
Thorneley and Lowe revealed the mechanism of nitrogenase action. They
introduced two schemes for the mechanism of nitrogenase action, the Fe
protein cycle and the MoFe protein cycle. The schemes in Figure 7 & 8 have
both been published together with the associated kinetic rate constants, total
concentrations, and activity corrections [90, 56, 91, 57, 92, 58, 22, 59, 3, 7].
We first describe the Fe protein cycle which was introduced in Section 1.2.3.
In vitro, the Fe protein is reduced by dithionite, the usual reducing agent
used in such experiments. In vivo, the reduction is most probably performed
by electron carriers such as ferredoxin or flavodoxin with electrons ultimately
coming via NADH, NADPH, or FADH2, from the citric acid cycle or from
glycolysis. Dithionite is used as the electron donor in this process. This
reduction is accompanied by a replacement of the two MgADP molecules
by new MgATP molecules, leading to Fered(MgATP)2 + MoFe. The next step
is the protein complex formation, which requires the Fe protein to be in
its reduced state and bound to MgATP. In this complex, MgATP is cleaved
to MgADP and phosphate (Pi)3 as shown in Figure 7, where one electron
is transferred to the MoFe protein. Next, the complex dissociates, which
is believed to be the rate-limiting step not only for the Fe protein cycle
but also for the whole substrate conversion when all components are at
saturating concentrations. The rate of complex dissociation is approximately
5 s−1 under saturating conditions leading to Feox(MgADP)2 + MoFered. The
electron at the MoFe protein is used for substrate conversion and the Fe
protein returns to its starting configuration in the Fe protein cycle.
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Figure 7: The Fe cycle adapted from Scheme 1 of [57]. Kp1 represents the functional
half of the MoFe protein and Kp2 the Fe protein. One electron is trans-
ferred from Kp2 to Kp1 with the concomitant hydrolysis of 2MgATP to
2MgADP+2Pi. ’red’ means reduced and ’ox’ used for oxidized conditions.
The MoFe protein cycle is presented in Figure 8. Starting from the resting
state E0, the MoFe protein is reduced by one electron and protonated once,
leading to state E1H1. The notation EiHj represents the protein with i
electrons and j protons added to the initial state of the enzyme. After the
next electron-proton transfer step, at E2H2, there is a certain probability of
hydrogen production taking place which would lead the system back to its
resting state. This probability has been shown to depend on the electron
flux. Under conditions of low flux a low concentration of the Fe protein
compared to the MoFe protein, the E1H1 accumulates whereas the E2H2
is removed by evolving H2. At high flux, E2H2 will then be reduced and
protonated, leading to E3H3, which again can produce H2. It is in this state
that dinitrogen can bind. This produces one H2 and leads to E3HN2. H2 can
displace bound N2 and thereby inhibit its reduction. The state E3H3 may
also be further reduced to E4H4 which then can bind to N2 with resulting
H2 production. When no substrate is available, H2 is released reverting
back to more oxidised states. The MoFe protein cycle continues to release 8
electrons.
The Fe protein cycle and the MoFe protein cycle are scattered throughout
a body of publications spanning over decades [90, 56, 91, 92]. The rapid-
quench flow system was used for pre steady state studies of mechanism of
nitrogenase action. However, none of the cycles presents the whole reactions
of the Thorneley and Lowe model. In addition, the routines to model this
system written by Lowe and Thorneley were developed in Fortran and
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Figure 8: The MoFe cycle adapted from Scheme 2 of [57]. The species Ei represents
the electron state of one of two independently functioning halves of Kp1.
The process from E5N2H3 to E6, E7, and E0 is the same as E2 to E3.
require the use of the NAG libraries. For this reason, the exchange and
further development of this important model was limited. To remedy this
situation, we established a complete SBML model of the Thorneley and
Lowe system.
3.2 the full thorneley and lowe model in smbl
In Figure 9 we present all the reactions in Thorneley and Lowe model, which
were communicated to the author of this thesis by David Lowe. Thorneley
and Lowe published the MoFe cycle but they never published the scheme in
Figure 9 that has all the reactions involved in the process of nitrogen fixation.
The MoFe protein cycle is a summarized version of this. The scheme in
Figure 9 contains very valuable information about the Thorneley and Lowe
model and represents distillation of years of research by Thorneley, Lowe,
and their colleagues.
To build an SBML model, we extracted data from the original publications
and used the scheme in Figure 9. All assumptions made by the original
Thorneley and Lowe model have been considered and incorporated into
this model. The inactive MoFe protein does not interact with the Fe protein,
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although the inactive Fe protein competes with the active one to interact
to MoFe protein. The initial reductant source is dithionite. The kinetic
parameters for K. pneumoniae nitrogenase at 23◦C in pH 7.4, 25 mM
HEPES buffer with 9 mM ATP, 10 mM MgCl2 and zero ADP, are listed in
Table 43 and the total concentrations can be found in Table 2.
We designed the SMBL model, given in Figures 10 to 17, using the Systems
Biology Workbench [37, 79] (See Section 2.5.2). O, I, and R represent the oxi-
dized Fe protein, inactivated Fe protein, and reduced Fe protein, respectively.
Reduction, oxidization, and inactivation of EiHj occurs by R, I, and O in each
step to produce EiHjr, EiHjo, and EiHji. These processes were not presented
in the original MoFe protein scheme. There were some species in the scheme
that were involved in different parts of the scheme. To monitor these species
, x and p were added to EiHj making them distinguishable from the same
species in other parts of the scheme such as E4N2H2 and E4N2H2x which
are the same species and were involved in different part of the scheme. We
tried a number of simulation tools to explore this scheme, most of which
handled the resulting system of ordinary differential equations remarkably
well giving consistently close results despite using different integration
schemes. An analysis of these differences will not be presented here. For
production work and our analysis, Copasi was employed [33] (See Section
2.5.1).
We computed time course data for all the species involved in the Thorneley
and Lowe pre-steady state kinetic model. The distance between experimental
data and original model together with SBML model was computed for H2
and NH3 production. The distance between experimental data and original
simulation for NH3 is 57 and between experimental data and SBML model
is 61. These two simulations are in agreement with experimental data. The
distance for H2 for original model is 39 and for SBML model is 58. These
simulations are also in agreement with the experimental data. We show
simulations for the production of the two most important products, namely
H2 and NH3 in Figure 18. Thorneley and Lowe published simulations of
H2 and NH3 in [91, 56]. The simulations of H2 and NH3 in the original
Thorneley and Lowe model and SBML model of Thorneley and Lowe are in
good agreement, although there is further room for fitting computational
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Figure 9: Lowe’s notes for the full Thorneley and Lowe scheme.
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Figure 10: E0 to E1 of the Thorneley and Lowe scheme in SBML.
data to experimental data in both models to optimize the parameters of the
system.
In addition to the numerical validation of the results, the model has been
passed through all available SMBL checking programs which validate the
standard SBML format [80, 87, 88, 75, 40]. The author submitted the model to
the BioModels database [51]. The identifier of the SBML model of Thorneley
and Lowe is MODEL1315592601.
3.3 investigation of the rate-limiting step
As an application of our full SMBL Model, we investigated the rate-limiting
step in the mechanism of nitrogenase action. As discussed above, under
most conditions dissociation of the Fe protein from the MoFe protein is
the rate-limiting step in the system (rate constant k−3). To investigate the
importance of k−3 we conducted a series of simulations in which we sampled
a range of different values for this parameter. For each value, we computed
time-series data and analysed ammonia production.
3.3 investigation of the rate-limiting step 69
Figure 11: E1 to E2 of the Thorneley and Lowe scheme in SBML.
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Figure 12: E2 to E3 of the Thorneley and Lowe scheme in SBML.
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Figure 13: E3 to E4 of the Thorneley and Lowe scheme in SBML.
Figure 14: E4 to E5 of the Thorneley and Lowe scheme in SBML.
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Figure 15: E5 to E6 of the Thorneley and Lowe scheme in SBML.
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Figure 16: E6 to E7 of the Thorneley and Lowe scheme in SBML.
Figure 17: E7 to E0 of the Thorneley and Lowe scheme in SBML.
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Table 1: The kinetic parameters used in the SBML model for K. pneumoniae nitro-
genase at 23◦C in pH 7.4, 25 mM HEPES buffer with 9 mM ATP, 10 mM
MgCl2 and zero ADP. The rate constants k+6 and k−6 (not listed in the
reaction schemes) are for the dissociation of dithionite into 2SO−2 [90].
Rate constant Value
k+1 5× 107 M−1s−1
k−1 15 s−1
k+2 200 s−1
k+3 4.4× 106 M−1s−1
k−3 6.4 s−1
k+4 3× 106 M−1s−1
k+5 4.4× 106 M−1s−1
k−5 6.4 s−1
k+6 1.2× 109 M−1s−1
k−6 1.7 s−1
k+7 250 s−1
k+8 8 s−1
k+9 400 s−1
k−10 8× 104 M−1s−1
k+11 2.2× 106 M−1s−1
k−11 3× 104 M−1s−1
Table 2: The initial species concentrations used in the SMBL model. E0 represents
the Mo-Fe protein in its resting state, I, R, and O represent the inhibited,
reduced and oxidised form of the Fe protein, respectively, and N2 the
nitrogen concentration.
Molecular species Initial concentration
E0 3.4× 10−5 mol/l
I 5.985× 10−5 mol/l
R 7.315× 10−5 mol/l
S2O−24 0.01 mol/l
O 0.0 mol/l
N2 0.001 mol/l
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Figure 18: Simulated hydrogen and ammonia concentration together with experi-
mental data points and original Thorneley and Lowe.
As the concentrations of Fe and MoFe protein can vary, these simulations
were carried out for different MoFe:Fe ratios. Thorneley and Lowe attempted
to investigate NH3 formation in the nitrogenase system based on N2 changes
in different MoFe:Fe ratios [57]. The ratio of the MoFe protein to Fe protein
can change in nitrogenase system and they showed the importance of the
MoFe:Fe ratio and N2 concentration on the formation of NH3.
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Figure 19: The time evolution of ammonia production for protein ratios of MoFe:Fe
1:1 and 1:2. (A) 1:1 in 100 s. (B) 1:1 in 600 s. (C) 1:2 in 100 s. (D) 1:2 in
600 s.
Table 3: Elasticity and control coefficients for Fe cycle
elasticity r1 r2 r3 r4
Kp2 0.9 0 0 0
Kp1 0 0 6.4 0
Kp1-Kp2 -15 200 0 0
Kp2o-Kp1r 0 0 -747 509
Kp2o 4.9 ×106 0 0 0
Kp1r 0 0 -747 509
control coefficients r1 r2 r3 r4
Kp2 -2 ×10−7 -1.2 ×10−8 8.6 ×10−8 1.2 ×10−7
Kp1 -2 ×10−7 -1.2 ×10−8 8.6 ×10−8 1.2 ×10−7
Kp1-Kp2 2.5 ×10−9 -0.004 0.0019 0.0029
Kp2o-Kp1r 1.9 ×10−7 0.004 -0.002 -0.002
Kp2o 5 ×10−10 1.2 ×10−5 0.0004 -0.0004
Kp1r 5 ×10−10 1.2 ×10−5 0.0004 -0.0004
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Simulations of the nitrogenase system were performed between ratios
of 1:1 to 1:5 of MoFe:Fe. We kept the concentration of the MoFe protein
constant and increased the concentration of the Fe protein. The range of k−3
starts from 3 s−1 to 20 s−1 with a stepwise increase of 1. For a ratio of 1:1,
increasing the rate of dissociation, decreases the time required to achieve a
steady state (Figure 19). The highest k−3 in the simulations is 20 s−1, which
leads the system to achieve a steady state in about 300 s while the lowest
one is 3 s−1, which does not lead the system into steady state within 600
s. The time required to get to the steady state decreases by increasing the
rate of dissociation in ratio of 1:2. The minimum time required to get to the
steady state in simulations with a ratio of 1:2 is 100 s while it was 300 s for
a ratio of 1:1. A dramatic increase in production of ammonia is the other
difference between ratios of 1:1 to 1:2. The maximum ammonia production
in a given time for ratio of 1:1 is 70 µM, but it is close to 950 µM in ratio of
1:2. The simulations using a ratio of 1:2 also show that increasing the rate of
dissociation decrease the time to get to the steady state, at the same time, it
decreases the production of ammonia (Figure 19).
The behavior of the simulations using a ratio of 1:3, 1:4, or 1:5 is similar
to the behavior using a ratio of 1:2. The maximum ammonia productions
are close to 1000 µM in all three simulations. The minimum time required
to get to a steady state decreases to 40 s, 30 s, and 20 s in ratios of 1:3,
1:4, and 1:5, respectively (Table 4). The interval between maximum and
minimum ammonia production decreases by increasing the ratio of proteins
demonstrating that increasing the ratio of protein, decreases the sensitivity
of ammonia production on k−3.
For optimal functioning, this complex enzyme must balance a number of
different signals. For example, if one considers the total ammonia production
after a time of, say 2 minutes, one can observe the emergence of a maximum
at around the experimentally determined value of k−3 which is 6.4 s−1
(Figure 18). This suggests that this slow enzyme has evolved to maximise
the production of NH3 under the range of protein concentrations that are
typical within the cell. Figure 18 also shows that ammonia production
is more sensitive to the rate of dissociation of proteins at lower proteins
ratio. In higher ratios the system is less sensitive to perturbation of rate of
dissociation of the MoFe-Fe complex.
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For further analysis of the system we also performed elasticity and control
coefficients from metabolic control analysis (MCA). We performed elasticity
analysis to measure the sensitivity of the system parameters in response to
changes in substrates and products (Table 3). The analysis confirms that k−3
is a rate limiting step as r3 which is the reaction of dissociation is strongly
inhibited by complex (-747). Control coefficient in that table present the
relative changes in concentration in response to changes in parameters. It
shows that relative changes of model components concentration is relatively
high for r3 leading us to confirm that r3 is a rate limiting step in this process.
Figure 20: The production of ammonia after 120 s as a function of the rate constant
k3 for different MoFe:Fe protein ratios.
Table 4: Time to steady state based on different ratios of proteins and various values
of k−3.
k−3 3 4 5 6 6.4 7 8 10 15 20
1:1 1058 845 749 677 652 606 547 515 432 373
1:2 260 214 192 173 167 162 154 141 128 118
1:3 220 174 147 127 121 115 105 93 77 72
1:4 220 172 141 120 114 106 98 81 63 56
1:5 227 172 143 120 113 104 94 80 60 49
Another recently developed model attempted to compensate for discrep-
ancies between theory and experiment by adjusting the MoFe and Fe protein
concentrations to fit the data [95]. Such numerical tasks can also easily be
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performed with our model, however, the rationale behind changing the con-
centrations on a plot-by-plot basis may be questioned. The simulations from
our model are overall in better agreement than this other recent attempt. We
speculate that this is because we have developed the full model under the
guidance from one of the originators, although differences in the numerical
simulation scheme may also be a cause.
3.4 conclusion
In this chapter, we have developed and implemented the full Thorneley
and Lowe pre-steady state kinetic model of Nitrogenase in K. pneumoniae
in the Systems Biology Markup Language (SBML) and submitted it to
the BioModels database. We validated our model and showed that it is in
good agreement with the original experimental data. In addition, we have
investigated the rate limiting step by performing a parameter scan of the
rate constant k−3. A close inspection of the simulations reveals that at low
MoFe:Fe ratios, the production of ammonia is more sensitive to the rate of
dissociation constant of the complex of the Fe protein and MoFe protein.
However, for increasing MoFe:Fe concentrations, this situation is reversed.
The ratio of proteins plays key role in ammonia production and it decrease
the sensitivity of the system to the dissociation constant (k−3).
Part III
THE NIFL -N IFA SYSTEM

4
THE 2 -OXOGLUTARATE SYSTEM
Modelling nitrogen fixation requires considerable biological knowledge
and experimental data. Our starting point was to extract the biological
knowledge from different sources so as to identify the system components
and master regulators in this complex regulatory system. There are two
important factors in modelling the NifL−NifA system. Firstly, most of the
experiments for the NifL−NifA system have been performed in steady
state conditions [53], and secondly, the low availability of the kinetic data
(Appendix C). Rate constants are the most common type of kinetic data
used for kinetic modelling, however there have not been measured many
rate constants experimentally for the NifL −NifA system. Most of the
reactions in the NifL −NifA system are protein-protein interactions or
protein-ligand interactions. These interactions are very fast and difficult
to measure experimentally. However, data is available for the dissociation
constant, which is a measure of the affinity of interaction between two
proteins or as protein and a ligand. In this chapter we initiate modelling the
NifL−NifA system for A. vinelandii.
4.1 methodology
We applied two methodologies to model the NifL−NifA sub-systems using
dissociation constants, which we name A and B. We now present a detailed
description of these two the methodologies.
4.1.1 Methodology A
In methodology A, we attempted to form mathematical equations using
Kd values, the dissociation constant is equal to the ratio of the backward
rate constant to the forward rate constant. As mentioned in the last section,
our aim was to model NifL−NifA system in the steady state condition.
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Therefore, the first step was arrangement of the steady state equations.
Figure 21 presents reaction scheme of an example of the NifL−NifA sub-
system. In this section the methodology is presented using the example
system below:
NifLred +ADP ⇀↽ NifLredADP,
NifLredADP+NifA ⇀↽ NifLredADPNifA,
NifA+ 2OG ⇀↽ NifA(2OG).
For ease of presentation we use the following substitutions:
x1 = [NifLred],
x2 = [ADP],
x3 = [NifLredADP],
x4 = [NifA],
x5 = [NifLredADPNifA],
x6 = [2OG],
x7 = [NifA(2OG)].
Figure 21: The 2− oxoglutarate system.
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Using the methodology described in Chapter 2, the law of mass action
was applied to produce a system of ODEs. In the following equations ki and
k−i denote the forward and backward rates.
x˙1 = −k1x1x2 + k−1x3,
x˙2 = −k1x1x2 + k−1x3,
x˙3 = k1x1x2 − k−1x3 − k2x3x4 + k−2x5,
x˙4 = −k2x3x4 + k−2x5 − k3x4x6 + k−3x7,
x˙5 = k2x3x4 − k−2x5,
x˙6 = k−3x7 − k3x4x6,
x˙7 = −k−3x7 + k3x4x6.
By assuming x˙i=0 for all i=1,..,7, we obtain:
−k1x1x2 + k−1x3 = 0,
k1x1x2 − k−1x3 − k2x3x4 + k−2x5 = 0,
−k2x3x4 + k−2x5 − k3x4x6 + k−3x7 = 0,
k2x3x4 − k−2x5 = 0,
k−3x7 − k3x4x6 = 0.
Solving these equations for the products of the system (x3, x5, x7) gave
the following equations:
x3 = k1x1x2/k−1,
x5 = k2k1x1x2x4/k−2k−1,
x7 = k3x4x6/k−3.
Applying the dissociation constants formulas,
Kd1 = k−1/k1,
Kd2 = k−2/k2,
Kd3 = k−3/k3.
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resulted in:
x3 = x1x2/Kd1 , (1)
x5 = x1x2x4/Kd2Kd1 , (2)
x7 = x4x6/Kd3 . (3)
This process shows how a system can be converted to a system of algebraic
equations involving dissociation constants instead of forward and backward
rate constants. x1 and x4 are two main components of the system and these
are part of its different products. As the system is in steady state and the
total concentration of x1 and x4 in the system is constant, the following
assumptions were also made (t indicates total):
x1 = x
t
1 − x3 − x5,
x4 = x
t
4 − x7 − x5.
The assumptions can be applied to (1), (2) and 3, giving:
x3 = (x
t
1 − x5)x2/(Kd1 + x2), (4)
(x2)x
2
5 + (x2(x3 − x
t
1 − x
t
4 + x7)−Kd2Kd1)x5+
x2(x
t
1x
t
4 − x
t
1x7 − x3x
t
4 + x3x7) = 0, (5)
x7 = (x
t
4 − x5)x6/(Kd3 + x6). (6)
In the experiments presented in [53] one or two of the components are
variables of the system and the experiments were performed a number of
times with different concentrations of the key components. In this particular
example x6, varied in each of the experiments in [53]. In section 3.3.1 we
present the results of this model. A simple Maple code was written by author
for the purpose of applying methodology A to model the system.
4.1.2 Methodology B
In the previous section, a methodology for modelling a biological system in
a steady state condition using the dissociation constants instead of forward
and backward rate constants was presented. In this section the focus is to
present a simpler way to use Kd values.
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The dissociation constant indicates the affinity of interaction of two or
more components of the system. Since the dissociation constant is given by:
Kd = kbackward/kforward,
if we assume the value of the forward rate constant (kforward) is equal to one,
the dissociation constant is equal to the backward rate constant (kbackward).
This assumption is valid in modelling the systems under the steady state
conditions because keeping the ratio of backward and forward constants to
the constant value of the dissociation constant, while changing the actual
values of rate constants, does not change the steady state concentration
of model components. It only alters the time to get to the steady state
conditions. There are no standard tools available for modelling using only
Kd, although some systems biology tools exist for modelling the system in
steady state conditions.
Apart from using available tools for modelling NifL−NifA system, the
author of this thesis developed a java code to model the NifL − NifA
system in steady state conditions using Kd (The Equilibrium program). The
motivation behind the development of the code was to provide specific tools
and perform simulation jobs in an automatic way to generate a considerable
amount of data for sampling and sensitivity analysis of the NifL−NifA
system. Methodology B was used more than Methodology A mainly due
to the availability of tools. Methodology A was used for sections 4.2.1 and
4.3.1. Methodology B was used in other sections.
4.1.3 Parameter estimation
The availability of biochemical parameters is a limiting factor in modelling
biochemical systems. We used an estimation method not only to estimate
the missing parameters but also to validate the models by estimating the
known parameters. An important part of model development is validation.
Comparing the output of the model with experimental data can help to
validate a model. Parameter estimation methods can also be used to estimate
the known parameters using the available data to compare the estimated
value to the original one for validation of the model. We used the genetic
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algorithm tool from Copasi to solve parameter estimation problems in this
thesis.
The genetic algorithm is a computational technique that is inspired by
biological evolution [62]. The genetic algorithm starts from a population of
individuals. Each individual has a set of model parameters. Reproduction
and selection of the population are the key elements of genetic algorithms.
The initial population is generated randomly. The population is updated in
each generation by reproduction and selection process. In the reproduction
process new individuals are generated by the processes called mutation and
cross-over. Mutation randomly alters one or more parameter values in an
individual. Genetic algorithms help prevent the algorithm getting trapped in
local minima by mutation processes. A cross-over process is used to produce
new individuals by combining two individuals. In the cross-over process
two individuals swap some of the parameters to generate the new ones. In
the selection process some of the individuals, which have a better fitness stay
in the population and the others, are deleted and replaced by the individuals
that were generated by the mutation and cross-over process. The generation
process is repeated until either a good fit is found or the algorithm reaches
the defined generation number.
4.1.4 Stability analysis
Most of the experimental data that we analysed was generated in steady state
conditions. Knowing the steady state points of a system helps to analyse
the system and also compare the generated data in that condition to the
experimental data. Apart from finding the steady state points, the stability
of these points can be determined to characterize the systems. In modelling
the NifL−NifA system, there were a number of potential models for each
sub-system. A stability analysis was used to provide more information about
these potential models. Potential models are categorized in two categories
of stable and unstable models. This helps narrow down the set of potential
models. The author developed a program written in java to calculate the
steady state points. Copasi was used to perform stability analysis.
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4.1.5 Sensitivity analysis
Sensitivity analysis plays an important role in the investigation of biochemi-
cal models. It helps to assess the effect of components of the system based
on the model output and to determine the key regulators and parameters
of the system. We performed a sensitivity analysis to provide information
about the NifL−NifA sub-systems. The sensitivity analysis in this thesis
was performed in two different ways.
Sampling is the simplest way to carry out a sensitivity analysis.NifA(2OG)
was assigned to be the main output of the NifL−NifA system. The NifL−
NifA system can be solved for NifA(2OG) many times through sampling
components, which reveals some of the characteristics of the system. The
range of model components and the number of samples were defined for
each component of the system. Uniformly distributed samples were taken
from model components in the defined range. Given the parameters and
different values for model components as inputs, as many as number of
samples the simulations of the NifL−NifA system were run to produce
output values. We explored the output values since the variations in out-
puts are the result of variations in the input. The Equilibrium program was
designed and used to perform this task.
Multi-parametric sensitivity analysis (MPSA) can also be used to study
the sensitivity of model output to the model components. MPSA introduces
uncertainty to the model by injecting randomly generated model component
values into the system and statistically evaluating the sensitivity of the
system to these values. The procedure of MPSA starts by selecting the
parameters as the variables of the system. A set of randomly generated
parameters is sampled in a given range by the Latin Hypercube Sampling
(LHS) method [96]. This is followed by simulation of the model for each
set of parameter values and calculation of the objective function. A set of
parameters is then classified into an acceptable or unacceptable sets by
comparing the objective function values with a predefined threshold. Finally,
the sensitivity of the parameters is evaluated statistically by computing the
cumulative frequency of both acceptable and unacceptable cases for each
parameter and measuring the separation of the two cumulative frequency
distributions using Kolmogorov-Simirnov statistics [96]. SBML-SAT is a
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freely available SBML type sensitivity analysis tool, which was used to
perform MPSA in this thesis [97]. It can be run to evaluate the sensitivity of
both parameters and initial conditions of model components. SBML-SAT has
tools to evaluate the sensitivity of the parameters and model components to
both the steady state and dynamic response of the system in a given time
(integrated response).
4.2 nifl and nifa interaction
Direct interaction of NifA and NifL inactivates the expression of nitrogen
fixation genes. This interaction occurs in different redox status and also
the presence of ADP and ATP can change the influence of NifL on NifA
activity. In the following sections we analyze the simplest sub-systems of
the NifL−NifA system in steady state conditions including the NifL and
NifA interaction in reduced conditions with ADP, in reduced conditions
with ATP, and finally in oxic conditions with ADP. The activity of NifL in
transcription of nif genes was determined by measurement of the formation
of open promoter complex [74].
4.2.1 NifL and NifA interaction in reduced conditions with ADP
The NifL−NifA system switches between oxidized and reduced conditions
based on the environmental situation and input signals. We investigated the
NifL−NifA system in different redox conditions separately to get a better
understanding of their behaviors. The following equations are the reactions
in the system in reduced conditions:
NifL+ e− → NifLred, (4.1)
NifLred +ADP ⇀↽
kd2
NifLredADP, (4.2)
NifLredADP+NifA ⇀↽
kd3
NifLredADPNifA. (4.3)
In the presence of reductants and when the system is not in the oxidized
condition, NifL interacts with the available reductant in the cell to produce
the reduced form of NifL, NifLred (reaction 4.1). NifLred is not able to
inhibit NifA activity unless it binds to ADP, which causes conformational
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changes in NifLred (reaction 4.2) [74, 9, 10]. NifLred can then finally interact
with NifA (reaction 4.3).
Table 5 presents the system of ODEs for the above reaction scheme. The
law of mass action was used to produce a system of ODEs. The rate of
change of all the components of the system is equal to zero in steady state
conditions. All forward rate constants have been set to 1 and the backwards
rate constants are equal to Kd (See Section 4.1.2).
Table 5: The ODEs for the NifL − NifA system in reduced conditions with
ADP. For ease of presentation we used the following substitutions
x1=[NifL], x2=[e−], x3=[NifLred], x4=[ADP], x5=[NifLredADP], x6=[NifA],
and x7=[NifLredADPNifA]. ki and k−i denote the forward and backward
rates (i=1, 2, 3).
x˙1 = −k1x1x2
x˙2 = −k1x1x2
x˙3 = k1x1x2 − k2x3x4 + k−2x5
x˙4 = −k2x3x4 + k−2x5
x˙5 = k2x3x4 − k−2x5 − k3x5x6 + k−3x7
x˙6 = −k3x5x6 + k−3x7
x˙7 = k3x5x6 − k−3x7
In many in vitro experiments for the NifL−NifA system, the truncated
form of NifL, NifL(147-519), has been used [74]. The reason behind this is
to prohibit NifL from getting into the oxidized form. It loses the ability to
sense oxygen, consequently, in this condition NifL is considered to be in the
NifLred form. For ease of calculation reaction 4.1 can be ignored and we can
assume that the total concentration of NifL is in NifLred form.
The activity of NifL in transcription of nif genes is increased by adding
NifA to the system (Figure 22 A). The reaction was carried out in the pres-
ence of NifL(147-519) while there is no ADP in the system. As expected in
the absence of ADP, NifL fails to inhibit NifA. The computational model
confirms the availability of free NifA in this condition (Figure 22 B). Reac-
tions 4.2 and 4.3 were used to calculate the steady state concentration of
free NifA in the system, where the Kd2 is 13 µM and Kd3 were set to 0.03
µM. The k2, k−2, k3, and k−3 are 1 M−1s−1, 13 s−1, 1 M−1s−1, and 0.03 s−1,
respectively (Relevant to reactions 4.2 and 4.3). The assumption was made
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that there is either no interaction between NifL and NifA in the absence of
ADP or a very low level of interaction. In this condition, since the interaction
of NifL and NifA is not significant, almost all NifA is in free form, thus the
transcription of nif genes is activated.
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Figure 22: (A) Experimental evidence for activity of NifA on activation of transcrip-
tion of Nitrogenase. The reaction was performed with 4 mM GTP, 0.2
µM of NifL, and NifA as indicated in graph A [74]. The experiment
was performed by experimentalist. (B) Computational evidence for ac-
tivity of NifA. B presents the change of concentration of NifA which is
correspond to activity of NifA. It has the same concentration as A.
ADP plays an important role in the NifL −NifA system in that NifL
binds to ADP and causes conformational changes in NifL. This binding
activates NifL and the interaction with NifA. An experiment was performed
to investigate the effect of ADP on the NifL−NifA system (Figure 23) [53].
The experiment had 0.1 µM of NifA, 4 mM GTP, 0.2 µM of NifL(147-519),
and ADP as indicated in Figure 23. Activity of NifA was determined by
monitoring the formation of open promoter complexes.NifA can utilise GTP
for open complex formation but neither GTP nor GDP are also competent
to bind to NifL in the system. Increasing ADP dramatically decreases the
activity of NifA in presence of NifL (Figure 23 A).
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We performed a number of simulations to investigate the influence of
ADP on the NifL−NifA system. In simulation 1, we perturbed the ADP
concentration using reactions 4.2 and 4.3 to monitor the activity of NifA.
The activity of NifA in our computational test is a ratio of free NifA to the
total amount of NifA. The simulation based on different concentrations of
ADP is in good agreement with the corresponding experimental data.
The physiological concentrations of NifL and NifA were experimentally
estimated in vivo is 0.01 µM. We carried out simulations with different
concentrations of NifA and NifL. In simulation 2 we used the ratio of
2:1 NifL/NifA as used in the vitro experiment, but with 10 fold lower
concentration of NifA and NifL. As it is indicated in Figure 23 (C), ADP can
decrease the activity of NifA but the system is not very sensitive to ADP. It
cannot decrease the activity of NifA to less than 75%. In this condition, 75%
activity of NifA, is considered to be active for the transcription of nif genes.
In the final simulation we used the same concentration of NifL and NifA,
0.01 µM (Figure 23 (D)). The activity of NifA in this condition, based on
different concentrations of ADP, is the lowest among all the simulations.
Simulation 2 shows that the concentrations of NifL and NifA are around
0.1 µM because the activity of NifA does not decrease when there are
0.01 µM of NifA and 0.02 µM of NifL available in the system. Although
the expression of NifL and NifA appears to be transcriptionally coupled
resulting in stoichiometric amounts of NifL and NifA in the cell, simulation
3 shows that the ratio of NifA and NifL plays an important role in the
activity of NifA as the activity does not decrease when the stoichiometric
amounts ofNifL andNifA is present. The simulation fits to the experimental
data when the amount of NifL is 2 fold higher than NifA. Thus these
simulations predict that there is more NifL than NifA in the cell and also
their concentrations are 0.1 µM.
4.2.2 NifL and NifA interaction in reduced conditions with ATP and ADP
ATP is also able to bind to NifL but with much lower affinity in comparison
to ADP. In the presence of ATP,NifL bindsNifA and form stable complexes
of NifL−NifA. Reactions 4.4 and 4.5 below occur in the presence of ATP,
consequently, the system in the presence of ADP and ATP yields reactions
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Figure 23: (A) Experimental evidence for the influence of ADP on the NifL−NifA
system [53]. (B) Simulation 1: the influence of ADP on NifA activity
using the same concentration as in the experiment. (C) Simulation 2: the
same computational test as Simulation 1 with a 10 fold less concentration
of NifL and NifA. (D) Simulation 3: the same computational test as
simulation 1 with 0.01 µM of NifA and NifL. The activity of NifA is
division of NifAfree to NifAtotal.
4.2, 4.3, 4.4, and 4.5. Considering the ATP hydrolysis activity of NifA, we
also added reaction 4.6 to the system.
For a better understanding of the influence of ATP and ADP on the
NifL−NifA system and the hydrolysis activity of NifA, sensitivity and
also robustness analysis were performed on the system with reactions 4.2,
4.3, 4.4, and 4.5 (model A) and on the system formed from the reactions
4.2, 4.3, 4.4, 4.5, 4.6 (model B). The total concentration of ATP in these
simulations was 3500 µM. Kd4 , Kd5 , and Kd6 were set to 130 µM, 0.03 µM,
and 800 µM, respectively.
NifLred +ATP ⇀↽
kd4
NifLredATP, (4.4)
NifLredATP+NifA ⇀↽
kd5
NifLredATPNifA, (4.5)
NifA+ATP ⇀↽
kd6
NifA+ADP+ Pi. (4.6)
As mentioned above, the multi-parametric sensitivity analysis method
was used in the SBML-SAT program. To perform a sensitivity analysis a
boundary for the parameters needed to be set. The up/down of 1000 fold of
the original parameters were used for parameter space. These boundaries
were set to prohibit infinite flexibility for parameter perturbation and also to
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give some degree of freedom for perturbation. Figure 24 demonstrates the
sensitivity of the integrated response of model components over a certain
simulation time. The integrated response of the model output is the total
amount of the model output during the time course. As the transcription
takes about 60 seconds in bacteria and translation 120 seconds [1] we chose
the simulation time to be 1000 seconds.
Figure 24: Top plot: The sensitivity of the integrated response of model A against
all model parameters and initial conditions. Bottom plot: The sensitivity
of the integrated response of model B against all model parameters and
initial conditions.
The main output of the NifL−NifA system is free NifA (S4 in Figure
24). Thus, the evaluation of the influence of model parameters and initial
conditions on NifA is the main topic of interest. Model A, apart from the
high sensitivity of the integrated response of NifA to its total concentration,
which is expected, was found to be sensitive to perturbation of NifLred.
Overall, the total amount of NifA over 1000s does not change by perturbing
the model parameters and total concentrations (Figure 24). The values for
ATP and ADP are very stable to model perturbations. NifLred and its driven
complexes are the most sensitive components of the system, and furthermore,
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NifLred is the most critical component among the model parameters and
total concentrations in terms of the influence on the model outputs.
For B, the analysis shows that NifA as in model A is sensitive to its total
concentration (Figure 24). The main difference between models A and B
in terms of sensitivity of integrated response of NifA is that NifA is less
sensitive to the total concentration of NifLred, and also, it is sensitive to
the k−5 the backward rate constant for interaction between NifLredATP and
NifA. The sensitivity of ATP in model A is the same as that of model B,
but ADP is more sensitive in model B against perturbations than model A.
NifLred driven complexes have the same behavior in both models A and B.
In general, both models A and B react similarly to the perturbation within a
timeframe of 1000s.
Figure 25: Top graph: The sensitivity of steady state response of model A against all
model parameters and initial conditions. Bottom graph: The sensitivity
of integrated response of model B for the same conditions.
Figure 25 presents the sensitivity of steady state response of models A
and B against the model parameters and initial conditions. This analysis
shows the effect of model parameters and initial conditions perturbations
on the steady state concentrations of the model outputs. We performed the
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sensitivity analysis on the steady state response of models A and B against
perturbation of parameters and initial conditions. NifA is not sensitive to
these perturbation in model A. Apart from its total concentration it shows
some low sensitivity to k2, the forward rate constant for NifLred and ADP
interaction, and k5, the forward rate constant for the NifLredATP and NifA
interaction. The steady state response of NifA in model B is very different
from that of model A. As the analysis shows, apart from the sensitivity
of NifA to its total concentration, NifA is more sensitive in model B in
comparison to model A. NifLred is the only component of the model B
which does not show any effect on NifA. The highest sensitivity of NifA
is on the its interaction with NifLredATP, k5. This implies that ATP plays a
more important role in model B than in model A. NifLred driven complexes
are dramatically more sensitive in model B than model A, in respect of the
model parameters and the initial conditions.
Although performing the sensitivity analysis is informative, it does not
show how the system reacts against multiple perturbations. We therefore per-
formed robustness analysis using SBML-SAT. We calculated the robustness
of the system in using the following formula [97]:
R =
−
∑N
p=1(fp − f0)
2
N
,
where the quantities N, fp, and f0 are defined as follows. A parameter space
is defined for parameters of the system, which has 1000 fold up/down of the
original parameter values in our study. A new set of parameters is generated
randomly in the defined space. The next step is the calculation of the model
output function under perturbed condition, fp, and under non-perturbed
condition, f0. The index of robustness, R, is calculated over N perturbations.
R is normally a negative number. It is zero when the system is absolutely
robust. R can be -∞ indicating that the index is too high and the system is
absolutely non-robust.
Table 6 presents the robustness analysis on outputs of both models A
and B in steady state and dynamic conditions. Although the main output
of both models is NifA, all other model reactants of the system were also
assumed as output of the systems and a robustness analysis was performed
for these too. In general model A is not robust in steady state conditions but
it is robust in dynamic conditions. Whereas model B is robust under both
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conditions. In respect to NifA, model B is robust in both conditions while
model A is not robust in steady state conditions. The robustness of ATP and
ADP are completely opposite in model A and B in steady state conditions.
Table 6: Robustness of model outputs by total parameters and variation of total
concentrations. ’A’, ’B’, ’Steady’, ’Integrated’ represent model A, model B,
steady state conditions, and dynamical conditions, respectively.
Model Output Steady A Steady B Integrated A Integrated B
NifLred -inf -5.4171 -1.4936 -1.5679
ADP -1.0395 -inf -1.0568 -1.6779
NifLredADP -inf -70.69 -2.7987 -2.9403
NifA -inf -0.0051 -1.4713 -1.5545
NifLredADPNifA -inf -0.0875 -2.8551 -2.8435
ATP -0.9828 -inf -1.0022 -0.9471
NifLredATP -inf -48.29 -2.5312 -2.3123
NifLredATPNifA -inf -49.95 -2.6076 -2.4282
In summary, this study shows that both models A and B are robust against
multi-parameter variation and also not sensitive to individual parameter
variations in dynamic conditions. Robustness and sensitivity of model A
and B are not the same in steady state conditions. NifA is more sensitive
to individual variation of the parameters and total concentrations in model
B in comparison to model A in steady state conditions, but model B is
more robust than model A against multi-parameter variations in steady
state conditions. Therefore, the ATP hydrolysis activity of NifA (reaction
4.6) changes a non-robust system into a robust system, although the model
components are more sensitive to individual perturbation. It indicates that
model B has flexibility to change its parameters and total concentration to
some extent, and it can tolerate perturbations by spreading them into the
system components.
4.2.3 NifL and NifA interaction in oxic conditions
The oxidized form of NifL, NifLox, is competent to inhibit the activity of
NifA. Since the experimental data confirms that the oxidized form of NifL
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affects the activity of NifA in vitro [67], we attempted to investigate this
aspect of the NifL−NifA system. Although the oxidized form of NifL is
active as an inhibitor of NifA in the absence of ADP, the presence of ADP
increases its inhibitory activity. The system of reactions under oxidising
conditions is as follows:
NifL+ ox →
kd7
NifLox, (4.7)
NifLox +ADP ⇀↽
kd8
NifLoxADP, (4.8)
NifA+NifLoxADP ⇀↽
kd9
NifLoxADPNifA. (4.9)
Under oxidising conditionsNifL senses the redox state and is converted to
NifLox (reaction 4.7). Since NifL is converted to NifLox in an irreversible re-
action, we can leave out reaction 4.7 and assume that the total amount
of NifLox is NifL to decrease the number of parameters. NifLox inter-
acts with ADP to form ADP-bond NifLox, NifLoxADP (reaction 4.8). In
the reaction 4.9, NifLoxADP interacts with NifA and forms the complex
NifLoxADPNifA.
Our first step to investigate the NifL−NifA interaction under oxidising
conditions was to predict the unknown parameters. We used the same
parameter values for the interaction of ADP with NifLox and NifLred to
reduce the numbers of unknown parameters. Since nitrogenase is highly
sensitive to oxygen, reaction 4.9 is crucial to the NifL−NifA system, and
it needs to be compared with the corresponding reaction (reaction 4.3) in
the reduced state. We then applied the genetic algorithm to estimate the
parameter of reaction 4.9 and compare the reduction with the oxidized state.
This task was performed in the steady state conditions.
An experiment was performed to investigate the influence of ADP con-
centration on the inhibition of NifA activity by NifLox as described in [67].
Figure 26 presents the experimental data, which was used to estimate Kd9
(reaction 4.9). The value of Kd3 , which is for the same interaction in the
reducted state, is 0.03 µM. One of the steady state points, through which
the concentration of ADP leads to complete inhibition of NifA, activity was
used to estimate Kd9 . The result of our parameter estimation shows that
Kd9 is around 100 fold less than Kd3 (0.00026 µM). The objective function
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Figure 26: The activity of NifA based on the ADP concentration by oxidized NifL.
The Reaction was performed with 125 nM of NifA, 250 nM of NifLox,
and ADP as indicated in graph [67]. The activity of NifA is the ratio of
NifAfree to NifAtotal.
value is 9 and the function evaluation is 4003 which are in accepted region.
This investigation indicates that the NifLoxADPNifA complex is 100 fold
tighter than that in the reducted state. It also implies that the formation of
the complex is faster in oxic conditions than reduced conditions.
The estimated parameter was used to compute the influence of different
concentrations ofADP onNifA byNifLox, the result of which is presented in
Figure 26. The simulation of the NifA and NifL interaction under oxidising
conditions is perfectly in agreement with the biological experiment.
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Figure 27: The activity of NifA based on variation of NifLox concentration. The
experiment was performed with 125 nM of NifA, 50 µM of ADP, and
the indicated amount of NifLox [67]. All NifA proteins are active in
simulation 1(125 nM of NifA) while only 50% of NifA is active in simu-
lation 2 (65 nM of NifA). The activity of NifA is division of NifAfree to
NifAtotal.
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To further investigate the system under oxidising conditions, we investi-
gated the influence of NifLox on NifA activity for a constant concentration
of ADP. The analogous biological experiment was performed in [67]. The
experimental data indicates that the activity of NifA is about 20% when the
system contained 50 nM of oxidised NifL (Figure 27). Assuming that NifA
protein is 100% active, this is logically impossible, since 50 nM of NifLox
should be able to interact with a maximum of 50 nM of NifA. In contrast
the simulation gave dramatically different result when compare with the
experiment. As explained above, it is impossible to get to that low activity
of NifA with a low concentration of NifLox simply because there is not
enough NifLox in the system to interact and consequently inhibit NifA.
The simulation suggests that the NifA protein may have not been 100%
active. To examine this suggestion, we performed the same computation
using 50% active NifA protein. Under these conditions the computation
is in agreement with the experiment. This work shows that the activity of
NifA could be as low as 50%, and furthermore, it confirms that Kd9 is about
100 fold less than Kd3 , which makes the complex of NifLoxADPNifA 100
times tighter than NifLredADPNifA.
4.3 the 2-oxoglutarate system
2− oxoglutarate releases NifA from inhibition by NifL under favorable
conditions for nitrogen fixation. Since the main regulator in these conditions
is 2 − oxoglutarate, we call it the 2 − oxoglutarate system and in the
following section we analyze this system in steady state conditions.
4.3.1 A model of the 2-oxoglutarate system in steady state conditions
The response of the NifL −NifA system to 2 − oxoglutarate has been
determined by biochemical experiments [53, 60, 9]. Figure 29 presents the
experimental results. The reaction scheme of the 2− oxoglutarate system
is depicted in Figure 28.
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Figure 28: The reaction scheme of the 2− oxoglutarate system.
The reactions in the 2− oxoglutarate system are as follows:
NifLred +ADP ⇀↽
kd1
NifLredADP, (4.10)
NifLredADP+NifA ⇀↽
kd2
NifLredADPNifA, (4.11)
NifA+ 2OG ⇀↽
kd3
NifA(2OG). (4.12)
The experiment was carried out with varying concentrations of 2 −
oxoglutarate to observe the influence of this ligand on the activity of
NifA. We simulated the 2− oxoglutarate system using the same concen-
trations of 2− oxoglutarate as used in the experiment. Table 7 shows the
2− oxoglutarate system parameters and concentrations that were used in
the experiment and simulations. The simulations are in agreement with
the experimental data (Figure 29) and the influence of 2− oxoglutarate
on the activity of the NifL −NifA system is confirmed. Increasing 2 −
oxoglutarate raises the amount of free released from NifL leading to in-
creasing NifA activity.
In summary, adding 2− oxoglutarate to the system increases the rate of
reaction 4.12 towards the production of NifA(2OG). There is less free NifA
available in the system to interact with NifLredADP, consequently, the rate
of reaction 4.11 decreases by adding 2− oxoglutarate, resulting in more
NifLredADP and less NifLredADPNifA available in the system. Having
more NifLredADP in the system increases the rate of backward reaction of
reaction 4.10. Therefore, adding 2− oxoglutarate to the system indirectly
increases the availability of NifLred and ADP in the system (Figure 29).
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Table 7: Concentrations (C/µM) and Parameters (Kd/µM) of the 2− oxoglutarate
system related to reactions 4.10, 4.11, and 4.12.
System Component Value
NifA 0.01
NifLred 0.02
ADP 50
2− oxoglutarate 0-2000
Kd1 13
Kd2 0.03
Kd3 57
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Figure 29: A simulation of NifLredADPNifA, NifLredADP, ADP, NifA(2OG),
NifA, and NifLred based on changing the 2 − oxoglutarate concen-
tration ([2OG]).
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4.3.2 Investigation of the steady state points
Although the simulation of the 2− oxoglutarate system is in agreement
with the experimental data, we performed parameter estimation, stability
analysis, and sensitivity analysis in order to understand the characteristics of
the system. The 2− oxoglutarate system was modelled in the steady state
condition using dissociation constants. As we have 14 different concentra-
tions of 2− oxoglutarate and 14 corresponding steady state concentrations
of NifA(2OG) measured experimentally, we performed parameter estima-
tion, forward modelling, stability analysis, and sensitivity analysis for all
14 steady state points using the Copasi and the Equilibrium program as
described above.
Chosen Steady State Points
As a representative of the 14 simulations, we present the analysis of three
of the steady state points. These three points were selected to monitor the
2− oxoglutarate system in the high, low, and medium concentrations of
2− oxoglutarate. The full analysis of all steady state points is presented in
Appendix B. Steady state points 4, 8, and 14 are those points that indicate
low, medium, and high concentrations of 2− oxoglutarate, respectively.
We call them points A, B, and C, respectively. In steady state point A, B,
and C the concentrations of 2− oxoglutarate are 0.5, 50, and 2000 µM,
respectively.
Parameter Estimation
In each steady state point, as NifA(2OG) is the main output of the 2 −
oxoglutarate system, the experimental concentration of NifA(2OG) for
that point was used to estimate the parameters. In each estimation task in
this section one data point was used to estimate three parameters. The con-
centrations of NifA(2OG) in points A, B, and C are 0.000118, 0.004061, and
0.0092 µM, respectively. Table 8 presents the results of parameter estimation
in steady state points. The estimated parameters are close to the original
ones for all three steady state points.
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Table 8: Estimated Parameters of the 2− oxoglutarate system for all three steady
state points in comparison to the original parameter values (Kd/µM).
Kd Point A Point B Point C Experiment
Kd1 35 19 18 13
Kd2 0.025 0.018 0.02 0.03
Kd3 35 54 115 57
Forward Modelling
In the last section the parameters of the system were estimated in three
different conditions. In this section we model the 2− oxoglutarate system
based on 14 different concentrations of 2 − oxoglutarate using the esti-
mated parameters. Modelling was performed to investigate the influence of
the estimated parameters, which were derived from the behavior of the sys-
tem within broad range of 2− oxoglutarate concentrations. In this regard
the concentration of all products of the system, NifA(2OG), NifLredADP,
and NifLredADPNifA, were monitored. The NifA(2OG) concentration was
compared to experimental data [53]. As the experimental data is not avail-
able for NifLredADP and NifLredADPNifA, they were compared with the
simulations with the original parameters.
Figure 30 indicates the result of modelling the 2− oxoglutarate system
using the estimated parameters in steady state point A. Although the es-
timated parameters were derived from the conditions of low availability
of 2− oxoglutarate, the simulation of NifA(2OG) is in agreement with
the experimental data within the whole range of 2− oxoglutarate. The
simulations of the NifLredADP using the estimated parameter and the orig-
inal parameters are not exactly the same. This could be the result of a
difference between the estimated parameter and original parameter of the
corresponding reaction (Kd1). The two simulations of NifLredADPNifA are
in agreement.
In the Figure 31, the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG) are presented for steady state point B. All the simulations in
steady state point B are in agreement with the original simulations. The
results of the simulations in steady state point C are also close to one
another (Figure 32). This investigation shows that the estimated param-
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Figure 30: A simulation of NifLredADPNifA, NifLredADP, and NifA(2OG) with
the estimated parameters from steady state point A. NifA(2OG)
compared with the experimental data, and NifLredADP and
NifLredADPNifA compared to the simulation using the original pa-
rameters.
eters from all three conditions of low, high, and medium concentrations
of 2 − oxoglutarate are able to reproduce the expected behavior of the
2− oxoglutarate system in a broad range of 2− oxoglutarate concentra-
tions.
Steady-state analysis
Stability analysis for steady state points A, B, and C was performed to
monitor the effect of 2− oxoglutarate on stability and also to investigate
if the system shows different characteristics of different concentration of
2− oxoglutarate. The steady state concentrations of the 2− oxoglutarate
system components were computed using the estimated parameters in each
state. We performed this task to investigate the influence of 2−oxoglutarate
on the concentration of the system components when the system reaches
the steady state.
The results show that the 2− oxoglutarate system is generally a stable
system and 2− oxoglutarate cannot change the stability. Table 9 presents
the concentration of metabolites of the 2− oxoglutarate system in steady
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Figure 31: A simulation of NifLredADPNifA, NifLredADP, and NifA(2OG)
with the estimated parameters from steady state point B. NifA(2OG)
is compared with the experimental data, and NifLredADP and
NifLredADPNifA are compared to the simulation using the original
parameters.
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Figure 32: A simulation of NifLredADPNifA, NifLredADP, and NifA(2OG) with
the estimated parameters from steady state point C. NifA(2OG)
is compared with the experimental data, and NifLredADP and
NifLredADPNifA are compared to the simulation with the original
parameters.
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state points A, B, and C. In general, this result shows that NifA(2OG), the
main component of the NifL−NifA system, continuously increases with
added 2− oxoglutarate. As expected adding 2− oxoglutarate dissociates
NifA from the NifL −NifA complex, and so there is less NifL −NifA
complex available.
Table 9: Concentration values (C/µM) of all the components of the 2 −
oxoglutarate system in steady state points A, B, and C.
metabolite Point A Point B Point C
NifLred 0.0035 0.0023 0.0026
ADP 49.99 49.99 49.99
NifLredADP 0.0049 0.0061 0.0072
NifA 0.0083 0.0044 0.00054
NifLredADPNifA 0.0016 0.0015 0.0002
2− oxoglutarate 0.49 49.99 1999.99
NifA(2OG) 0.00012 0.004 0.0092
Sensitivity analysis
We performed sensitivity analysis to explore the effect of parameter pertur-
bation on the 2− oxoglutarate system and also to better understand the
importance of the parameters in the 2− oxoglutarate system in conditions
of high, low, and medium concentrations of 2− oxoglutarate. The analysis
was performed by sampling the parameters in a defined range, simulating
the system with new parameters, and finally comparing the model output
with new parameters to model output with the original parameters.
Figure 33 presents the result of the sensitivity analysis of Kd1 , Kd2 , and
Kd3 for steady state points A, B, and C. In steady state point A, both of
NifLredADP and NifLredADPNifA are sensitive to Kd1 in a very similar
manner. The highest perturbation of Kd1 leads point A to the maximum 20%
change in NifLredADP. NifLredADPNifA is sensitive to perturbation of Kd2
and it is more sensitive in decreasing Kd2 in comparison to its increasing. Kd2
perturbations increase the concentration of NifLredADPNifA up to 250%.
NifA(2OG) is not so sensitive to perturbation of Kd1 . The interesting result
is that the sensitivity of Kd2 on both NifLredADP and NifA(2OG) is the
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Figure 33: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point A, B, and C.
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same in this case. Kd3 shows considerably higher sensitivity on productivity
of NifA(2OG), though perturbation of Kd3 does not induce any effect on
NifLredADP and NifLredADPNifA in this state. 95% decreasing of Kd3
results in around 1700 % more NifA(2OG) productivity.
In steady state point B, the sensitivity of Kd1 remains the same as steady
state point A. The sensitivity of Kd2 to NifA(2OG) and NifLredADP as be-
fore indicates the same behavior. The sensitivity of Kd2 to NifLredADPNifA
is raised in this steady state point in comparison to steady state point A
to a maximum of 400% changes. The sensitivity of Kd3 is very different in
comparison to where the concentration of 2− oxoglutarate is low (steady
state point A). The sensitivity of Kd3 decreases dramatically on NifA(2OG)
from a maximum 1700% to 140% changes in comparison to sensitivity of
steady state point A. In contrast, the sensitivity of Kd3 increases depending
on NifLredADPNifA in comparison to the sensitivity of steady state point
A. The sensitivity of Kd3 on NifLredADP remains the same as steady state
point A.
In steady state point C, Kd2 is highly sensitive to NifLredADPNifA and
Kd2 perturbation can change the NifLredADPNifA up to maximum of
1500%. Kd2 has not shown any sensitivity on NifA(2OG) and NifLredADP.
In this state, there is no evidence for sensitivity of Kd3 to NifA(2OG) and
NifLredADP while there is a high sensitivity of Kd3 to NifLredADPNifA. In
this respect the system also presents very different behavior in comparison
to steady state points A and B.
4.3.2.1 Results and summary of the investigation of equilibrium points
Stability Analysis
We performed stability analysis for all the steady state points with the
estimated parameters. The result of this analysis showed that the 2 −
oxoglutarate system is a stable system for all of the states concerned.
Sensitivity Analysis
We performed the sensitivity analysis for all three parameters of the 2−
oxoglutarate system in all steady state points. As the final step, we present
the sensitivity of parameters based on the change of 2−oxoglutarate on the
maximum increase and decrease of parameters. The maximum increase used
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is 100% perturbation and maximum decrease used is about 95% perturbation
in (Figure 34).
We found that adding 2− oxoglutarate changed the sensitivity of Kd1 ap-
proximately up to 400 µM of 2− oxoglutarate. Above that concentration of
2− oxoglutarate, the sensitivity of Kd1 remains unchanged for NifA(2OG),
NifLredADP, and NifLredADPNifA. The sensitivity of Kd2 shows the same
behavior as for Kd1 up to the maximum decrease of the parameters, though
the sensitivity of Kd2 on NifLredADPNifA increases dramatically by adding
2− oxoglutarate in the maximum decrease of the parameters. However, it
remains unchanged and insensitive toNifA(2OG) andNifLredADP. Increas-
ing the amount of 2−oxoglutarate in the system increases the sensitivity of
Kd3 to NifLredADPNifA and decreases the sensitivity of Kd3 to NifA(2OG)
for the maximum increasing perturbation. Also, in this condition the sensitiv-
ity of Kd3 onNifA(2OG)was unchanged after 1000 µM of 2−oxoglutarate.
The sensitivity of Kd3 remains unchanged and insensitive to NifLredADP for
the maximum increasing perturbation. In the maximum decreasing pertur-
bation, the sensitivity of Kd3 to NifLredADP and NifLredADPNifA remains
unchanged to adding 2− oxoglutarate and it is insensitive to NifA(2OG)
when the concentration of 2− oxoglutarate is around 10-50 µM.
In summary, Kd1 is very insensitive to NifA(2OG) in all of the steady
state points, insensitive to increasing the concentration of 2− oxoglutarate,
and also insensitive to NifLredADP and NifLredADPNifA. The sensitivity
of Kd1 to NifLredADP and NifLredADPNifA is exactly the same for high
concentrations of 2−oxoglutarate(1000 µM). Kd2 does not show sensitivity
to NifA(2OG) and NifLredADP causing less than 10% changes in low con-
centration of 2− oxoglutarate, and it gets less sensitive to them by adding
2−oxoglutarate. Kd2 is sensitive to NifLredADPNifA and it gets more sen-
sitive to it by adding 2− oxoglutarate. It is the most sensitive parameter in
high concentrations of 2−oxoglutarate. Kd3 is very sensitive toNifA(2OG)
in low concentration of 2− oxoglutarate causing up to 1800% changes. It
is insensitive to NifA(2OG) in high concentration of 2− oxoglutarate and
adding 2− oxoglutarate decrease the sensitivity of Kd3 to NifA(2OG). Kd3
is insensitive to NifLredADP in increasing 2− oxoglutarate. Kd3 is insensi-
tive to NifLredADPNifA in low concentration of 2− oxoglutarate while it
becomes more sensitive to NifLredADPNifA by adding 2− oxoglutarate.
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Figure 34: The sensitivity of parameters based on a change of 2− oxoglutarate for
the maximum increase and decrease of parameters. The plots on the left
are for 100% increase and on the right are for 95% decrease. The plots
from top to bottom are the sensitivity of Kd1 ,Kd2 , and Kd3 , respectively.
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NifLredADPNifA is the most sensitive component of the 2− oxoglutarate
system to perturbation of Kd3 in high concentration of 2− oxoglutarate.
This investigation shows that 2− oxoglutarate system is sensitive to its pa-
rameters in some conditions and reacts differently in different concentrations
and parameters.
4.4 conclusion
The complexity of the NifL−NifA system in responding to different envi-
ronmental signals demands breakage of the system. We first investigated
the NifL −NifA system by modelling NifA and NifL interaction in re-
duced and oxic conditions in the absence of 2− oxoglutarate and GlnK.
The investigation of the NifL −NifA system was then extended by in-
cluding 2 − oxoglutarate. As 2 − oxoglutarate plays an important role
in the NifL−NifA system we not only modelled that part of the system
but we also performed a series of tests to provide more information. We
now summarise our investigation of NifA and NifL interaction and the
2− oxoglutarate system by characterizing them.
NifL and NifA interaction in reduced conditions with ADP
• Modelling NifL and NifA interaction in reduced conditions confirms
the influence of ADP in increasing inhibitory activity of NifL on NifA.
• The ratio of NifL to NifA plays an important role in the inhibitory
activity of NifL in the presence of ADP. Although the expression of
NifL and NifA appears to be transcriptionally coupled, the simulation
shows that NifL needs to be available in twice the amount of NifA to
perform its inhibitory activity.
• Not only is the ratio of these two proteins important but also the range
of their concentrations. Although the biologists believe they may be
0.01 µM in the cell, the simulation reveals that they must be around
0.1 µM to explain the experimental data.
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NifL and NifA interaction in reduced conditions with ATP and ADP
• The ATP hydrolyzing activity of NifA increases the robustness of
the system against the multi-perturbation of parameters and total
concentrations.
• In general NifL and its related products are among the most sensitive
components of the system.
• NifA is among the least sensitive components of the system. As the
main output of this system is NifA, it shows that the system is robust
against perturbations.
NifL and NifA interaction in oxic conditions
• Modelling NifL and NifA interaction in oxic conditions confirms the
inhibitory activity of NifL in these conditions.
• The result of this investigation showed that the NifLoxADPNifA com-
plex is 100 fold tighter than the same complex in the reduced state
leading to faster formation of the complex in the oxic conditions in
comparison to the reduced conditions.
The 2− oxoglutarate system
• Modelling the 2 − oxoglutarate system confirms the role of 2 −
oxoglutarate in dissociation of the NifL−NifA complex.
• Stability analysis shows that the 2− oxoglutarate system is stable
in all three states of low, high, and medium concentrations of 2 −
oxoglutarate.
• Within a low concentration of 2− oxoglutarate, NifA(2OG) is very
sensitive to decreasing Kd3 . 95% decrease in the value of Kd3 leads to
1800% increase in the NifA(2OG) concentration.
• A high concentrations of 2−oxoglutarate,NifA(2OG) is not sensitive
to any parameters of the system.
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In the next chapter we will continue our investigation by including GlnK.

5
THE GLNK SYSTEM
As mentioned in Chapter 1, GlnK is important in controlling the transcrip-
tion of nif genes in response to the availability of fixed nitrogen. It acts as a
key regulator in A. vinelandii to promote the formation of the NifL−NifA
complex and to stop transcription of nif genes by sensing fixed nitrogen. Fig-
ure 35 presents the scheme for the GlnK system under conditions of fixed ni-
trogen sufficiency. In these conditionsGlnK is mainly in the non-uridylylated
form. Therefore, we modelled the system under these conditions assuming
that there is no GlnD in the system to uridylylate GlnK. NifLred inter-
acts with ADP to produce NifLredADP (Figure 35 r1). NifLredADP binds
NifA to produce NifLredADPNifA, an inhibitory complex that prevents
transcription of nif genes (r2). 2− oxoglutarate prohibits the formation
of the NifL −NifA complex by interacting with NifA (r3). GlnK binds
2− oxoglutarate and this reaction produces GlnK2OG (r6), which binds
NifLredADP leading to the formation of NifLredADPGlnK2OG (r4). This
complex is a key component in the system as it can interact with NifA(2OG)
(r5). This interaction keeps NifA in the NifLredADPGlnK2OGNifA(2OG)
complex and thus prohibits the transcription of nif genes.
The following are the proposed reactions for the GlnK system; the corre-
sponding ODE model is presented in Table 10:
NifLred +ADP ⇀↽
kd1
NifLredADP,
NifLredADP+NifA ⇀↽
kd2
NifLredADPNifA,
NifA+ 2OG ⇀↽
kd3
NifA(2OG),
NifLredADP+GlnK(2OG) ⇀↽
kd4
NifLredADPGlnK(2OG),
NifLredADPGlnK(2OG) +NifA(2OG) ⇀↽
kd5
NifLredADPGlnK(2OG)NifA(2OG),
GlnK+ 2OG ⇀↽
kd6
GlnK(2OG).
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Figure 35: Scheme of the GlnK system. Dots in this figure represent the type of reac-
tions (association and dissociation). The empty square represents the di-
rection to the product of a reaction. Blue components are activators of the
GlnK system and red ones are inhibitors. In general, 2− oxoglutarate
acts as an activator of nitrogen fixation, while GlnK and ADP are in-
hibitors. 2− oxoglutarate acts through NifA, while, GlnK and ADP act
through NifL.
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Table 10: The ODEs for the NifL−NifA system derived from the set of reactions in
the text. The ODE system was generated using mass action equations. Sub-
stitutions: x1=[NifLred], x2=[ADP], x3=[NifLredADP], x4=[NifA],
x5=[NifLredADPNifA], x6=[2OG], x7=[NifA(2OG)], x8=[Glnk],
x9=[GlnK(2OG)], x11=[NifLredADPGlnk(2OG)NifA(2OG)], and
x10=[NifLredADPGlnk(2OG)]; ki and k−i denote the forward and
backward rates (i=1, 2, 3).
x˙1 = −k1x2x1 + k−1x3
x˙2 = −k1x2x1 + k−1x3
x˙3 = k1x2x1 − k−1x3 − k2x3x4 + k−2x5 − k4x9x3 + k−4x10
x˙4 = −k2x3x4 + k−2x5 − k3x4x6 + k−3x7
x˙5 = k2x3x4 − k−2x5
x˙6 = −k3x4x6 + k−3x7 − k6x8x6 + k−6x9
x˙7 = k3x4x6 − k−3x7 − k5x10x7 + k−5x11
x˙8 = −k6x8x6 + k−6x9
x˙9 = −k4x9x3 + k−4x10 + k6x8x6 − k−6x9
x˙10 = k4x9x3 − k−4x10 − k5x10x7 + k−5x11
x˙11 = k5x10x7 − k−5x11
Previous experimental data characterised the influence of the inhibitory
activity of GlnK on NifL−NifA in the presence of 2− oxoglutarate [53].
These experiments demonstrated inhibition of NifA by NifLred in response
to different concentrations of GlnK. The concentration of 2− oxoglutarate
was relatively high in most of these experiments and the ratio of NifL
to NifA was 2:1 with concentrations of 0.2 µM and 0.1 µM, respectively.
Experiments were performed in steady state conditions and confirmed
that adding GlnK dramatically reduces the activity of NifA(2OG) even in
presence of 2− oxoglutarate. Figure 36 presents the effect of GlnK in one
of these experiments (Top graph "Experiment") [53].
Using the model in Table 10, the behavior of the GlnK system was sim-
ulated to measure its response to six different concentrations of GlnK in
steady state conditions. We used the same approach and methodology as we
used for the modelling the 2− oxoglutarate system in Chapter 4, Section
5.1.2. Table 11 presents the component concentrations and the dissociation
constants used. Six simulations corresponding to 3 different concentrations
of NifLred and 2 different concentrations of 2− oxoglutarate were carried
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Table 11: Concentration (C/µM) and parameter (Kd/µM) relevant to the reactions
in text and the model in Table 10.
System Component Value Source
NifA 0.1 [53]
NifLred 0.1,0.2,0.3 [53]
ADP 50 [53]
2− oxoglutarate 1000,2000 [53]
GlnK 0.0,0.05,0.1,0.25,0.5,1 [53]
Kd1 20 Provided by biologist
Kd2 0.03 Provided by biologist
Kd3 57 Provided by biologist
Kd4 1 Provided by biologist
Kd5 1 Provided by biologist
Kd6 60 Provided by biologist
out to investigate the response to GlnK with different ratios of NifL and
NifA in addition to two different concentrations of 2− oxoglutarate.
In the first simulation, the same total concentrations of NifA and NifL
were used as in the experiment. The ratio of NifL to NifA was 1:2 and the
concentration of 2− oxoglutarate was 1000 µM. The main output of the
system is NifA(2OG), the positive activator of nif genes, which we used
to monitor the activity of the system. A high concentration of NifA(2OG)
represents strong activities of nif genes. The total concentration of NifA was
0.1 µM. Thus, in the 100% active system all the available NifA is converted
to NifA(2OG) with a concentration of 0.1 µM.
The computational simulation does not show any changes in the con-
centration of NifA(2OG) when raising the amount of GlnK. Whereas the
experiment showed that a very low amount of GlnK reduces the activity
of the system dramatically, the computational simulation does not behave
like this even with high concentrations of GlnK (Figure 36 top graph "Ex-
periment" and "Simulation 1"). The computational system has the advantage
that the concentrations of all the components can be simulated (Figure 36).
Raising the GlnK concentration does not change the behavior of free
NifA, which remains very low at an amount of 4%. The total free NifA
and NifA(2OG) concentration constitutes about 83% of NifA in the sys-
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Figure 36: Computational simulation of the GlnK system based on increasing
amounts of GlnK. The dissociation constants for all the simulations
are as indicated in Table 11. The total concentrations in both experi-
mental data and simulations are the same as shown in Table 11 ex-
cept for NifLred and 2− oxoglutarate. Concentrations of these were
as follow; Experiment: 0.2 µM NifLred and 1000 µM 2− oxoglutarate;
Simulation 1: 0.2 µM NifLred and 1000 µM 2− oxoglutarate; Simula-
tion 2: 0.2 µM NifLred and 2000 µM 2− oxoglutarate; Simulation 3:
2000 µM 2− oxoglutarate and 0.1 µM NifLred; Simulation 4: 2000 µM
2− oxoglutarate and 0.3 µM NifLred; Simulation 5: 0.1 µM NifLred
and 1000 µM 2− oxoglutarate; Simulation 6: 0.3 µM NifLred and 1000
µM 2− oxoglutarate. The first graph presents the activity of the system
and shows the influence of GlnK on NifA(2OG) in comparison to the
experimental data. Other graphs present the generated data for all other
components of the system in the simulation.
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tem with the remaining NifA is incorporated in NifLredADPNifA and
NifLredADPGlnK2OGNifA(2OG).
As was observed in the 2− oxoglutarate system, different amounts of
NifL and NifA and their ratio can change the simulation. We simulated
the system with different ratios of NifA and NifL and when two concentra-
tions of 2− oxoglutarate to observe whether these changes could deliver
the experimental data. Simulation 6, in which NifL and 2− oxoglutarate
are 0.3 µM and 1000 µM, respectively, shows the lowest concentration of
NifA(2OG) among all of the simulations. Simulation 3, in which NifL and
2− oxoglutarate are 0.1 µM and 2000 µM, respectively, gave the highest
activity. Both computational simulations confirm that a higher ratio of NifL
to NifA combined with concentration a lower of 2− oxoglutarate produce
lower activity of the system although none of the simulations show any
response to GlnK.
Adding GlnK to the system decreases the amount of NifLred. This de-
crease in NifLred is expected because GlnK2OG interacts with NifLredADP
and produces the complex of NifLredADPGlnK2OG. Consequently, the con-
centration of the components NifLred, NifLredADP, NifLredADPNifA, and
ADP decreases when they are sequestered to GlnK in the system. Although
GlnK does not show any effect on free NifA, as expected, the simula-
tions with 2000 µM 2− oxoglutarate have a lower level of free NifA in
comparison to the simulations with 1000 µM 2− oxoglutarate. As antic-
ipated, adding GlnK to the system increases both NifLredADPGlnK2OG
and NifLredADPGlnK2OGNifA(2OG). The highest increase is in simula-
tion 4 in which NifL is 0.3 µM and the lowest increase is in simulation
5 in which NifL is 0.1 µM, as expected. Considering the effect of GlnK
on NifLredADPGlnK2OGNifA(2OG), the main concern is that increasing
GlnK does not change the concentration of the complex as much as expected.
Consequently a low amount ofNifA remains inNifLredADPGlnK2OGNifA(2OG)
which causes the system to remain in the active mode.
Since the simulation does not fit the experimental data, we perturbed the
total concentrations of the key system components in an attempt to obtain
closer fit, but this strategy also failed. There are two possible reasons for
this. The first might be because of experimental errors in measuring the
parameters of the system. The second reason might be the lack of knowledge
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about the reactions in the experimental system itself. In this chapter we
investigate the effect of GlnK on NifL−NifA system. We will analyse the
GlnK system to improve our model and show the possibilities which lead
the model to agree with experimental data. For example, the current set of
reactions and consequently the ODEs system might be incomplete. There
could be a different set of reactions, which can produce quantitatively the
same behavior as the experiment with the given parameters. In the next sec-
tion we explore the GlnK system based on these possibilities. We first focus
on estimating system parameters to fit the output with the experimental
data. Then we explore various sets of reactions with given parameters to fit
to the experimental data.
5.0.1 Analysis of possible GlnK models
The process of model exploration was started by forming new GlnK models
using additional interactions, which are biologically plausible. 41 different
sets were chosen from a larger set of models on the basis of biological knowl-
edge and the literature reviewed in Chapter 1. The generation of potential
models was started from the original model. The reactions categorized based
on the match to original models and the reactions were switched by the
alternative ones to find the minimal adequate reaction which fulfill the ex-
perimental observations. Having formed the new system our next step was
parameter estimation. In Figure 36, the experimental data shows that, even
at low concentrations of GlnK, the system can be inactivated by decreasing
the concentration of NifA(2OG) to less than 0.01 µM. We used a genetic
algorithm for parameter estimation as described in Chapter 4, section 5.1.3.
We then performed parameter estimation for all generated models to check
which one is capable of producing the expected behavior with estimated
parameters that are close to the original ones.
Furthermore, we performed stability analysis for all 41 systems. We car-
ried out stability analysis using the original parameters and the estimated
parameters for all the models. The combination of parameter estimation and
stability analysis helped to narrow down the possibilities. The following
pages present all the reactions, which were used for all the models. In the
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following reactions, D, NA, NL, G, and r represent ADP, NifA, NifL, GlnK,
and red (reduction state), respectively.
NLr +D ⇀↽ NLrD, (5.1)
NLrD+NA ⇀↽ NLrDNA, (5.2)
NA+ 2OG ⇀↽ NA(2OG), (5.3)
NLrD+G ⇀↽ NLrDG, (5.4)
NLrDG+NA(2OG) ⇀↽ NLrDGNA(2OG), (5.5)
NLrDG+NA(2OG) ⇀↽ NLrDGNA+ (2OG), (5.6)
NLrD+G(2OG) ⇀↽ NLrDG(2OG), (5.7)
NLrDG(2OG) +NA(2OG) + 2OG ⇀↽ NLrDG(2OG)NA(2OG)2, (5.8)
G+ 2OG ⇀↽ G(2OG), (5.9)
NLrDG(2OG) +NA(2OG) ⇀↽ NLrDG(2OG)NA(2OG), (5.10)
NLrD+NLrDG(2OG)NA(2OG) ⇀↽ NLrDNLrDG(2OG)NA(2OG),(5.11)
NLrD+G(2OG)2 ⇀↽ NLrDG(2OG)2, (5.12)
NLrDG(2OG)2 +NA(2OG) ⇀↽ NLrDG(2OG)2NA(2OG), (5.13)
G+ 2 (2OG) ⇀↽ G(2OG)2, (5.14)
NLrD+NLrDG(2OG)2NA(2OG) ⇀↽ NLrDNLrDG(2OG)2NA(2OG),(5.15)
NLrDG(2OG)2 +NA(2OG) + 2OG ⇀↽ NLrDG(2OG)2NA(2OG)2, (5.16)
NLrDG+NA ⇀↽ NLrDGNA, (5.17)
NLrDG(2OG) +NA ⇀↽ NLrDG(2OG)NA, (5.18)
NLrDG(2OG)2 +NA ⇀↽ NLrDG(2OG)2NA, (5.19)
G+NA ⇀↽ GNA, (5.20)
G(2OG) +NA ⇀↽ NAG(2OG), (5.21)
NAG(2OG) +NLrDG ⇀↽ NAG(2OG)NLrDG, (5.22)
G(2OG)2 +NA ⇀↽ NAG(2OG)2, (5.23)
NAG(2OG)2 +NLrDG ⇀↽ NAG(2OG)2NLrDG, (5.24)
G+NA(2OG) ⇀↽ GNA(2OG), (5.25)
G(2OG) +NA(2OG) ⇀↽ G(2OG)NA(2OG), (5.26)
126 the glnk system
G(2OG)NA(2OG) +NLrDG(2OG) ⇀↽ NLrDG(2OG)G(2OG)NA(2OG),(5.27)
GNA(2OG) +NLrDG ⇀↽ GNA(2OG)NLrDG, (5.28)
G(2OG)2 +NA(2OG) ⇀↽ G(2OG)2NA(2OG), (5.29)
NLrDG(2OG)2 +G(2OG)2NA(2OG) ⇀↽ NLrDG(2OG)2G(2OG)2NA(2OG),(5.30)
G(2OG)2NA(2OG) +NLrD ⇀↽ G(2OG)2NA(2OG)NLrD, (5.31)
G(2OG)NA(2OG) +NLrD ⇀↽ G(2OG)NA(2OG)NLrD, (5.32)
NA+ 4 2OG ⇀↽ NA(2OG)4, (5.33)
NLrDG(2OG)2 +NA(2OG)4 ⇀↽ NLrDG(2OG)2NA(2OG)4, (5.34)
NLrD+ 2 G ⇀↽ NLrD(G)2, (5.35)
NLrD(G)2 +NA(2OG) ⇀↽ NLrD(G)2NA(2OG), (5.36)
NLrD+ 2 G(2OG) ⇀↽ NLrD(G(2OG))2, (5.37)
NLrD(G(2OG))2 +NA(2OG) ⇀↽ NLrD(G(2OG))2NA(2OG), (5.38)
NLrD+ 2 G(2OG)2 ⇀↽ NLrD(G(2OG)2)2, (5.39)
NLrD(G(2OG)2)2 +NA(2OG) ⇀↽ NLrD(G(2OG)2)2NA(2OG), (5.40)
NLr +D+ 2OG ⇀↽ NLrD(2OG), (5.41)
NLrD+NA+ 2OG ⇀↽ NLrDNA(2OG), (5.42)
NA+ 2 (2OG) ⇀↽ NA(2OG)2, (5.43)
NLrD+G+ 2OG ⇀↽ NLrDG(2OG), (5.44)
NLrD+G ⇀↽ NLrG+D, (5.45)
NLrD+G(2OG) ⇀↽ NLrG(2OG) +D, (5.46)
NLrD(2OG) +NA ⇀↽ NLrD(2OG)NA, (5.47)
NLrD(2OG) +G ⇀↽ NLrD(2OG)G, (5.48)
NLrD(2OG)G+NA(2OG) ⇀↽ NLrD(2OG)GNA(2OG), (5.49)
NLrDG+NA(2OG)2 ⇀↽ NLrDGNA(2OG)2, (5.50)
NLrG+NA(2OG) ⇀↽ NLrGNA(2OG), (5.51)
NLrG(2OG) +NA(2OG) ⇀↽ NLrG(2OG)NA(2OG). (5.52)
Based on the results of the stability analysis and the parameter estimations,
we gave the models fail or pass labels. The models with one estimated
parameter outside the boundary by 10 fold less or more than the original
value failed in the parameter estimation test, otherwise it passed. We carried
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out the stability analysis for all the models with estimated parameters and
original parameters. The models, which were either unstable or had no
steady state, were categorized as a fail in the stability test.
Table 12 presents a summary of the result of the model exploration with
parameter estimation and stability analysis. We have categorized the models
in three groups A, B, and C. Group A contains the models 3, 25, 28, and 37,
which passed both parameter estimation and stability analysis tests. Group
B contains the models that failed in the parameter estimation and passed
in the stability analysis. This group includes the models 1, 8, 10, 13, 16, 19,
22, 23, 24, 25, 31, 33, 34, 36, 39, 40, and 41. Group C contains the models
that failed in both the parameter estimation and stability analysis tests. It
includes the models 2, 4, 5, 6, 7, 9, 11, 12, 14, 15, 17, 18, 20, 21, 26, 27, 29, 30,
32, 35, and 38.
Table 12: Summary of model exploration for the GlnK system. Columns M, R, Po,
Pe, and So-Se indicate the model number, reaction numbers of system,
original parameters, estimated parameters, and finally the result of stabil-
ity analysis with original parameters and the result of the stability analysis
with the estimated parameters, respectively. The reaction numbers repre-
sent the second digit of reaction numbers in text. We have not included
Reactions 1, 2, and 3 in the table as they are common to all models, except
models 32,36, 37, and 38. Model 32 does not have reaction 3. Model 36
does not have reaction 1 and 2. Model 37 does not have reaction 2, and
model 38 does not have reaction 3. Reaction numbers, original parameters,
and estimated parameters are in a chronological manner. In the stability
analysis column, S, Us, and Ud denote stable, unstable, and undetermined.
The result of the stability analysis is undetermined in case no steady state
was found.
M R Po Pe So-Se
1 4,5 20,0.03,57,1,1 8,0.0005,1037,0.0006,1.3 S,S
2 4,6 20,0.03,57,1,1 6,0.001,1744,1.5,1.3 S,Us
3 7,8,9 20,0.03,57,1,1,60 27,0.03,56,2.1,2.3,41 S,S
4 7,9,10 20,0.03,57,1,60,1 2,0.008,51,0.01,1.5e+006,0.3 S,Ud
5 7,9,10,11 20,0.03,57,1,60,1,1 3,0.02,15,0.002,1.7e+006,0.02,1 S,Ud
6 12,13,14,15 20,0.03,57,1,1,60,1 12,0.03,43,0.7,1,50,0.5 Us,Us
7 12,16,14 20,0.03,57,1,1,60 8,0.04,229,1,1,84 Ud,Ud
8 7,9,10 20,0.03,57,1,60,1 9,0.001,2354,1.8,45,0.03 S,S
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9 12,13,14 20,0.03,57,1,1,60 14,0.005,162,0.5,0.2,51 Ud,Ud
10 4,17 20,0.03,57,1,1 12,0.0006,1257,2.3,1.5 S,S
11 7,9,18 20,0.03,57,1,60,1 14,0.0007,1353,2.5,57,3.5 S,S
12 12,14,19 20,0.03,57,1,60,1 Ud Ud,Ud
13 4,5,17 20,0.03,57,1,1,1 6,0.0004,970,1,1,0.2 S,S
14 7,9,10,18 20,0.03,57,1,60,1,1 6,0.0009,1440,4.3,27,0.2,2.6 S,Ud
15 12,13,14,19 20,0.03,57,1,1,60,1 Ud Ud,Ud
16 4,5,20 20,0.03,57,1,1,1 9,0.001,1777,5,1,0.6 S,S
17 7,9,10,20 20,0.03,57,1,60,1,1 7,0.0006,1107,2.4,58,0.1,1.5 S,Ud
18 12,13,14,20 20,0.03,57,1,1,60,1 11,0.001,3069,1.5,0.2,39,0.4 S,Us
19 4,5,9,21 20,0.03,57,1,1,60,1 1.6,0.001,1351,0.5,0.5,66,0.2 S,S
20 4,5,9,21,22 20,0.03,57,1,1,60,1,1 8,0.0007,1026,2.4,1.2,21,0.8,0.8 S,Us
21 4,5,14,23,24 20,0.03,57,1,1,60,1,1 6,0.0005,1480,0.3,1.7,64,0.5,2.7 Ud,Ud
22 4,5,25 20,0.03,57,1,1,1 90,0.01,32,0.9,0.5,0.009 S,S
23 7,9,10,26 20,0.03,57,1,60,1,1 18,0.02,262,1.2,10,0.4,0.009 S,S
24 7,9,10,26,27 20,0.03,57,1,60,1,1,1 15,0.02,18,1,52,0.4,0.02,0.07 S,S
25 4,5,25,28 20,0.03,57,1,1,1,1 16,0.03,29,2.4,0.6,0.01,0.4 S,S
26 12,13,14,29 20,0.03,57,1,1,60,1 27,0.04,75,0.6,0.7,55,0.4 Us,Us
27 12,13,14,29,30 20,0.03,57,1,1,60,1,1 17,0.02,56,0.6,0.7,60,0.01,0.4 Us,Us
28 4,5,9,26 20,0.03,57,1,1,60,1 17,0.01,121,1.4,1.3,45,0.01 S,S
29 4,5,14,29,31 20,0.03,57,1,1,60,1,1 9,0.03,73,0.8,0.6,98,0.01,0.4 Ud,Ud
30 4,5,14,29 20,0.03,57,1,1,60,1 20,0.003,68,1.2,0.9,127,0.009 S,Ud
31 4,5,9,26,32 20,0.03,57,1,1,60,1,1 20,0.02,30,0.9,0.7,28,0.04,0.05 S,S
32 12,14,33,34 20,0.03,1,60,57,1 7,0.02,0.2,37,92,0.8 Ud,Ud
33 35,36 20,0.03,57,1,1 8,0.0008,1457,2.3,1 S,S
34 9,37,38 20,0.03,57,60,1,1 8,0.0005,982,49,2,0.1 S,S
35 14,39,40 20,0.03,57,60,1,1 9,0.005,166,40,1.5,1.3 Ud,Ud
36 41,47,48,49 57,20,0.03,1,1 2127,14,0.001,2.8,0.01 S,S
37 4,5,42 20,57,1,1,0.03 21,51,0.8,1.1,0.03 S,S
38 4,43,50 20,0.03,1,57,1 13,0.02,0.05,46,0.001 S,Ud
39 10,44 20,0.03,57,1,1 10,0.03,184,0.001,0.9 S,S
40 45,51 20,0.03,57,1,1 8,0.001,1357,0.5,0.3 S,S
41 9,46,52 20,0.03,57,60,1,1 4,0.001,1256,23,1.7,1 S,S
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The models in group C were not considered further because they did
not pass any test. Although all the models of group B passed the stability
analysis test, they did not fit the experimental data with the estimated
parameters close to the original ones. Considering that there is no strong
biological evidence for reaction schemes for the models of group B except
model 8, and that the estimated parameters were outside the stimulated
boundary of the original parameters, no further investigation was carried
out with them except for model 8, which is the original model. Model 8
was selected from this group for further analysis because it is biologically
plausible, even though it failed the parameter estimation test.
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Figure 37: Simulation of model 8 using 0.001 µM as an estimate for kd10 .
In the first computational test, the parameters for all the models were
estimated to check whether there is a set of parameters that is close to the
original parameters and capable of fitting the model to the experimental
data. There were a set of the parameters, which are capable of leading the
simulation of model 8 to be in agreement to the experimental data, however,
this set of parameters was not close to the original set.
The dissociation constant betweenNifA(2OG) andNifLredADPGlnK(2OG)
is the most difficult to estimate under laboratory conditions. Consequently,
Kd10 is the least experimentally reliable parameter of the GlnK system. Set-
ting all other parameters to be the same as the original parameters, the
computationally estimated value for Kd10 (reaction 5.10) is 0.001 µM in
comparison to the experimentally estimated value of 1 µM. One data point
was used to estimate one parameter in this task. Objective function value
is 3.02262 e−16 and the function evaluation is 9293 in this estimation task.
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As the objective function value is very low, this estimation is very reliable.
The simulation of model 8 was compared with the experimental data using
a Kd10 of 0.001 µM. The simulation is in agreement with the experimental
data (Figure 37). Consequently, model 8 was kept with the estimated Kd10
as one of the potential GlnK models.
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Figure 38: Comparison of the models in Group A with the experimental data for
activity of NifA(2OG). Estimated parameters have been used for all the
models.
In group A, there are 4 models, which passed both computational tests.
Using the estimated data we performed forward modelling for all the models
in this group. The task was carried out for all 6 different concentrations of
GlnK to compare with the experimental data. Figure 38 shows the result of
this analysis.
There is one difference in one of these models, model 3, in comparison to
the original model (model 8). Reactions 5.1, 5.2, 5.3, and 5.4 are the same in
both models, but model 3 has reaction 5.8 instead of reaction 5.5. In reaction
5.8, we added an additional 2− oxoglutarate molecule into the equation
as follows:
NifLredADPGlnK(2OG) +NifA(2OG) + 2OG ⇀↽ NifLredADPGlnK(2OG)NifA(2OG)2.
Model 3 passed both computational tests and Figure 38 shows that the
simulation fits the experimental data. Therefore, model 3 was kept for
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further analysis. Reaction 5.8 in model 3 was divided into two separate
reactions for greater clarity:
NifLredADPGlnk(2OG) +NifA(2OG) ⇀↽ NifLredADPGlnk(2OG)NifA(2OG),
NifLredADPGlnk(2OG)NifA(2OG) + 2OG ⇀↽ NifLredADPGlnk(2OG)NifA(2OG)2.
Using the new version of model 3, we performed the simulation to compare
the result with the experimental data and the old version of model 3 (Figure
39) using the original parameters (Table 12). The simulations of new version
and old version of model 3 are very similar and in agreement with experi-
mental data (Figure 39). We therefore use new version of model 3 for further
analysis.
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Figure 39: Comparison of the new version of model 3 to the old version and the
experimental data.
Model 25 also passed both computational tests. It has the following extra
reactions in comparison to our original model, while it does not have reaction
5.9:
GlnK+NifA(2OG) ⇀↽ GlnKNifA(2OG),
GlnKNifA(2OG) +NifLredADPGlnK ⇀↽ GlnKNifA(2OG)NifLredADPGlnK.
Model 25 passed both computational tests and the simulation fitted to
the experimental data. However we can argue against this system on the
basis of first extra reaction (reaction 5.25) as NifA(2OG) has been artificially
taken away from the system. In this system, disregarding other reactions,
only GlnK can titrate away all the NifA(2OG) as it is present at a higher
concentrations thanNifA. We did not nominate model 25 for further analysis
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because its first extra reaction (reaction 5.25) makes the simulation work
merely by taking NifA(2OG) out of the system in an artificial manner.
Model 28 also passed both computational tests and has all the reactions
in the original model with the following extra reaction:
GlnK(2OG) +NifA(2OG) ⇀↽ GlnK(2OG)NifA(2OG).
A simulation was performed using estimated parameters. The results show
that when the concentration of GlnK is 0.0, 0.05, and 0.25 µM, the steady
state cannot be attained. Also model 28 artificially takes NifA(2OG) out of
the system in a similar way to model 25. We therefore deleted model 28
from the potential GlnK models.
The last model in Group A, which passed the first two computational tests,
is model 37. Model 37 has one difference in comparison to the original model
(model 8). In the second reaction of the original model,NifLredADP interacts
with NifA and the interaction produces NifLredADPNifA. In model 37, we
added 2− oxoglutarate to this equation:
NifLredADP+NifA+ 2OG ⇀↽ NifLredADPNifA(2OG).
In a similar way to the other models, the simulations of the system were
performed with 6 concentrations of GlnK. Figure 38 presents the result
of this analysis. There are two main points concerning model 37. Firstly,
this model has no steady state, when the concentration of GlnK is zero.
Secondly, even a very low concentration of GlnK inactivates NifA(2OG)
but this result is not supported by the experimental data. The experiment
shows that 0.05 µM GlnK decreases the activity of the system to 22 % but
in model 37 the same amount of GlnK decreases the activity of the GlnK
system dramatically to 0.6 % (Figure 38). Model 37 was therefore deleted
from the potential GlnK models.
In summary, computational tests were carried out to narrow down the
number of potential GlnK models. Based on these initial tests, we catego-
rized the potential models in Group of A, B, and C. We deleted all the
models from Group C. In Group B of the models that failed in the param-
eter estimation task, model 8 was kept because the model is the original
model and is biologically more plausible than the others. In Group A, there
were four models, which passed the initial analysis. However, only one of
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them, model 3, passed our further analysis and was kept in this group as a
potential GlnK model.
5.0.2 Comparison of potential GlnK models
In last section, we explored all possible GlnK models and concluded that
there were two potential GlnK models: model 8 and model 37. For ease of
notation, model 8 will now be called model A and model 37 model B. The
following reactions are for model A and the ODE system corresponding to
model A is presented in Table 10:
NifLred +ADP ⇀↽
kd1
NifLredADP, (1)
NifLredADP+NifA ⇀↽
kd2
NifLredADPNifA, (2)
NifA+ 2OG ⇀↽
kd3
NifA(2OG), (3)
NifLredADP+GlnK(2OG) ⇀↽
kd4
NifLredADPGlnK(2OG), (4)
NifLredADPGlnK(2OG) +NifA(2OG) ⇀↽
kd5
NifLredADPGlnK(2OG)NifA(2OG),
(5)
GlnK+ 2OG ⇀↽
kd6
GlnK(2OG). (6)
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Model B has one extra reaction in comparison to model A. The following
reactions are for model B of the GlnK system and the ODE system of model
A is presented in Table 13:
NifLred +ADP ⇀↽
kd1
NifLredADP, (1)
NifLredADP+NifA ⇀↽
kd2
NifLredADPNifA, (2)
NifA+ 2OG ⇀↽
kd3
NifA(2OG), (3)
NifLredADP+GlnK(2OG) ⇀↽
kd4
NifLredADPGlnK(2OG),
(4)
NifLredADPGlnK(2OG) +NifA(2OG) ⇀↽
kd5
NifLredADPGlnK(2OG)NifA(2OG),
(5)
GlnK+ 2OG ⇀↽
kd6
GlnK(2OG), (6)
NifLredADPGlnK(2OG)NifA(2OG) + 2OG ⇀↽
kd7
NifLredADPGlnK(2OG)NifA(2OG)2.
(7)
We first performed simulations using both models and generate data for all
components of model A and B so as to compare them. Table 14 presents the
total concentrations and parameters, which were used in the simulations for
both models. Simulated data was generated for all components of model
A and B then the results compared for some of the components (Figure
40). The simulations of NifA(2OG) in both models are almost identical.
Furthermore, they are equally good in mimicking the experimental data.
The simulation of free NifA is identical in both models. NifA decreases
dramatically by adding GlnK to both models A and B. In high concentrations
of GlnK, there a is very low amount of free NifA available to activate
the transcription of nif genes as expected in models A and B. Adding
GlnK to both models decreases NifA and NifLredADP, consequently the
concentration of NifLredADPNifA in both of them also decreases.
Adding GlnK to both models A and B increases the concentration of
NifLredADPGlnK(2OG). Generation ofNifLredADPGlnK(2OG)NifA(2OG)
from the interaction of NifLredADPGlnK(2OG) and NifA(2OG) is the next
step in model A and B. The amount of NifLredADPGlnK(2OG)NifA(2OG)
is increased to the highest level of NifA by adding GlnK to model A leading
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Table 13: The ODEs for the GlnK system of model B. The ODE system was gener-
ated using mass action equations. Substitutions for ease of presentation are:
x1=[NifLred], x2=[ADP], x3=[NifLredADP], x4=[NifA], x7=[NifA(2OG)],
x9=[GlnK(2OG)], x8=[Glnk], x10=[NifLredADPGlnK(2OG)],
x5=[NifLredADPNifA], x11=[NifLredADPGlnk(2OG)NifA(2OG)],
and x6=[2OG], x12 =[NifLredADPGlnk(2OG)NifA(2OG)2]; ki and k−i
denote the forward and backward rates (i=1, 2, 3).
x˙1 = −k1x2x1 + k−1x3
x˙2 = −k1x2x1 + k−1x3
x˙3 = k1x2x1 − k−1x3 − k2x3x4 + k−2x5 − k4x9x3 + k−4x10
x˙4 = −k2x3x4 + k−2x5 − k3x4x6 + k−3x7
x˙5 = k2x3x4 − k−2x5
x˙6 = −k3x4x6 + k−3x7 − k6x8x6 + k−6x9 − k7x6x11 + k−7x12
x˙7 = k3x4x6 − k−3x7 − k5x10x7 + k−5x11
x˙8 = −k6x8x6 + k−6x9
x˙9 = −k4x9x3 + k−4x10 + k6x8x6 − k−6x9
x˙10 = k4x9x3 − k−4x10 − k5x10x7 + k−5x11
x˙11 = k5x10x7 − k−5x11 − k7x6x11 + k−7x12
x˙12 = k7x6x11 − k−7x12
Table 14: Concentrations (C/µM) and parameters (Kd/µM) of models A and B.
System Component Value model A Value model B
NifA 0.1 0.1
NifLred 0.2 0.2
ADP 50 50
2− oxoglutarate 1000 1000
GlnK 0.0,0.05,0.1,0.25,0.5,1 0.0,0.05,0.1,0.25,0.5,1
Kd1 20 20
Kd2 0.03 0.03
Kd3 57 57
Kd4 1 1
Kd5 0.001 1
Kd6 60 60
Kd7 - 1
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Figure 40: Comparison of simulations of some of the components of model A and
B.
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to very low availability of free NifA and NifA(2OG). In model A, high affin-
ity of NifLredADPGlnK(2OG) and NifA(2OG) leads the system to take all
the NifA(2OG) to the complex. Model B also takes all the NifA(2OG) to
the complex but in a different way. Adding an additional 2− oxoglutarate
accelerate the rate of reaction 7 as the concentration of 2− oxoglutarate
is very high (1000 µM) in comparison to NifA (0.1 µM) leading to very
low availability of NifA(2OG). This is the main difference between these
two models. However, both models drop to the inactive mode by increasing
the amount of GlnK to the system and they are equally good in fitting the
experimental data. In summary the result of the simulations suggests that
there are at least two equally good GlnK models. The first one, model A,
is the same as the original model with one different parameter while the
second one is different to the original but has the original set of parameters.
In the model B next sections we perform a series of tests to try to distinguish
between models A and B and also to characterize their properties.
5.0.3 Test 1
Four main computational tests were performed with the aim of characteriz-
ing the properties of models A and B. These tests are mainly based upon
changing the concentrations of GlnK and 2 − oxoglutarate, in order to
mimic different environmental conditions. In test 1, 2− oxoglutarate was
kept in low concentration and GlnK was perturbed. This test was carried out
to simulate limited carbon conditions when the 2− oxoglutarate concen-
tration is about 100 µM and the concentration of GlnK was varied from 0 to
2.5 µM. Test 1 mimics the conditions when the organism is in carbon limited
conditions and transits from low nitrogen to excess nitrogen conditions.
As Figure 41 shows, both models A and B have a low level of NifA(2OG)
less than as 25% even when there is no GlnK in the system. By increasing
GlnK in this condition the activity of NifA(2OG) decreases. The difference
in these two systems in this condition is that the GlnK system drops to a
complete switch off condition by increasing GlnK in model A. The complete
switch off phenomena in model B is not observed.
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Figure 41: The activity of the GlnK system at the low concentration of 2 −
oxoglutarate, whilst varying of GlnK from 0 to 2.5 µM. The activity
of the system is measured by calculating the percentage of NifA(2OG)
with respect to the total concentration of NifA.
5.0.4 Test 2
In test 2 the excess carbon and energy condition were applied to the system
and 2− oxoglutarate raised to 1000 µM. GlnK was varied in the same way
as test 1 from 0 to 2.5 µM. Test 2mimics the conditions when the organism is
in carbon excess conditions and transits from low nitrogen to excess nitrogen
conditions.
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Figure 42: Activity of the GlnK system at high concentrations of 2− oxoglutarate,
whilst varying GlnK from 0 to 2.5 µM. The activity of the system is
measured by calculating the percentage of NifA(2OG) with respect to
the total concentration of NifA.
As expected, both models A and B have the highest activity when GlnK
is not present into the system. Adding GlnK, even within a high concen-
tration of 2 − oxoglutarate , decreases the concentration of NifA(2OG)
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in both model A and B dramatically. Comparison of test 1 and 2 shows
that, with a low amount of GlnK both model A and B reach zero activ-
ity in test 2, while this is not the case in test 1. At high concentrations of
2− oxoglutarate, model A reaches zero activity at about 0.5 µM GlnK,
while at a low concentration model A reaches zero activity at 1.5 µM GlnK.
Considering the reaction schemes in models A and B, there is an interac-
tion between GlnK and 2− oxoglutarate in each model, reaction 6. High
concentrations of 2− oxoglutarate accelerate the forward interaction of
2− oxoglutarate and GlnK to push most of the free GlnK to GlnK(2OG).
Consequently, at each total concentration of GlnK, the system produces
more GlnK(2OG) at high concentrations of 2− oxoglutarate in compari-
son to low concentration of 2− oxoglutarate(comparison of test 2 to teat
1). To validate this idea, we looked at the concentration of GlnK(2OG) in
both conditions in model A. It appears that when the starting concentra-
tion of 2− oxoglutarate is 0.5 µM, the model reaches a steady state when
the concentration of GlnK(2OG) is 0.24 µM, whereas with 1000 µM of
2− oxoglutarate leads to 0.36 µM of GlnK(2OG). More GlnK(2OG) con-
centration at each point leads to greater inhibition of NifA(2OG), which
causes the system to stay in an inactive mode at a lower total concentration
of GlnK.
5.0.5 Test 3
In last two tests the 2− oxoglutarate concentration was either low or high,
and GlnK in both models was varied. These tests kept the concentration of
GlnK low at 0.1 µM while varying the concentration of 2− oxoglutarate
from 0 to 2500 µM. Test 3 mimics the conditions of the bacteria when under
nitrogen deficiency conditions and moving from carbon deficiency to carbon
replete conditions, which increases the level of 2− oxoglutarate.
As 2− oxoglutarate is the activator of the NifL−NifA system and the
amount of GlnK is low, increasing 2− oxoglutarate in test 3 increases the
activity of the system (Figure 43). The maximum activity, which can be
reached by model A in this condition, is 25% presumably because of the low
level of GlnK.
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Figure 43: Plots of activity of model A and B at a low concentration of GlnK in
response to varying the concentration of 2− oxoglutarate. The concen-
tration of GlnK is 0.1 µM and 2− oxoglutarate varies from 0 to 2500
µM.
The behavior of model B is different to model A in test 3. Model B reaches
the maximum activity of 27.5%, but at 2−oxoglutarate concentration above
400 µM the NifA(2OG) concentration decreases. This is a very interesting
result because it was not apparent from the original experimental obser-
vations. This behavior can be because of present of 2− oxoglutarate in
reaction 7. When the concentration of NifLredGlnK(2OG)NifA(2OG)gets
higher 2− oxoglutarate accelerates the productivity of complex leading to
decrease in NifA(2OG).
5.0.6 Test 4
In test 3 the GlnK concentration was kept as low as 0.1 µM to examine
the behavior of models at relatively low concentrations of GlnK. In test 4
the concentration of GlnK was raised up to 1 µM and 2− oxoglutarate
was varied from 0 to 2500 µM. Test 4 mimics the conditions for when the
bacteria are in excess fixed nitrogen conditions and during the transition
from carbon limiting to carbon excess condition, which results in an increase
in the level of 2− oxoglutarate.
The analysis shows that in both models the activity increases transiently
in response to the 2− oxoglutarate concentration(Fig 38). The activity of
the system in model A increases to a maximum of 3% with about 20 µM
of 2− oxoglutarate, while the maximum activity in model B is about 14%
the glnk system 141
10
5
 0  500  1000  1500  2000  2500
N
if
A
o
x
o
%
[oxo]
Model A
Model B
10
5
 0  50  100  150  200  250
N
if
A
o
x
o
%
[oxo]
Model A
Model B
Figure 44: Plots of activity of model A and B at a high concentration of GlnK, 1 µM,
with 2− oxoglutarate concentrations varying from 0 to 2500 µM. The
top graph presents the full range of the 2− oxoglutarate concentrations
and the bottom one narrows it down this range to 0 to 250 µM.
reached after the amount of 2 − oxoglutarate has risen to 60 µM. The
activity of both models decreases after maximum activity. Assuming 1-2%
activity is an inactive mode, both of them finally reach inactivity.
We can argue that the concentration of the GlnK is 1 µM and 10 times the
concentration ofNifA, 2−oxoglutarate in certain concentration accelerates
the production of GlnK(2OG) in comparison to NifA(2OG) leading to more
complex and consequently decrease in NifA(2OG). This is more effective
in model B and 2− oxoglutarate is also one of the reactants of the final
product of the system. To summarise, increasing amounts 2− oxoglutarate
leads to more GlnK(2OG), more GlnK(2OG) leads to more NifLredADP
GlnK(2OG)NifA(2OG). Finally increasing amounts of 2 − oxoglutarate
and NifLredADPGlnK(2OG)NifA(2OG) leads to the formation of more
NifLredADPGlnK(2OG)NifA(2OG)2 in model B.
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5.1 comparison on model a and b
In Chapter 4 we showed that 2− oxoglutarate is a key regulator of the
NifL−NifA system. The system is in favour of stimulating the synthesis of
mRNA transcripts encoding nitrogenase when the fixed nitrogen is a limiting
factor. The 2− oxoglutarate allows the system to remain in active mode
in nitrogen deficiency conditions. On the other hand, there is a mechanism
to protect the bacteria from using carbon energy in conditions when the
fixation of N2 is not necessary. In this chapter, this mechanism, i.e. the Glnk
system, was investigated in detail.
The GlnK system was modelled initially using a set of reactions and
parameters that incorporates current biological knowledge. The results of
modelling the GlnK system were far from the experimental observations. We
then generated 41 different models for the GlnK system. These systems were
investigated through parameter estimation and stability analysis leading
to two potential models. In addition to this, four computational tests were
performed to monitor the sensitivity of the potential models to GlnK and
2− oxoglutarate with the aim of distinguishing the potential models. They
showed different behavior in those tests.
It was important to investigate the NifL − NifA system in detail to
clarify how the system tunes its activity based on 2− oxoglutarate and
GlnK. GlnK passes the message of nitrogen status to the system and
2− oxoglutarate passes the message of carbon energy working together
to tune the system in different environmental conditions. In conclusion
for characterizing and separating the potential models, the concentrations
of 2− oxoglutarate and GlnK were perturbed up to 2000 and 2 µM, re-
spectively. The author’s program, Equilibrium, was used to simulate the
GlnK system based on different 2 − oxoglutarate and GlnK concentra-
tions. The starting concentration of 2 − oxoglutarate for simulating of
GlnK was 5 µM. Consequently, there were 400 different concentrations of
2− oxoglutarate to be investigated by the program. For each concentration
of 2− oxoglutarate there were 400 different concentrations of GlnK. In
total, the program therefore simulated the GlnK system 160,000 times with
different total concentrations of 2− oxoglutarate and GlnK.
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Figure 45: 3D plot presenting the effect of both GlnK and 2− oxoglutarate (2OG)
at the same time on the activity of the GlnK system. Activity of the
system is calculated by taking the ratio ofNifA(2OG) to the total amount
of NifA. The bar shows the activity as a percentage. The upper graph
comes from model A and the lower from model B.
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The investigation into the activity of the GlnK system using both models
A and B indicates that a higher ratio of 2− oxoglutarate to GlnK increases
the activity of the GlnK system. However, the ratio is not the only factor for
modulating the activity. The system acts differently in different range of the
GlnK and 2− oxoglutarate concentrations. For low concentrations of GlnK
and 2− oxoglutarate, the concentration of 2− oxoglutarate raises the ac-
tivity of the system. At high concentrations of GlnK, even high amounts
of 2− oxoglutarate are not able to change the activity of the system and
it stays in a very low range. To investigate the system using the ratio of
2− oxoglutarate to GlnK, it is important to monitor the activity of the
system based on individual concentrations of GlnK and 2− oxoglutarate
and their combinations. Figure 45 presents data for all of 2− oxoglutarate
and GlnK concentrations within the range of 0-2000 µM and 0-2 µM , re-
spectively, for model A and model B (Figure 45).
In summary our findings for GlnK models A and B are as follows:
Model A:
• There is a small range for the 2− oxoglutarate and GlnK concentra-
tions that leads to high activity of the system.
• Increasing the concentration of GlnK to higher than 0.2 µM switches
the system to an inactive mode.
• There is a threshold for the amount of GlnK in the system across which
the behavior from active mode to inactive mode switches, disregarding
2− oxoglutarate concentration.
• In very low concentrations of GlnK the activity of the system is depen-
dent on the 2− oxoglutarate concentration.
• There is a very narrow range in which the system is fully active. This
happens when the concentration of 2− oxoglutarate is higher than
1000 µM and when the concentration of GlnK is in the range of 0.01
µM.
Model B:
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• There is a small range for the 2− oxoglutarate and GlnK concentra-
tions that leads the system to high activity in model B, although this
range is bigger than the active in model A.
• Increasing the concentration of GlnK decreases the activity of the
system. Unlike model A, it does not switch the system to the inactive
mode.
• There is no threshold for the amount of GlnK in model B to switch the
behavior of the system from active to inactive mode.
• Like model A, when concentrations of GlnK are very low, the activity
of model B is the dependent of the 2− oxoglutarate concentration.
• There is a very narrow range in model B similar to model A when the
system is fully active. This situation occurs, when the concentration of
2− oxoglutarate is higher than 1000 µM and concentration of GlnK
is around 0.01 µM.
• In model B, even in high concentration of GlnK, the GlnK system
shows some degree of activity while the GlnK system in model A does
not show any activity in higher than 0.2 µM of GlnK.
• Model B unlike model A is not inactive in the present of 2 µM of
GlnK.
5.2 conclusion
The modelling has shown that both model A and B and mimic some of
the experimental observations. However, each model has its characteristics
leading to two different models responses to the perturbation. We showed
that although increasing the concentration of GlnK decreases the activity
of the system, model B unlike model A does not switch the system to
the inactive mode (Figure 45 and Figure 41). There is strong experimental
evidence showing that at a high concentration of GlnK the activity of
NifA(2OG) is almost zero [53, 60, 10]. Therefore model B does not mimic
the experimental system in this regard.

6
DYNAMIC REGULATION OF NITROGEN F IXAT ION IN
A .V INELANDI I AND K .PNEUMONIAE
The complexity of regulation of nitrogen fixation and the low availability of
data means that dynamic modelling is a very challenging task. Comparing
the dynamics of nitrogen fixation in A. vinelandii to K. pneumoniae,
which regulate nitrogen fixation the same components but in a different way,
can help to reveal the characteristics of nitrogen fixation.
We initiated the modelling of the NifL−NifA system in A. vinelandii by
forming a complete set of reactions involved in nitrogen fixation. Appendix
A presents all the reactions involved in system. Three layers of gene, protein,
and metabolic were considered in forming the scheme the NifL −NifA
system. Most of the reactions are in the protein layer, which contains the
protein-protein interactions. Metabolic reactions are in metabolic layer of
the scheme and the gene layer contains the transcription and translation
reactions. There is currently not much data available for set of reactions.
Furthermore, putting all the reactions together increases the complexity
of the system. We attempted to model the complete NifL−NifA system
dynamically but by doing so the complexity of the system was increased and
so the chance of revealing the characteristics of the system was decreased.
Consequently modelling the dynamics of nitrogen fixation at an abstract
level is more plausible than modelling the complete system.
We have studied the two main sub-systems of the NifL−NifA system
in A. vinelandii in the last two chapters. We learnt that the system is
more sensitive to total concentrations of the system components than to
the parameters of the system (Chapter 5). Hence we can set the parameters
of the abstract model to arbitrary values, the focus can be shifted to the
transcription of model components. Perturbation of the transcription rates
changes the concentrations of key components of model. Furthermore we
found out that the ratio of NifL to NifA is important in addition to their
ranges of concentration (Chapter 5). As NifA is either free or complexed
with NifL, our studies showed that the ratio of NifL to NifA is crucial, so
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we dismiss all the intermediate steps and only present two forms of active
and inactive NifA in this study.
We learnt from Chapter 6 that GlnK is the master regulator in this system.
In particular, we showed that, although 2− oxoglutarate, ADP, and ATP
play roles in regulation of nitrogen fixation, the system has two different
behaviors based on presence and absence of GlnK [55]. We showed that even
low amounts of GlnK reduce the activity of the system dramatically. We
can apply this knowledge to model nitrogen fixation abstractly by ignoring
some of the interactions of the system and including the active and inactive
forms of GlnK to the abstract model.
The global mechanism of nitrogen fixation is deceptively simple. When
insufficient fixed nitrogen is available nif genes are transcribed leading
to atmospheric nitrogen fixation and once fixed nitrogen is available, the
transcription of nif genes slows down. Similarly, if too much oxygen is
present, transcription of nif genes slows down. So, in ambient conditions,
nitrogen fixation is regulated by the availability of fixed nitrogen (Chapter 1
Section 1.3.8).
The regulation of nitrogen fixation in A. vinelandii is different to that
in K. pneumoniae with regards to nitrogen status. Figure 46 presents a
very basic model of nitrogen fixation regulation in A. vinelandii and K.
pneumoniae. In both species, transcription of the nif genes requires NifA
to bind to an upstream promoter site. The transcription of nif genes are then
activated leading to more available nitrogenase to catalyze the conversion
of atmospheric nitrogen to ammonia [27]. This process is the same in both
systems, but the mechanism of responding to production of ammonia in the
systems is different. Sensing the nitrogen status and the bacteria’s responses
to it are the key differences in regulating nitrogen fixation between these
species.
Ignoring all the details in sensing the nitrogen in the cell in both systems,
we have introduced ’Signal’ as the sensor of nitrogen, which includes all
the processes involved in sensing nitrogen in the cell. In addition, there
was no attempt to model all the reactions in this study. Once NifA, has
activated transcription, both systems produce Signal to send the message
of nitrogen sufficiency that gets relayed to other components of the system.
The next step is from Signal to GlnK which is different for A. vinelandii
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and K. pneumoniae (Figure 46). Signal in K. pneumoniae not only acts
differently in comparison to Signal in A. vinelandii, but it also does its
task in different way. Unlike in A. vinelandii, the Signal in K. pneumoniae
acts as a repressor of the glnk gene to decrease the transcription of GlnK
[76, 86]. Thus glnk gene is subject to nitrogen regulation in K. pneumoniae,
whereas this is not the case for A. vinelandii [10].
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Figure 46: Conceptual model of nitrogen fixation in A. vinelandii (A) and K.
pneumoniae (B).
In A. vinelandii Signal only activates GlnK via protein modification, and
the glnk gene is not affected by it. GlnK itself also plays different roles in A.
vinelandii and K. pneumoniae. GlnK in A. vinelandii inactivates NifA
by forming the NifL−NifA complex, which stops activation of nif genes,
whereas GlnK in K. pneumoniae promotes the dissociation of NifL−NifA
complex to activate the system (Figure 46).
6.1 the abstract model of nitrogen fixation in a .vinelandii
Using the conceptual model in Figure 46 A, a set of reactions was formed
for A. vinelandii. It consists of degradation reactions, regulatory reactions,
and transcriptional reactions:
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NifAa +nif → NifAa +nif+mRNA, (6.1)
Signal+GlnKi ⇀↽ GlnKa, (6.2)
GlnKa +NifAa ⇀↽ NifAi, (6.3)
nifa → NifAa, (6.4)
glnk → GlnKa, (6.5)
mRNA+ R → Nitrogenase+mRNA+ R, (6.6)
Nitrogenase+N2 → ammonia+Nitrogenase+N2, (6.7)
ammonia → Signal+ ammonia, (6.8)
NifAa → ∗, (6.9)
Signal → ∗, (6.10)
GlnKi → ∗, (6.11)
GlnKa → ∗, (6.12)
NifAi → ∗, (6.13)
mRNA → ∗, (6.14)
Nitrogenase → ∗, (6.15)
ammonia → ∗. (6.16)
In this system, NifA is represented in the active form by NifAa and in the
inactive form by NifAi. NifAa is the free form of NifA, which can activate
the transcription of nif genes. The NifAi is interacted form of NifA to NifL.
GlnK is also represented as two forms active Glnka and inactive, Glnki.
GlnK inactivates NifA in A. vinelandii. GlnKa and NifAa are products of
glnk and nifa genes. R represents the ribosome that interacts with mRNA
to translate nitrogenase.
Table 15 presents the rate of all the reactions (7.1)-(7.16) of the system
and the corresponding ODE system. The rate of equation 7.1 was calculated
using the Hill function for an activator. The rate of all other reactions was
calculated using the law of general mass action. The Signal activates GlnKi
(7.2) leading to inactivation of NifAa by GlnKa (7.3). Equations 7.4 and
7.5 are the transcriptions reaction of the nifa and glnk genes. Equation
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Table 15: The rate of reactions and ODEs for the abstract system of A.
vinelandii. Substitutions for ease of presentation: y1=[NifAa], y2=[nif],
y3=[Signal], y4=[Glnki], y5=[Glnka], y6=[NifAi], y8=[nifa], y10=
[Ribosome], y7=[mRNANitrogenase], y9=[glnk], y13=[Ammonia],
y12=[N2], y11=[Nitrogenase].
v1 =
B(y1)
n
(k1)n+(y1)n
y˙1 = −v3 − v9 + v4
v2 = y3y4k2 − y5k3 y˙2 = 0
v3 = y5y1k4 − y6k5 y˙3 = v8 − v2 − v10
v4 = t1y8 y˙4 = −v2 − v11 + v5
v5 = t5y9 y˙5 = v2 − v3 − v12
v6 = y7y10k6 y˙6 = v3 − v13
v7 = y11y12k7 y˙7 = v1 − v14
v8 = y13k8 y˙8 = 0
v9 = d1y1 y˙9 = 0
v10 = d3y3 y˙10 = 0
v11 = d4y4 y˙11 = v6 − v15
v12 = d5y5 y˙12 = 0
v13 = d6y6 y˙13 = v7 − v16
v14 = d7y7
v15 = d11y11
v16 = d13y13
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7.6 represents the translation of mRNA to nitrogenase. The fixation of N2
occurs in equation 7.7. As the source of N2 is abundant, N2 was placed
deliberately in the products of equation 7.7 to keep the amount of N2
constant in the system. Signal senses the production of the ammonia in 7.8.
Finally, equations 7.9 to 7.16 represent the degradation of the components of
the system.
6.2 the abstract model of nitrogen fixation in k .pneumoniae
There are three differences between the abstract model of K. pneumoniae
and A. vinelandii. Firstly, GlnK is regulated at the transcriptional level in
K. pneumoniae. Signal acts as a repressor of the corresponding glnk gene
in equation (7.18). The rate of equation 7.18 is calculated using Hill function
for a repressor. Secondly, the transcription of nifa gene is controlled by the
Signal. It represses the transcription of the nifa gene equation (7.19). The
rate of equation 7.19 is also calculated using Hill function for a repressor.
Thirdly, GlnKa activates NifAi to NifAa equation (7.20). Table 16 presents
the rate of all reactions and corresponding ODE system for K. pneumoniae.
The conceptual model in Figure 46 B was used to form the abstract model
of nitrogen fixation in K. pneumoniae, made up of the following reactions:
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Table 16: The rate of reactions and ODEs for the abstract system of K. pneumoniae.
Substitutions for ease of presentation are x1=[NifAa], x2=[nif],
x3=[Signal], x4=[glnk], x5=[Glnka], x6=[NifAi], x9= [Ribosome],
x8=[nifa], x7=[mRNANitrogenase], x10=[Nitrogenase], x11=[N2],
x12=[Ammonia].
v17 =
Axn1
(k1)n+(x1)n
x˙1 = v19 + v20 − v24
v18 =
B
1+(
x3
k2
)n
x˙2 = 0
v19 =
C
1+(
x3
k3
)n
x˙3 = v23 − vd3
v20 = x5x6k4 − x1k5 x˙4 = 0
v21 = x7x9k6 x˙5 = v18 − v20 − v26
v22 = x10x11k7 x˙6 = −v20 − v27
v23 = x12k8 x˙7 = v17 − v28
v24 = d1x1 x˙8 = 0
v25 = d3x3 x˙9 = 0
v26 = d5x5 x˙10 = v21 − v29
v27 = d6x6 x˙11 = 0
v28 = d7x7 x˙12 = v22 − v30
v29 = d10x10
v30 = d12x12
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NifAa +nif → NifAa +nif+mRNA, (6.17)
Signal+ glnk → Glnka + glnk, (6.18)
Signal+nifa → NifAa +nifa, (6.19)
GlnKa +NifAi ⇀↽ NifAa, (6.20)
mRNA+ R → Nitrogenase+mRNA+ R, (6.21)
Nitrogenase+N2 → ammonia+Nitrogenase+N2, (6.22)
ammonia → signal+ ammonia, (6.23)
NifAa → ∗, (6.24)
Signal → ∗, (6.25)
GlnKa → ∗, (6.26)
NifAi → ∗, (6.27)
mRNA → ∗, (6.28)
Nitrogenase → ∗, (6.29)
ammonia → ∗. (6.30)
6.3 comparison of abstract models
We simulated nitrogen fixation in both abstract models of A. vinelandii
and K. pneumoniae using the ODEs in Table 15 and Table 16. The same
parameter values and total concentrations were used for modelling both
systems (Table 17). Since both of these systems regulate nitrogen fixation
by regulating NifAa, leading to regulation of nif gene transcription and
finally productivity of ammonia, we monitored the simulation data for
NifAa and ammonia. These two components of the system were monitored
in two opposite environmental conditions. One where there is no ammonia
available in the system and the species start fixing N2, and the other where
an excessive amount of ammonia is available at the starting point.
The result of modelling the two species shows that both systems oscillate
in prescribed conditions. Figure 47 presents the comparison of these models
with respect to NifAa. There is no ammonia available at the starting time
of simulations. The amplitude of the first peak in A. vinelandii is higher
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than the other peaks. The ammonia starvation in A. vinelandii leads to this
peak, but K. pneumoniae does not show any differences between the first
peak and others. The amplitude of first peak in concentration of ammonia
is higher than the other peaks in both A. vinelandii and K. pneumoniae
(Figure 48). Signal in K. pneumoniae controls the transcription of NifAa,
therefore production of ammonia increases Signal leading to stop first
peak be higher in K. pneumoniae. In general, the peaks in A. vinelandii
are sharper than the peaks in K. pneumoniae. This sharper increase and
decrease in transcription of NifAa indicates that A. vinelandii has stronger
response.
High amounts of ammonia at the starting point of the simulations in both
species stop the transcription of NifAa in K. pneumoniae and reduce the
transcription of NifAa in A. vinelandii (Figure 49). This is not unexpected
as K. pneumoniae controls the transcription of NifAa leading to the halt in
transcription for a short period of time, while A. vinelandii does not halt
transcription completely as there is no NifAa transcriptional regulation in
A. vinelandii. Both species reduce the amount ammonia with the same rate
(Figure 50).
 0
 1
 2
 3
 4
 5
 6
 0  200  400  600  800  1000
[N
if
A
a
] 
in
 µ
M
Time (s)
A.vinelandii
K.pneumoniae
Figure 47: Simulation of NifAa for both species of A. vinelandii and K.
pneumoniae when no ammonia is available initially.
6.4 parameter perturbation
To investigate the effect of parameter perturbation we performed a number
of simulations with different parameters. The effect of perturbation was
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Table 17: The parameter values relevant to the ODE model of the abstract system in
A. vinelandii and K. pneumoniae.
Model Components A.vinelandii K.pneumoniae
k1 1 1
k2 1000 1
k3 10 1
k4 10000 10000
k5 100 100
k6 1 1
k7 0.1 0.1
k8 0.0001 0.0001
A - 0.1
B 0.1 0.1
C - 0.1
n 4 4
d1 0.1 0.1
d3 0.1 0.1
d4 0.1 -
d5 - 0.1
d6 0.1 0.1
d7 0.1 0.1
d10 - 0.1
d11 0.1 -
d12 - 0.1
d13 0.1 -
t1 1 -
t5 1 -
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Figure 48: Simulation of ammonia for both species of A. vinelandii and K.
pneumoniae when no ammonia is available initially.
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Figure 49: Simulation of NifAa for both species of A. vinelandii and K.
pneumoniae when 400000 µM ammonia is available initially.
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Figure 50: Simulation of ammonia for both species of A. vinelandii and K.
pneumoniae when 400000 µM ammonia is available initially.
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investigated in A. vinelandii. Here, we present the perturbations of two
key rates of the system, rate of transcription of NifAa and productivity of
ammonia. The rate of transcription of NifA was perturbed by increasing
t1 from 1 M−1s−1 to 1.03 M−1s−1 and the productivity of ammonia was
perturbed by increasing k8 from 0.0001 M−1s−1 to 0.0005 M−1s−1.
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Figure 51: Simulations of NifAa with the original parameters and with the per-
turbed parameters for A. vinelandii, when no ammonia is available
initially. Data1 is the simulation with original parameters. In Data2, the
rate of transcription of NifAa was increased by 3%.
Increasing t1 decreases the amplitude of spikes in NifAa transcription
(Figure 51) and increases the wavelength, i.e. which is the time between
two consecutive spikes. As t1 increase the amplitude of the spikes tends
to zero after the first spike for both NifAa and ammonia (for t1 higher
than 1.04M−1s−1 the amplitude is close to zero after first spike). Increasing
the level of NifAa increases the ratio of this protein to GlnKa leading to
lowering the effect of feedback mechanism for the system. This indicates
a high sensitivity of the system to t1. In other words, the system is highly
sensitive to the rate of transcription of NifAa.
The system is also sensitive to the productivity of ammonia. Increasing k8
decreases the amplitude of the spikes in NifAa transcription and ammonia
production ((Figure 52 and Figure 53)). Although the system is sensitive to
k8, the sensitivity to k8 is lower than the sensitivity to t1, as 3% perturbation
of t1 can change the concentration of ammonia and NifAa in almost the
same way as a 500% perturbation of k8. The amplitudes of the spikes tend
to zero after a 10 fold increase in k8.
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Figure 52: Simulations of NifAa with the original parameters and with the per-
turbed parameters for A. vinelandii, when no ammonia is available
initially. Data1 is the simulation with original parameters. In the Data2,
the rate of production of ammonia was increased by 5 fold.
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Figure 53: Simulations of ammonia with the original parameters and with the
perturbed parameters for A. vinelandii, when no ammonia available
initially. Data1 is the simulation with original parameters. In the Data2,
the productivity of ammonia was increased by 5 fold.
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6.5 nifaa against ammonia
Availability of ammonia and NifAa are the main factors of the system. For
further analysis, the phase plot of these two components against each other
was plotted (Figure 54 and Figure 55) for both species. The result shows
that both of them tend to a limit cycle after the first spike. Both systems
were simulated with no ammonia available at the start point. The outer
curves in both models transit to a limit cycle. Thus, it confirms that both
system given the initial conditions stay in oscillation forever. It also shows
that the behavior of NifAa changes for certain concentrations of ammonia.
The transcription of NifAa clearly spikes when ammonia is around 5000
µM and stops after around 20000 µM ammonia in A. vinelandii.
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Figure 54: The phase diagram of NifAa against ammonia when no ammonia is
available initially in A. vinelandii.
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Figure 55: The phase diagram of NifAa against ammonia when no ammonia is
available initially in K. pneumoniae.
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6.6 conclusion
We developed abstract models that were found to be in agreement with
the general properties of A. vinelandii and K. pneumoniae. From these
models we learned that A. vinelandii more complete species in comparison
to K. pneumoniae in respect to nitrogen fixation. The system switches
on and off in A. vinelandii faster to react to the different environmental
conditions. In addition, we learned that given the initial conditions, each
system stays in oscillation forever, although, changing the rates of reaction
can change the overall behavior. Finally, the system has some critical points
of concentration of ammonia leading to change in the behavior of the system.
It would be interesting to study this further, but the author had no additional
time to undertake a study.
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CONCLUDING REMARKS
Much effort is currently being made to better understand biological phenom-
ena at the systems level. Biology is evolving from reductionist point of view,
which focused on individual cellular components, to systems point of view,
driven by the quantitative nature and increasing amounts of biological data
[66, 69, 52]. This integrative analysis focuses on system properties of cellular
functions. Generally speaking, knowledge about complex biological systems,
such as nitrogen fixation, can be separated to ’what we know’, ’what we
think we know’, ’what we know we do not know’, and simply ’what we do
not know’.
7.1 what we know → what we think we know
The importance of understanding of nitrogen fixation has prompted many
wet scientists to do research in this field over recent decades, resulting in
over six thousand nitrogen fixation related papers plus four hundred hits
of nitrogenase kinetics in a recent PubMed search. From what we have
presented in this thesis, the following key questions have arisen on the
systems biology of nitrogen fixation:
• Is there a limitation to systems biology in regard to the availability of
data?
• Is there the possibility of extra interactions in the GlnK system?
7.2 what we do not know → what we know
In addition to the questions raised in the last section, we have improved our
understanding of nitrogen fixation as follows:
• We have developed a model of nitrogenase action and made it available
to the scientific community.
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• The availability of stoichiometric amount of NifA and NifL does not
fit experimental data, and the ratio of NifL to NifA has to be around
2.
• The concentration of NifA and NifL need to be 10 times more than
what we think to fit to experimental data.
• We know that the NifL−NifA system is more sensitive to the total
concentrations of its components in comparison to the model parame-
ters.
• A model was presented for the mechanism of the GlnK system.
• The affinity of NifLredADPGlnK(2OG) to NifA(2OG) can be 1000
times higher than what is currently thought.
• An abstract model of nitrogen fixation in A. vinelandii based on
current understanding of the system was presented.
• We presented an abstract model of nitrogen fixation in K. pneumoniae
based on our understanding of that system.
• We showed that A. vinelandii has probably evolved a more sensitive
system for nitrogen fixation than K. pneumoniae, leading to a quicker
response to the availability of fixed nitrogen.
• Using the abstract models we have developed, we have shown that
given the initial conditions, regulation of nitrogen fixation in both
species is probably oscillatory.
7.3 what we know we do not know
Our investigation was limited by the complexity of nitrogen fixation and
also time. We suggest that more time and effort should be invested in
investigating the following:
• More kinetic data needs to be obtained for our system, as we are not
able to model the complete system of nitrogen fixation with the current
data.
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• We do not know how sensitive our abstract model is with regard to
changes in parameters.
• We do not know what the boundaries are for the initial conditions of
the abstract models so that they stay in oscillation.
• We do not know if adding noise to the abstract returns to former state
or goes to another state.
7.4 what we do not know
• We do not know many things and
many aspects of nitrogen fixation are
still a mystery to the author!
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A
THE COMPLETE REACT IONS OF NIFL -N IFA SYSTEM
NifLox + e
− ⇀↽ NifLred, (A.1)
NifLox +ADP ⇀↽ NifLoxADP, (A.2)
NifLred +ADP ⇀↽ NifLredADP, (A.3)
NifLredADP+NifA⇀↽ NifLredADPNifA, (A.4)
NifA+ 2OG⇀↽ NifA(2OG), (A.5)
NifA+NifLoxADP ⇀↽ NifLoxADPNifA, (A.6)
NifA(2OG) +NifLoxADP ⇀↽ NifLoxADPNifA(2OG), (A.7)
GlnkATP(2OG) +NifLox ⇀↽ NifLoxGlnkATP(2OG), (A.8)
NifLoxADP+GlnkATP(2OG)⇀↽
NifLoxADPGlnkATP(2OG), (A.9)
NifA(2OG) +NifLoxGlnKATP(2GO)⇀↽
NifLoxGlnKATP(2GO)NifA(2GO), (A.10)
NifA(2OG) +NifLoxADPGlnKATP(2GO)⇀↽
NifLoxADPGlnKATP(2GO)NifA(2OG), (A.11)
2GO+ATP+Glnk→ GlnKATP(2GO), (A.12)
NifLoxADPNifA+ e⇀↽ NifLredADPNifA, (A.13)
NifLred +GlnKATP(2GO)⇀↽
NifLredGlnKATP(2GO), (A.14)
GlnKATP(2GO) +NifLredADP ⇀↽
NifLredADPGlnKATP(2GO), (A.15)
NifA(2OG) +NifLredADPGlnKATP(2GO)⇀↽
NifLredADPGlnKATP(2GO)NifA(2OG), (A.16)
NifLoxADP+ e⇀↽ NifLredADP, (A.17)
NifLredADPNifA+ 2GO⇀↽ NifLredADP+NifA(2OG), (A.18)
NifLredGlnKATP(2GO) +NifA(2OG)⇀↽
NifLredGlnKATP(2GO)NifA(2OG), (A.19)
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glutamate+ ammonia→ glutamine, (A.20)
2GO+ glutamine→ 2− oxo− glutamate, (A.21)
2− oxo− glutamate+ ammonia→ glutamate, (A.22)
NifA(2OG) +NitrogenaseGenesNifGenes→
mRNANitrogenase, (A.23)
mRNANitrogenase→ Nitrogenase, (A.24)
NifA(2OG) + rnfGenes→ mRNArnf, (A.25)
mRNArnf→ rnfProducts, (A.26)
UtaseUR+ glutamine→ UtaseUR− glutamine, (A.27)
ATase+GlnKATP(2GO)→ GlnKATP(2GO)ATase, (A.28)
ATase+GlnKATP(2GO)UMP →
GlnKATP(2GO)UMPATase, (A.29)
GlnKATP(2GO) +UTP+UtaseUR→
GlnKATP(2GO)UMP, (A.30)
UtaseUR− glutamine+GlnKATP(2GO)UMP →
GlnKATP(2GO) +UMP, (A.31)
glutamineSynthetase+GlnKATP(2GO)ATase→
glutamineSynthetase−AMP, (A.32)
GlnKATP(2GO)UMPATase+ glutamineSynthetaseAMP
→ glutamineSynthetase+AMP, (A.33)
NifL+ ox→ NifLox, (A.34)
NifL+ e→ NifLred, (A.35)
N2+Nitrogenase→ ammonia. (A.36)

B
INVEST IGAT ION OF THE STEADY STATE POINTS IN
THE 2 -OXOGLUTARATE SYSTEM
b.1 steady state point 1
In steady state point 1 the concentration of 2− oxoglutarate is zero, indi-
cating that there is not any interaction between NifA and 2− oxoglutarate
and only reaction 6 and 7 happen in 2− oxoglutarate system.
Parameter Estimation
Table 18 presents the result of parameter estimation in steady state point. As
it is indicated in the Table 18, the estimated parameters are extremely close
to the natural.
Table 18: Estimated Parameters (Kd/µM) for steady state point 1.
Kd Estimation Experiment
Kd1 14.34 13
Kd2 0.033 0.03
Kd3 40.05 57
Forward Modeling
Using the estimated parameters in steady state point 1, we performed
forward modeling for all steady state points. The Equilibrium program was
applied for forward modeling of all points with the estimated parameters.
Figure 52 shows the in silico production of NifA(2OG) based on different
concentrations of 2− oxoglutarate in comparison with the experimental
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data. The NifA(2OG) simulation is in agreement with the experimental
results as it is indicated in Figure 52.
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Figure 56: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) us-
ing the estimated parameters from steady state point 1. NifA(2OG)
is compared with the experimental data, and NifLredADP and
NifLredADPNifA are compared to the simulation with the original
parameters.
We extended our in silico experiment to produce data for production
of NifLredADP and NifLredADPNifA with estimated parameters in all 14
different concentrations of 2− oxoglutarate. The result of this analysis is
presented in Figure 52. We compare the simulation of NifLredADP with
the estimated parameters and experimental parameters for all steady state
points in 2− oxoglutarate system. They are in agreement. We performed
the same task for NifLredADPNifA as it is indicated in Figure 52. There is
also agreement between these two simulations.
Steady-state analysis
The stability analysis shows that the system in this state is asymptotically
stable using the estimated parameters. Table 19 presents the concentration
of metabolites of 2− oxoglutarate system in this state, using estimated
parameters.
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Table 19: Concentration values (C/µM) in steady state conditions for steady state
point 1.
metabolite value
NifLred 0.0018
ADP 49.99
NifLredADP 0.0065
NifA 0.0083
NifLredADPNifA 0.0016
2− oxoglutarate 0
NifA2oxo 0
Sensitivity analysis
We performed a sensitivity analysis for all three parameters of the 2 −
oxoglutarate system in steady state point. The results of this are presented
in Figure 57. Since the concentration of 2− oxoglutarate is zero at this
point, there is no production of NifA(2OG) and so it is not sensitive to any
parameter. Both of NifLredADP and NifLredADPNifA are sensitive to Kd1
in a very similar manner. NifLredADPNifA is quite sensitive to perturbation
of Kd2 and it is more sensitive to decreasing Kd2 in comparn to its increasing.
Decreasing Kd2 by 95% has the most effect for this steady state point (260%
change of NifLredADPNifA). The interesting result for this point is that,
although NifLredADP is production of reaction 1 with dissociation constant
Kd1 , it is more sensitive to Kd2 as it interacts with NifA.
b.2 steady state point 2
In steady state point 2 the concentration of 2− oxoglutarate is equal to 0.01
µM, and the concentration of NifA(2OG), which was used for parameter
estimation is equal to 0. Table 20 presents the result of parameter estimation
in this steady state point. As the Table 20 shows the estimated parameters
are far from the original values. The concentration of NifA(2OG) which
was used in this state is 0 too. As the concentration of 2− oxoglutarate
is 0.01 µM in this point, there should be some production in NifA(2OG)
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Figure 57: Sensitivity analysis of Kd1 , Kd2 ,and Kd3 in steady state point 1.
but the experimental value doesn’t imply this. The result of this estimation
proposes that the activity of NifA(2OG) is more than zero with the 0.01 µM
of 2− oxoglutarate(Experimental error) .
Table 20: Estimated Parameters (Kd/µM) for steady state point 2.
Kd Estimation Experiment
Kd1 0.24 13
Kd2 2.49e-10 0.03
Kd3 8.9e+12 57
Since the estimated parameters are dramatically far from the lab provided
parameters in steady state point 2, it makes no sense to perform forward
modeling and steady state analysis with this estimated parameters. The
concentrations of NifA(2OG), NifLredADP, and NifLredADPNifA in this
steady state point with the original parameters are respectively 1.44e-6 µM
, 0.0065 µM , and 0.0017 µM, while in the same state the concentrations
of these metabolites using estimated parameters (Table 20) are 4.8e-18 µM,
4.2e-06 µM , and 4.3e-06 µM, respectively, a dramatic difference.
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Sensitivity analysis
Figure 58 presents the result of sensitivity analysis for this point. The
sensitivity of Kd1 on NifLredADP and NifLredADPNifA is the same as
steady state point one and adding 2− oxoglutarate does not change the
sensitivity of Kd1 on NifLredADP and NifLredADPNifA. NifA(2OG) is not
so sensitive to perturbation of Kd1 . The effect of perturbation of Kd2 on
NifLredADP and NifLredADPNifA is the same as the last steady state point.
The interesting result is that the sensitivity of Kd2 on both NifLredADP
and NifA(2OG) is the same in this case. Kd3 shows a high sensitivity on
production of NifA(2OG), though perturbation of Kd3 does not produce
any effect on NifLredADP and NifLredADPNifA in this state. Decreasing of
Kd3 by 95
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Figure 58: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 2.
b.3 steady state point 3
In steady state point 3 the concentration of 2−oxoglutarate is 0.1 µM. Table
21 presents the result of parameter estimation for this steady state point.
Although the concentration of 2− oxoglutarate is 0.1 µM, the experimental
value which was used for NifA(2OG) in this state is 0. This point shows
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dramatic difference between estimated parameters and original ones as point
2. The same condition that of the last state does apply through this state.
Table 21: Estimated Parameters (Kd/µM) for steady state point 3.
Kd Estimation Experiment
Kd1 1.79 13
Kd2 5.27e-11 0.03
Kd3 9.52e+13 57
Sensitivity analysis
Figure 59 presents the result of sensitivity analysis for steady state point 3.
It is the same same as the last point.
b.4 steady state point 4
In steady state point 4 the concentration of 2− oxoglutarate is 0.5 µM. The
concentration of NifA(2OG) which was used for parameter estimation was
0.000118 µM.
Parameter Estimation
Table 22 presents the results of parameter estimation for this steady state
point. There is a huge difference in estimation for this state in compared to
last two. The estimated parameters, however, are very close to original ones.
Table 22: Estimated Parameters (Kd/µM) for steady state point 4.
Kd Estimation Experiment
Kd1 35.23 13
Kd2 0.024 0.03
Kd3 34.98 57
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Figure 59: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 3.
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Forward Modeling
Using the estimated parameters in steady state point 4 we performed for-
ward modeling for all steady state points. The Equilibrium program was
used for forward modeling of all points with the estimated parameters.
Figure 60 shows the in silico production of NifA(2OG) based on different
concentrations of 2− oxoglutarate in comparison to the experimental data.
NifA(2OG) simulation is in agreement with the experimental results as can
be seen in Figure 60.
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Figure 60: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 4. NifA(2OG) is compared
with the experimental data, and NifLredADP and NifLredADPNifA
are compared to the simulation with the original parameters
We further extended our in silico experiment to produce data for the pro-
duction of NifLredADP and NifLredADPNifA with estimated parameters.
Figure 60 presents the result of this analysis. We then compared the simula-
tion of NifLredADPNifA with the estimated parameters and experimental
parameters for all steady state points in the 2− oxoglutarate system. These
two simulations are qualitatively in agreement, which implies this that the es-
timation task was performed based on available data of NifA(2OG) but not
NifLredADP. We then carried out the same analysis for NifLredADPNifA.
In Figure 60 the comparison of computational simulations with experimen-
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tally verified and computationally estimated parameters is presented. This
shows agreement between these two simulations.
Steady-state analysis
Stability analysis of 2− oxoglutarate system in steady state point 4 shows
that this system in this state is asymptotically stable using estimated parame-
ters. Table 23 presents the concentration of metabolites of 2− oxoglutarate
system in this state.
Table 23: Concentration values (C/µM) in steady state conditions for steady state
point 4.
metabolite value
NifLred 0.00346268
ADP 49.9935
NifLredADP 0.00491276
NifA 0.00825744
NifLredADPNifA 0.00162456
2− oxoglutarate 0.499882
NifA2oxo 0.000117999
Sensitivity analysis
Figure 61 presents the result of the sensitivity analysis in steady state point
4. As it is shown, the sensitivity of Kd1 and Kd2 on model components
are the same as last points, though perturbation of Kd3 has less effect on
NifA(2OG).
b.5 steady state point 5
In steady state point 5 the concentration of 2− oxoglutarate is 1 µM and
the concentration of NifA(2OG) used for parameter estimation is 0. Table
24 presents the result of parameter estimation for this steady state point.
The estimation is similar to steady state points 2 and 3 while the amount
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Figure 61: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 4.
of NifA(2OG) is zero. There is a dramatic difference between estimated
parameters and original ones. The argument against using this point is
similar to points 2 and 3.
Table 24: Estimated Parameters (Kd/µM) for steady state point 5.
Kd Estimation Experiment
Kd1 0.44 13
Kd2 7.095e-11 0.03
Kd3 7.28e+13 57
Sensitivity analysis
Figure 62 presents the result of sensitivity analysis in steady state point
5. As can be seen the sensitivity of Kd1 and Kd2 on model components
are the same as last points, though perturbation of Kd3 has less effect on
NifA(2OG).
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Figure 62: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 5.
b.6 steady state point 6
In steady state point 6 the concentration of 2−oxoglutarate is 10 µM while
the concentration of NifA(2OG) which was used for parameter estimation
is 0.00029 µM .
Parameter Estimation
Table 25 presents the result of parameter estimation for this steady state
point. The estimated parameters are fairly close to original ones, though, not
as close as steady state points 1 and 4.
Table 25: Estimated Parameters (Kd/µM) for steady state point 6.
Kd Estimation Experiment
Kd1 6.71 13
Kd2 0.017 0.03
Kd3 240.23 57
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Forward Modeling
Figure 63 presents the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG). The estimated parameters in steady state point 6 are not as
close as estimated parameters in steady state point 1 and 4, consequently,
the simulations are not as good as mentioned steady state points.
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Figure 63: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 6. NifA(2OG) is compared
with the experimental data, and NifLredADP and NifLredADPNifA
are compared to the simulation with the original parameters.
Steady-state analysis
Stability analysis of 2− oxoglutarate system in steady state point 6 shows
that this system in this state is asymptotically stable using estimated parame-
ters. Table 26 presents the concentration of metabolites of 2− oxoglutarate
system in this state.
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Table 26: Concentration values (C/µM) in steady state conditions for steady state
point 6.
metabolite value
NifLred 0.00087
ADP 49.99
NifLredADP 0.0065
NifA 0.0071
NifLredADPNifA 0.0025
2− oxoglutarate 9.99
NifA2oxo 0.00029
Sensitivity analysis
Figure 64 presents the result of sensitivity analysis for steady state point 6.
Sensitivity of Kd1 remains the same as the last points. The sensitivity of Kd2
to NifA(2OG) and NifLredADP, shows the same behavior as before. But
sensitivity of Kd2 onNifLredADPNifA increases in comparison to last points.
As can be seen in Figure 64 the sensitivity of Kd3 onNifA(2OG) jumps down
from 1600 % change to 500 % change for a 95% decrease perturbation. Up to
this point there was no evidence for sensitivity of Kd3 on NifLredADP and
NifLredADPNifA, but from this steady state point NifLredADPNifA starts
to show sensitivity on perturbation of Kd3 .
b.7 steady state point 7
In steady state point 7 the concentration of 2− oxoglutarate is 25 µM and
the concentration of NifA(2OG) which was used for parameter estimation
was 0.0011 µM.
Parameter Estimation
Table 27 presents the result of parameter estimation for this steady state
point. The estimated parameters are close to original ones.
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Figure 64: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 6.
Table 27: Estimated Parameters (Kd/µM) for steady state point 7.
Kd Estimation Experiment
Kd1 16.15 13
Kd2 0.010 0.03
Kd3 134.42 57
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Forward Modeling
Figure 65 presents the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG). The estimated Kd3 for this point is closer than the estimated
one in steady state point 6 and the simulation is in better agreement with
experimental data for the case of NifA(2OG) and simulations with the
original parameters in the case of NifLredADP and NifLredADPNifA.
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Figure 65: This figure demonstrates the simulation of NifA(2OG), NifLredADP,
and NifLredADPNifAwith the estimated parameters of steady state
point 7. NifA(2OG) is compared with the experimental data, and
NifLredADP and NifLredADPNifA are compared to the simulation
with the original parameters.
Steady-state analysis
The stability analysis of 2 − oxoglutarate system in steady state point
7 shows that this system in this state is asymptotically stable using esti-
mated parameters. Table 28 presents the concentration of metabolites of
2− oxoglutarate system in this state.
190 investigation of the steady state points in the 2-oxoglutarate system
Table 28: Concentration values (C/µM) in steady state conditions for steady state
point 7.
metabolite value
NifLred 0.0017
ADP 49.99
NifLredADP 0.0053
NifA 0.0059
NifLredADPNifA 0.0029
2− oxoglutarate 24.99
NifA2oxo 0.0011
Sensitivity analysis
In Figure 66 the result of sensitivity analysis in steady state point 7 is
presented. Sensitivity of Kd1 remained the same as the last points. The
sensitivity of Kd2 on NifA(2OG) and NifLredADP, as always, shows the
same behavior. Sensitivity of Kd2 on NifLredADPNifA is raised in this
steady state point. Sensitivity of Kd3 decreases on NifA(2OG) and increases
on NifLredADPNifA.
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Figure 66: Sensitivity analysis of Kd1 , Kd2 , Kd3 in the steady state point 7.
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b.8 steady state point 8
In steady state point 8, the concentration of 2− oxoglutarate is 50 µM and
the concentration of NifA(2OG) which was used for parameter estimation
is 0.0040 µM .
Parameter Estimation
In the Table 29 the result of parameter estimation in this steady state point
is presented. The estimated parameters are very close to original ones.
Table 29: Estimated Parameters (Kd/µM) for steady state point 8.
Kd Estimation Experiment
Kd1 19.01 13
Kd2 0.017 0.03
Kd3 54.42 57
Forward Modeling
In the Figure 65, the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG) are presented. The set of estimated parameters in this steady
state point are in very agreement within the simulation and experimental
data for NifA(2OG) and in between simulations in NifLredADPNifA.
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Figure 67: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 8. NifA(2OG) is compared
with the experimental data, and NifLredADP and NifLredADPNifA
are compared to the simulation with the original parameters.
Steady-state analysis
The stability analysis of 2− oxoglutarate system in steady state point 8
indicates that in this state the system is asymptotically stable using the
estimated parameters. Table 30 presents the concentration of metabolites of
2− oxoglutarate system in this state.
Table 30: Concentration values (C/µM) in steady state conditions for steady state
point 8.
metabolite value
NifLred 0.0023
ADP 49.99
NifLredADP 0.0061
NifA 0.0044
NifLredADPNifA 0.0015
2− oxoglutarate 49.99
NifA2oxo 0.0040
Sensitivity analysis
In Figure 68 the result of the sensitivity analysis in steady state point 8.
The sensitivity of Kd1 remains the same as the last point. The sensitivity of
Kd2 on NifA(2OG) and NifLredADP shows the same behavior as always.
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The sensitivity of Kd2 on NifLredADPNifA is raised in this steady state
point. The sensitivity of Kd3 decreases on NifA(2OG) and increases on
NifLredADPNifA.
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Figure 68: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 8.
b.9 steady state point 9
In steady state point 9 the concentration of 2− oxoglutarate is 50 µM and
the concentration of NifA(2OG) which was used for parameter estimation
is 0.0054 µM .
Parameter Estimation
In the Table 31 the result of the parameter estimation in this steady state
point is presented. The estimated parameters are very close to original ones.
Forward Modeling
Figure 69 presents the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG). The simulations are in agreement with the experimental data in
NifA(2OG) and also simulation with the original parameters inNifLredADPNifA.
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Table 31: Estimated Parameters (Kd/µM) for steady state point 9.
Kd Estimation Experiment
Kd1 19.85 13
Kd2 0.03 0.03
Kd3 67.57 57
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Figure 69: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 9.
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Steady-state analysis
The stability analysis of 2 − oxoglutarate system in steady state point
9 shows that this system in this state is asymptotically stable using the
estimated parameters. Table 32 presents the concentration of metabolites of
2− oxoglutarate system in this state.
Table 32: Concentration values (C/µM) in steady state conditions for steady state
point 9.
metabolite value
NifLred 0.0056
ADP 49.99
NifLredADP 0.0041
NifA 0.0016
NifLredADPNifA 0.00022
2− oxoglutarate 99.99
NifA2oxo 0.0081
Sensitivity analysis
Figure 70 presents the result of sensitivity analysis in steady state point 9.
The behavior of sensitivity is similar to the last point. NifLredADPNifA is
very sensitive to Kd2 . In contrast to the last steady state points in which
Kd3 was more sensitive to NifA(2OG) than NifLredADPNifA, Kd3 is more
sensitive to NifLredADPNifA in comparison to NifA(2OG).
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Figure 70: Sensitivity analysis of Kd1 , Kd2 , Kd3 in the steady state point 9.
b.10 steady state point 10
In steady state point 10 the concentration of 2−oxoglutarate is 100 µM and
the concentration of NifA(2OG) which was used for parameter estimation
is 0.0069 µM.
Parameter Estimation
In Table 33 the result of parameter estimation in this steady state point is
presented. The estimated parameters are close to original ones.
Table 33: Estimated Parameters (Kd/µM) for steady state point 10.
Kd Estimation Experiment
Kd1 14.69 13
Kd2 0.027 0.03
Kd3 51.6 57
Forward Modeling
Figure 71 presents the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG). The simulations are in agreement with the experimental data in
NifA(2OG) and simulation with the original parameters inNifLredADPNifA.
It also shows closer simulations in NifLredADP.
B.10 steady state point 10 197
 0
 0.001
 0.002
 0.003
 0.004
 0.005
 0.006
 0.007
 0.008
 0.009
 0.01
 0  500  1000  1500  2000
[N
if
A
2
o
x
o
] 
in
 µ
M
[oxo] in µM
Experiment
Simulation
 0.0062
 0.0064
 0.0066
 0.0068
 0.007
 0.0072
 0.0074
 0.0076
 0.0078
 0.008
 0  500  1000  1500  2000
[N
if
L
re
d
A
D
P
] 
in
 µ
M
[oxo] in µM
Experiment
Simulation
 0
 0.0002
 0.0004
 0.0006
 0.0008
 0.001
 0.0012
 0.0014
 0.0016
 0.0018
 0.002
 0  500  1000  1500  2000
[N
if
L
re
d
A
D
P
N
if
A
] 
in
 µ
M
[oxo] in µM
Experiment
Simulation
Figure 71: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 10. NifA(2OG) is compared
with the experimental data, andNifLredADP andNifLredADPNifA are
compared to the simulation with the original parameters.
Table 34: Concentration values (C/µM) in steady state conditions for steady state
point 10.
metabolite value
NifLred 0.0021
ADP 49.99
NifLredADP 0.0072
NifA 0.0024
NifLredADPNifA 0.00062
2− oxoglutarate 149.99
NifA2oxo 0.0069
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Steady-state analysis
The stability analysis of 2 − oxoglutarate system in steady state point
10 shows that in this state the system is asymptotically stable the using
estimated parameters. Table 34 presents the concentration of metabolites of
2− oxoglutarate system in this state.
Sensitivity analysis
Figure 72 presents the result of the sensitivity analysis in steady state point
10. The behavior of sensitivity is similar to that of the last point.
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Figure 72: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 10.
b.11 steady state point 11
In steady state point 11 the concentration of 2−oxoglutarate is 200 µM and
the concentration of NifA2oxo which was used for parameter estimation is
0.0067 µM.
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Parameter Estimation
Table 35 presents the result of the parameter estimation in this steady state
point. The estimated parameters are close to original ones.
Table 35: Estimated Parameters (Kd/µM) for steady state point 11.
Kd Estimation Experiment
Kd1 14.04 13
Kd2 0.033 0.03
Kd3 77.49 57
Forward Modeling
In Figure 73 the simulation ofNifLredADPNifA,NifLredADP, andNifA(2OG)
are presented. The estimated parameters in this steady state point are the
best simulations amongst all the steady state points we checked.
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Figure 73: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 11. NifA(2OG) is compared
with the experimental data, andNifLredADP andNifLredADPNifA are
compared to the simulation with the original parameters.
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Steady-state analysis
The stability analysis of 2 − oxoglutarate system in steady state point
11 shows that at the corresponding state this system is asymptotically
stable using estimated parameters. Table 36 presents the concentration of
metabolites of 2− oxoglutarate system in this state.
Table 36: Concentration values (C/µM) in the steady state conditions for steady
state point 11.
metabolite value
NifLred 0.002
ADP 49.99
NifLredADP 0.007
NifA 0.0026
NifLredADPNifA 0.00057
2− oxoglutarate 199.99
NifA2oxo 0.00678
Sensitivity analysis
Figure 74 presents the result of the sensitivity analysis in steady state point
11. The behavior of sensitivity is similar to last point. The sensitivity of
NifA(2OG) to perturbation of Kd3 is low for this steady state point.
b.12 steady state point 12
In steady state point 12 the concentration of 2− oxoglutarate is 400 µM
and the concentration of NifA(2OG) which was used for the parameter
estimation is 0.0082 µM.
Parameter Estimation
Table 37 presents the result of parameter estimation in this steady state point.
The estimated parameters are close to original ones.
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Figure 74: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 11.
Table 37: Estimated Parameters (Kd/µM) for steady state point 12.
Kd Estimation Experiment
Kd1 9.38 13
Kd2 0.045 0.03
Kd3 69.9 57
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Forward Modeling
Figure 75 presents the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG) for this steady state point. The simulations are in agreement
with the data.
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Figure 75: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 12. NifA(2OG) is compared
with the experimental data, andNifLredADP andNifLredADPNifA are
compared to the simulation with the original parameters.
Steady-state analysis
The stability analysis of 2 − oxoglutarate system in steady state point
12 shows that at the corresponding state this system is asymptotically
stable using estimated parameters. Table 38 presents the concentration of
metabolites of 2− oxoglutarate system in this state.
Sensitivity analysis
Figure 76 presents the result of the sensitivity analysis in steady state point
12. The behavior of sensitivity change of parameters is similar to that of the
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Table 38: Concentration values (C/µM) in steady state conditions for steady state
point 12.
metabolite value
NifLred 0.0015
ADP 49.99
NifLredADP 0.0082
NifA 0.0014
NifLredADPNifA 0.00025
2− oxoglutarate 399.99
NifA2oxo 0.0082
last point and the sensitivity of NifA(2OG) to perturbation of Kd3 is very
low.
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Figure 76: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 12.
b.13 steady state point 13
In steady state point 13 the concentration of 2− oxoglutarate is 1000 µM
and the concentration of NifA(2OG) which was used for the parameter
estimation is 0.0092 µM.
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Parameter Estimation
Table 39 presents the result of parameter estimation in this steady state point.
The estimated parameters are close to original ones.
Table 39: Estimated Parameters (Kd/µM) for steady state point 13.
Kd Estimation Experiment
Kd1 18.45 13
Kd2 0.034 0.03
Kd3 62.96 57
Forward Modeling
In the Figure 77 the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG) for this steady state point are presented. The simulations are in
agreement with the data.
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Figure 77: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 13. NifA(2OG) is compared
with the experimental data, andNifLredADP andNifLredADPNifA are
compared to the simulation with the original parameters.
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Steady-state analysis
The stability analysis of 2 − oxoglutarate system in steady state point
13 shows that at the corresponding state this system is asymptotically
stable using estimated parameters. Table 40 presents the concentration of
metabolites of 2− oxoglutarate system in this state.
Table 40: Concentration values (C/µM) in the steady state conditions for steady
state point 13.
metabolite value
NifLred 0.0026
ADP 49.99
NifLredADP 0.0072
NifA 0.00058
NifLredADPNifA 0.00012
2− oxoglutarate 999.91
NifA2oxo 0.0092
Sensitivity analysis
Figure 78 presents the result of the sensitivity analysis in steady state point
13. The sensitivity behavior is similar to that of the last point. There is a
slight change in the sensitivity of Kd1 since the sensitivity Kd1 on both of
NifLredADP and NifLredADPNifA are exactly the same for this state. The
sensitivity of Kd2 on NifLredADPNifA is considerably increased. In this
state, there is no evidence for sensitivity of Kd3 on NifA(2OG) while there
is a high sensitivity of Kd3 on NifLredADPNifA.
b.14 steady state point 14
In steady state point 14 the concentration of 2− oxoglutarate is 2000 µM
and the concentration of NifA(2OG) which was used for the parameter
estimation is 0.0092 µM.
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Figure 78: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 13.
Parameter Estimation
Table 41 presents the result of parameter estimation in this steady state point.
The estimated parameters are close to the original ones.
Table 41: Estimated Parameters (Kd/µM) for steady state point 14.
Kd Estimation Experiment
Kd1 18.08 13
Kd2 0.019 0.03
Kd3 115.64 57
Forward Modeling
Figure 79 presents the simulation of NifLredADPNifA, NifLredADP, and
NifA(2OG) in this steady state point. The simulations are in agreement with
the data.
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Figure 79: Simulations of NifLredADPNifA, NifLredADP, and NifA(2OG) using
estimated parameters from steady state poin 14. NifA(2OG) is compared
with the experimental data, andNifLredADP andNifLredADPNifA are
compared to the simulation with the original parameters.
Steady-state analysis
The stability analysis of 2− oxoglutarate system in steady state point 14
shows that at the corresponding state this system is asymptotically stable
using the estimated parameters. Table 42 presents the concentration of
metabolites of 2− oxoglutarate system in this state.
Table 42: Concentration values (C/µM) in the steady state conditions for steady
state point 14.
metabolite value
NifLred 0.0026
ADP 49.99
NifLredADP 0.0071
NifA 0.0005
NifLredADPNifA 0.00019
2− oxoglutarate 1999.9
NifA2oxo 0.0092
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Sensitivity analysis
Figure 80 presents the results of the sensitivity analysis in steady state point
14. The result is similar to the last point.
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Figure 80: Sensitivity analysis of Kd1 , Kd2 , Kd3 in steady state point 14.
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Table 43
Reaction Forward rate constant Backward Dissociation constant
A.1 5× 107 M−1s−1 15 s−1 10 µM
A.2 NA NA NA
A.3 NA NA 13− 25 µM
A.4 4.5× 105 M−1s−1 0.02 s−1 0.1− 0.23 µM
A.5 NA NA 57 µM
A.6 NA NA NA
A.7 NA NA NA
A.8 NA NA NA
A.9 NA NA NA
A.10 NA NA NA
A.11 NA NA NA
A.12 NA NA NA
A.13 NA NA NA
A.14 NA NA NA
A.15 NA NA NA
A.16 NA NA NA
A.17 NA NA NA
A.18 NA NA NA
A.19 NA NA NA
A.20 NA NA NA
A.21 NA NA NA
A.22 NA NA NA
A.23 NA NA NA
A.24 NA NA NA
A.25 NA NA NA
A.26 NA NA NA
A.27 NA NA NA
A.28 NA NA NA
A.29 NA NA NA
A.30 NA NA NA
A.31 NA NA NA
A.32 NA NA NA
A.33 NA NA NA
A.34 NA NA NA
A.35 NA NA NA
A.36 NA NA NA
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